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Thesis abstract 
White matter (WM) deterioration is increasingly being recognised as a 
hallmark of Huntington disease (HD) and is correlated to disease severity. 
Environmental experience has also been shown to alter white matter 
structure and function, and microbiota-gut-brain bidirectional communication 
has been implicated in the regulation of oligodendrocyte differentiation and 
myelination. This suggests that environmental and microbiota manipulations 
can be used as assays to interrogate white matter plasticity in HD. This could 
provide new insights into the mechanisms and role of white matter changes 
in HD pathogenesis, and inform discovery of novel biomarkers and 
therapeutic approaches in the disorder. 
This thesis describes three studies that address this question directly. In the 
first study, we examined the effects of environmental enrichment on white 
matter characteristics and behaviour in the YAC128 mouse model of HD and 
wild-type (WT) controls. This was followed by a second study in which the 
same outcomes were examined in response to environmental deprivation 
through social isolation in identical mouse genotypes. Finally, we examined 
the effect of microbiota on white matter in BACHD mouse models of HD and 
WT controls, housed under germ-free (GF) and specific pathogen free (SPF) 
conditions. White matter plasticity was examined using a range of techniques 
including transmission electron microscopy, immunohistochemistry, and 
immunoblotting, and behaviour and motor function evaluated using a battery 
of targeted tests.   
Our findings provide evidence that environmental and microbiota 
manipulation has differential and complex effects on white matter in WT and 
HD mice, including alterations in axonal diameter, myelin thickness, as well 
as oligodendrocytes cell populations. The work described herein therefore 
offers new insights into white matter plasticity and abnormalities in HD and 
lays the foundation for future studies. 
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1.1. Huntington Disease 
Huntington disease (HD) is a fatal autosomal-dominant neurodegenerative 
disorder that affects approximately 5-10 in 100,000 individuals, and is 
particularly prominent amongst those of Caucasian European descent  
(Fisher & Hayden, 2014; Morrison, 2012; Wexler et al., 2016). HD was first 
characterised by George Huntington in the late 19th century (Huntington, 
1872), and it is now well established to be associated with a triad of 
clinical features such as progressive motor, cognitive, and psychiatric, 
decline. Disease onset is inferred from the manifestation of perceptible 
motor signs, such as chorea, dystonia and bradykinesia, and occurs on 
average at 40 years of age, with death normally following within 15-20 
years (Ross & Tabrizi, 2011). The period prior to a formal diagnosis of 
manifest HD is normally referred to as the pre-manifest, or pre-
symptomatic, period, although these terms may be somewhat of a 
misnomer, given that neuropathological changes, particularly in the 
striatum, and cognitive and psychiatric disturbances, may precede motor 
onset by several years (Cha et al., 1998; Gutekunst et al., 1999; Hobbs et 
al., 2010; Marder et al., 2000; Tabrizi et al., 2013). HD is caused by the 
expansion of the cytosine-adenine-guanine (CAG) triplet repeat in the 
huntingtin (HTT) gene, located on the short arm of chromosome 4, that 
encodes the 350kDa huntingtin (HTT) protein with a polyglutamine (polyQ) 
stretch located at the N-terminus (Macdonald, 1993). HD is associated 
with CAG repeats greater than 36, with HTT CAG repeat length being 
inversely correlated to age of motor onset (Andrew et al., 1993; Duyao et 
al., 1993; Snell et al., 1993).This relationship accounts for approximately 
50-70% of the observed variance in clinical onset, with greater onset 
variance associated with lower CAG repeats, potentially due to a greater 
influence of genetic and environmental modifiers, and lower variance with 
larger repeat sizes greater than 44 (Langbehn et al., 2004). A parametric 
survival model predicts that a 40-year old individual with 42 CAG repeats 
has a 91% chance to present with motor symptoms by the age of 65 (i.e 
the disease is essentially fully penetrant), whilst that with 36 repeats has a 
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14% chance of onset before the age of 75 (Langbehn et al., 2004). 
Importantly, many patients possessing CAG repeats less than 41 may not 
present with clinical symptoms during their lifetime (i.e. the disease is 
partially penetrant) (Langbehn et al., 2004). 
The HTT protein is composed of approximately 50 recurring amino-acids, 
known as HEAT (Huntingtin, Elongation factor 3 (EF3), protein 
phosphatase 2A (PP2A), yeast kinase TOR1) repeats, that form a 
superhelical structure with a hydrophobic core (Andrade & Bork, 1995;  Li 
et al., 2006). HTT is predominantly cytoplasmic, normally palmitoylated at 
cysteine 218 (Yanai et al., 2006), and is expressed in cells throughout the 
human body, although more preponderantly in the brain and testes 
(DiFiglia et al., 1995). HTT appears to be important for early embryonic 
development (Ross & Tabrizi, 2011) and is thought to play a key role in 
neurogenesis (Nguyen et al., 2013). It is considered to be a scaffolding 
protein that can coordinate complexes of other proteins.  
While the pathogenesis of HD is still poorly understood, it is well 
established that the presence of a polyQ expansion forms an abnormal 
conformation of mutant HTT (mHTT) and confers a so-called gain in toxic 
function (Poirier, Jiang, & Ross, 2005; Ross & Tabrizi, 2011). Mutant HTT 
is also more susceptible to proteolysis, relative to the wild-type HTT 
protein, and its truncation is known to promote generation and aggregation 
of N-terminal fragments (Lunkes & Mandel, 1998; Walker, 2007; 
Wellington, Leavitt, & Hayden, 2000). These fragments may be generated 
via a variety of proteases such as caspase-3 and 6 (Wellington et al., 
2002), calpains (Kim et al., 2001) and matrix metalloproteinase-10 (Miller 
& Bezprozvanny, 2010), and/or abnormal splicing of HTT (Sathasivam et 
al., 2013). Accumulation and aggregation of N-terminal fragments in 
neuronal nuclei has been shown to be promoted by phosphorylation of the 
N-terminal S16 in HTT (Havel et al., 2011). Furthermore, polyQ expansion 
in HTT is associated with reduced palmitoylation, which promotes the 
formation of intra-nuclear inclusion bodies (i.e. large abnormal HTT 
aggregates (Yanai et al., 2006). Intra-cellular mutant HTT aggregates, a 
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pathological signature of HD, are not only confined to cell nuclei, but have 
also been observed in dendrites, axonal terminals, in addition to the 
cytoplasm (DiFiglia, 1997; Gutekunst et al., 1999; Ross & Tabrizi, 2011). 
However, whether mutant HTT aggregation, in of itself, promotes 
cytotoxicity, or provides neuroprotection, or is simply an epiphenomenon, 
remains a topic of intense debate (Hackam et al., 1998; Bjørkøy et al., 
2005). Moreover, the effect of cellular location of these inclusions has only 
recently been revealed, suggesting that nuclear inclusions are well 
tolerated, but cytoplasmic peri-nuclear inclusions are correlated with cell 
death ( Liu et al., 2014).  
1.1.1. Neurodegeneration and pathogenic mechanisms in 
HD  
HD is associated with profound and selective loss of striatal cells, 
particularly GABAergic medium spiny neurons (MSNs), which project to 
the globus pallidus (GP) and substantia nigra (SN). Of these, enkephalin-
containing MSNs that project to the external area of the GP (GPe) appear 
to be particularly susceptible to degeneration compared to substance P-
containing MSNs that project to the internal area of the GP (GPi); in turn, 
the latter neurons projecting to the pars reticulata portion of the SN (SNr) 
are more vulnerable than those which project to the compacta portion of 
the SN (SNc) (Reiner et al., 1988; Sapp et al., 1995). Interestingly, large 
interneurons are spared from degeneration. These neuropathological 
changes are consistent with the observation of chorea in the early stages 
of HD due to dysregulation of basal ganglia-thalamocortical circuitry. Other 
areas that undergo atrophy in HD include the cerebral cortex, thalamus, 
hypothalamic lateral tuberal nuclei, and notably, sub-cortical white matter, 
and can be even more widespread in cases of juvenile HD onset (Ross & 
Tabrizi, 2011).  
Mutant HTT disrupts normal (i.e. wild-type HTT regulated) vesicle 
transport and recycling (Caviston & Holzbaur, 2009), partly through 
interaction with Huntingtin-Associated Protein 1 (Hap1), leading to 
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inhibition of cortical trafficking/release of pro-survival brain derived 
neurotrophic factor (BDNF), and thus diminished neurotrophic support for 
striatal cells (Gauthier et al., 2004). Mutant HTT also disrupts fast axonal 
transport of organelles (Gunawardena et al., 2003; Szebenyi et al., 2003), 
and can reduce mitochondrial trafficking to synapses, affecting production 
of ATP (Orr et al., 2008; Shirendeb et al., 2011). Furthermore, mutant HTT 
also disrupts the mitochondrial protein import complex TIM23, to impair 
transport of proteins into mitochondria, leading to mitochondrial 
dysfunction and neuronal cell death (Yano et al., 2014). 
Mutant HTT may also impair the autophagy-lysosome and ubiquitin-
proteasome systems (UPS) that form two of the major pathways of 
degradation of intracellular proteins. Specifically, mutant HTT was found to 
diminish the ability of autophagic vacuoles to recognise cytosystolic cargo, 
thus compromising autophagic clearance (Martinez-Vicente et al., 2010). 
In turn, dysfunctional proteasome activity, possibly due to sequestration of 
UPS components into inclusion bodies, was also reported by early studies 
(Bence, 2001; Bennett et al., 2005). However, other work did not report a 
dysfunctional UPS in HD (Maynard et al., 2009), although this was later 
reconciled by UPS impairment being found to be restricted to a time-
window preceding the presentation of inclusion bodies (Mitra, Tsvetkov, & 
Finkbeiner, 2009). Dysregulation of these protein degradation pathways 
may therefore lead to impaired clearance and toxic intra-cellular protein 
accumulation. 
Another aspect believed to play a key role in HD pathogenesis pertains to 
the effect of mutant HTT on gene transcription. Microarray studies have 
demonstrated that several genes exhibit altered expression patterns in HD 
(Hodges, 2006; Luthi-Carter, 2000; Sipione et al., 2002). Mutant HTT has 
been shown to interact with a number of regulators of transcription, 
including cyclic adenosine monophosphate (cAMP) response element 
binding (CREB) protein, and CREB-binding protein (CBP) ( Nucifora, 
2001; Steffan et al., 2001), associated with cell proliferation and survival, 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
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(PGC-1α) (Cui et al., 2006), associated with energy metabolism, and 
others such as Sp1 transcription factor (Dunah et al., 2002) and basal 
transcription factors (Ross & Tabrizi, 2011). Importantly, decreased 
transcription of brain derived neurotrophic factor (BDNF) in HD may 
underpin the increased relative susceptibility of the striatum to 
neurodegeneration (Zuccato & Cattaneo, 2009).  
Since MSNs are innervated by glutamatergic axons, a long-standing 
hypothesis is that over-stimulation of glutamate, particularly N-methyl-D-
aspartate (NMDA), receptors may lead to excitotoxicity and death in these 
cells (Coyle & Schwarcz, 1976; Flint Beal, 1994; Zeron et al., 2002). 
Changes in NMDA receptor subunits early in HD (Ali & Levine, 2006); 
(Benn et al., 2007), as well as impaired trafficking of NMDAR due to 
mutant HTT (Fan et al., 2007), may thus selectively predispose MSNs to 
excitotoxicity. Alternatively, glutamate clearance by glia may also be 
diminished in the presence of mutant HTT, that could also result in 
excitotoxicity (Shin et al., 2005).  
1.1.2. The role of glial cells in HD pathogenesis 
Little is known about the role of glia, comprising of astrocytes, microglia 
and oligodendrocytes, on HD pathogenesis. However, reactive gliosis has 
been observed in a number of HD animal models as well as patients 
(Reddy et al., 1998). Expression of mutant HTT in astrocytes was 
correlated to disease severity, reduced the expression of the glutamate 
transporters, GLT-1 and GLAST, in HD mouse models and patients, thus 
decreasing glutamate uptake, and suggesting this mechanism could play 
a key role in HD neurodegeneration through promotion of excitotoxicity 
(Bradford et al., 2009; Faideau et al., 2010; Shin et al., 2005). A recent 
study has highlighted the likely causal role for glia in HD, by demonstrating 
striatal transplantation of normal glia in transgenic HD mice slowed patho-
progression and increased survival (Benraiss et al., 2016). Expression of 
mutant HTT in astrocytes was also seen to suppress release of BDNF, 
vital for cell proliferation and survival (Hong et al., 2016; Wang et al., 
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2012). Kir4.1 K+ ion channel expression was found to be decreased in a 
HD mouse model, and associated with increased MSN excitability; viral 
delivery of Kir4.1 channels to striatal astrocytes subsequently diminished 
MSN dysfunction, decreased motor deficits, and increased survival (Tong 
et al., 2014). In addition, neuroinflammation may also play a key role in 
HD neuro-degeneration, since microglia have been demonstrated to be 
robustly activated in pre-symptomatic and early stages of HD (Sapp et al., 
2001; Tai et al., 2007), in a manner correlated to disease severity, and 
leading to increased release of pro-inflammatory cytokines and 
chemokines (Björkqvist et al., 2008; Wild et al., 2011). Furthermore, 
expression of mutant HTT in microglia was shown to facilitate pro-
inflammatory transcriptional activation, and that such microglia were more 
predisposed to inducing neurodegeneration (Crotti et al., 2014).  
Lastly, recent studies have begun to elucidate the effect of mutant HTT on 
oligodendrocytes, and the roles of such glia on HD pathogenesis; this 
forms a central theme to this thesis, and is described in detail in the 
following sections.  
1.1.3. Current treatment for HD 
HD is a single-gene disease and as such is an ideal model to study 
neurodegenerative diseases as a whole, and test for possible therapeutic 
interventions that can slow or suppress disease onset. However, despite 
this, and numerous clinical trials, there are currently no disease-modifying 
drugs available to stop or reverse HD. Therapeutic strategies are limited to 
ameliorating motor, behavioural and psychiatric symptoms only, for which 
there are only two FDA-approved pharmacological agents available. 
These consist of tetrabenazine, also licensed in the UK, and its deuterium 
altered milder cousin deutetrabenazine, to treat chorea, a common 
symptom in HD. Neuroleptics, also, may be beneficial in patients that have 
concurrent psychosis, and selective serotonin reuptake inhibitors (SSRIs) 
may help to manage depression and suicidal ideation - symptoms that can 
be compounded by identical side-effects of tetrabenazine. Furthermore, as 
described earlier, not all the variability in onset and progression of HD can 
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be explained by CAG repeat length and much of this variability may be 
underpinned by environmental factors. This suggests that disease onset, 
progression, and symptomatology, can be modulated, to some extent, by 
lifestyle factors and multi-disciplinary interventions. Accordingly, this 
possibility forms another central theme to this thesis. 
1.1.4. Mouse models of HD 
Much of the knowledge we have on the pathogenesis of HD has derived 
from the use of model systems, the most common of which being that of 
the mouse. Mouse models of HD are generated using knock-in or 
transgenic approaches (see Table 1.1 for a summary of common mouse 
models of HD).  
Knock-in mouse models probably recapitulate the genetic insult more 
faithfully than transgenic models, have normal life-span, and display a 
relatively slow and mild behavioural and neurodegenerative phenotype. 
Full-length mutant HTT knock-in mouse models, which include the 
CAG140, HdhQ111 and HdhQ150 lines, have been largely generated 
through knock-in of a CAG tract-expanded HTT exon 1 into the 
endogenous Htt gene locus, with CAG repeat sizes ranging 5-200, and 
can be homozygous or heterozygous for the mutation (Pouladi, Morton, & 
Hayden, 2013a). 
Another class of genetic mouse models includes transgenic lines, which 
express N-terminal fragments of human HTT and include the R6/2 (the 
first transgenic mouse of HD), R6/1 and N171-Q82 lines. These mice are 
associated with a fast disease onset, motor, cognitive and behavioural 
deficits, and loss of body weight and reduced life-span. The N171-82Q 
shows motor deficits from 11 weeks of age, while in the R6/1 model 
behavioural deficits appear around 6-8 weeks of age and in the juvenile 
R6/2 HD model, deficits were seen as early as 3.5 weeks (Lione et al., 
1999). 
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Finally, and of direct relevance to this thesis, transgenic models have 
been created that express the full-length mutant HTT using yeast artificial 
chromosome (YAC) (Hodgson et al., 1999) and bacterial artificial 
chromosome (BAC) (Gray et al., 2008) technology. BACHD and YAC128 
models express the entire human HTT locus with 125 and 97 CAG 
repeats, respectively (Hodgson et al., 2008; Gray et al., 2008). These 
models are well known to display progressive motor, cognitive and 
psychiatric abnormalities, increases in body weight, as well as relatively 
late-onset selective striatal atrophy. 
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Table 1.1 Commonly used mouse models of HD  
 
Model 
 
Transgene 
Product 
 
Promoter 
 
CAG 
Length 
 
Behavioural 
Phenotype 
 
Neuropathology 
Phenotype 
 
Full length knock-in models 
CAG140 Full-length 
chimeric 
human HTT 
exon 
1:mouse Htt 
Endogenous 
mouse Htt 
promoter 
140 Hyperactivity 
at 4 weeks 
then hypo- 
activity by 12 
weeks. Gait 
deficits by 48 
weeks. Body 
weight loss. 
Neuronal loss. 
Intra-nuclear 
inclusions and 
neuropil 
aggregates by 8 
months. 
HdhQ111 As above As above 111 Gait deficits 
by 24 months. 
Nuclear inclusions 
at 48 weeks, 
neuropil 
aggregates at 68 
weeks. 
Astrogliosis by 96 
weeks.  
HdhQ150 As above As above 150 & 200 
Gait and 
locomotor 
deficits, 
clasping, 
between 4-10 
months 
Intra-nuclear 
aggregates, 
gliosis, axonal 
dysfunction at 14 
months. 
Hdh4/Q72 
& 
Hdh4/Q80 
As above As above 72 & 80 Aggressive 
behaviour. 
Impaired 
rotarod 
performance 
Aggregates by 28 
weeks with 
nuclear inclusions 
by 96 weeks 
zQ175 As above As above 188 Hypo-activity 
at 8 weeks 
and impaired 
rotarod 
performance 
at 30 weeks 
Decreased cortico-
striatal volume, 
and neuronal 
density at 4 
months. 
Truncated N-terminal fragment models 
R6/1 
67 amino 
acids of N-
terminal 
fragment 
(human 
HTT) 
Human HTT 
promoter 
116 Body weight 
loss at 22 
weeks. Motor 
deficits at 4-5 
months 
Neuronal atrophy 
and loss. 
Aggregates at 2 
months. 
Decreased brain 
volume by 18 
weeks. 
R6/2 As above As above 144-150 Rotarod 
impairments 
by 5 weeks. 
Dystonia with 
clasping by 6 
Gross brain 
atrophy by 60 
days with neuronal 
loss and 
astrogliosis by 90 
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weeks. Body 
weight loss by 
9 weeks.  
days. Aggregates 
from day 1 
N171-Q82 171 amino 
acids of N-
terminal 
fragment 
(human 
HTT cDNA) 
Mouse Prp 
promoter 
82 Motor deficits 
and clasping 
at 11 weeks. 
Body weight 
loss. 
Gross brain 
atrophy with 
striatal neuron 
loss. Aggregates 
at 16 weeks 
Full length transgenic models 
YAC128 Full-length 
human HTT 
Human HTT 
promoter 
and 
regulatory 
elements 
128 Motor 
performance 
abnormalities 
at 3 months 
and rotarod 
impairment by 
6 months. 
Increase in 
body weight 
at 2 months.  
Striatal and 
cortical neuron 
loss and 
decreased cortical 
and striatal volume 
by 12 months. 
Macroaggregates 
at 12 months.  
YAC72 As above As above 77 Hyperactivity 
at 7 months. 
Body weight 
loss. 
Selective striatal 
neurodegeneration 
at 12 months. 
BACHD As above As above 97 Rotarod 
impairment at 
8 weeks. 
Gain in body 
weight. 
Decreased cortico-
striatal volume and 
gross brain 
atrophy at 12 
months. Cortical 
inclusions 12-18 
months.  
Prp, prion protein; HTT, huntington. 
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1.2. Oligodendroglial populations dynamics and adaptive 
myelination  
1.2.1. Overview of glial cells in the central nervous system 
Four major types of glial cells populate the central nervous system (CNS): 
astrocytes, microglia, oligodendrocytes, and oligodendrocytes precursor cells 
(OPCs) or neuron-glia 2 (NG2) cells. Historically, glial cells were viewed as 
forming the glue or connective tissue of the brain. However, more recent 
work has demonstrated each type of glial cell to be highly specialized and 
plays supportive roles in the function and plasticity of the CNS, including 
response to injury, homeostatic function and trophic support, as well as 
modulation of signal propagation along axons (Domingues et al., 2016; 
Zuchero & Barres, 2015). Astrocytes have critical roles in supporting the 
blood-brain barrier, contributing to neuronal survival and synapse 
maintenance (Barres, 2008; Graeber, Li, & Rodriguez, 2011). Microglia, in 
turn, are the principal resident immune cells of the brain, and are involved in 
defense against pathogens and clearance of dead cells (Chan, Kohsaka, & 
Rezaie, 2007). NG2 cells are oligodendrocyte precursor cells (OPCs), and 
generate myelinating oligodendrocytes in the post-natal brain, and participate 
in maintaining CNS homeostasis and tissue repair (Hughes et al., 2013; 
Nishiyama et al., 2016; Raff, Miller, & Noble, 1983). Critical roles for 
oligodendrocytes include myelination (Tomassy, Dershowitz, & Arlotta, 
2016), trophic (Bankston, Mandler, & Feng, 2013), and metabolic, support for 
axons (Fünfschilling et al., 2012; Lee et al., 2012), and modulation of 
neuroplasticity (Bechler, Swire, & Ffrench-Constant, 2017; Osso & Chan, 
2017).  
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1.2.2. Oligodendroglial lineage – from OPCs to mature 
myelinating oligodendrocytes 
Oligodendrocytes precursor cells (OPCs) 
OPCs, also known as polydendrocytes, or as neuron-glia 2 (NG2) cells, are 
bipolar, highly proliferative cells that have the ability to migrate and 
differentiate into oligodendrocytes (Nishiyama et al., 2009; Nishiyama et al., 
2016). Adult OPCs remain in a constant and slow proliferative state (Clarke 
et al., 2012; Hughes et al., 2013; Kang et al., 2010) and generate 
oligodendrocytes continuously throughout life (Yeung et al., 2014). This 
process takes place at a much slower rate in adulthood relative to 
development (Dimou et al., 2008; Rivers et al., 2008). However, it is still 
unclear whether all OPCs cells differentiate into oligodendrocytes, or whether 
a proportion of these lose their capacity to do so with age (Nishiyama et al., 
2016). OPCs are homogenously distributed throughout the brain, in both 
gray and white matter regions, such as the corpus callosum, the cerebellum, 
the cortex and the optic nerve (Clarke et al., 2012; Hughes et al., 2013;  
Levine, Stincone, & Lee, 1993; Shi, Marinovich, & Barres, 1998). The 
capacity for OPCs to generate oligodendrocytes in the adult brain is greater 
and faster in white, compared to gray, matter, where they also exhibit faster 
differentiation and high proliferation rate, as well as a faster cell cycle (Dimou 
et al., 2008; Hill et al., 2013; Rivers et al., 2008; Viganò & Dimou, 2016; 
Viganò et al., 2013; Yeung et al., 2014; Young et al., 2013; Zhu et al., 2011). 
These regional differences in OPC proliferation and differentiation could 
therefore explain the observed variation in myelination in the adult brain 
(Osso & Chan, 2017). 
Oligodendrocytes development 
Cell-intrinsic, extrinsic, and environmental, factors regulate oligodendrocyte 
differentiation from OPCs (reviewed in Mitew et al. (2014) and Viganò et al. 
(2013)). When cells become committed to oligodendroglial lineage, the 
transcription factor Olig2 (oligodendrocyte lineage transcription factor 2) is 
expressed (Lu et al., 2002; Novitch, Chen, & Jessell, 2001). This is followed 
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by the onset of Sox10 (SRY (sex determining region Y)-box 10) expression, 
a transcription factor that precedes PDGFRα (platelet-derived growth factor 
receptor A) and NG2 expression (Noble et al., 1988; Stolt et al., 2002; Stolt, 
2004; Takada, Kucenas, & Appel, 2010). Sox10 is expressed throughout all 
developmental stages (Küspert et al., 2011), whereas Olig2 was shown to be 
downregulated with oligodendrocyte maturation (Ligon et al., 2006). Olig2 is 
established to have an important role in differentiation, but its potential role in 
modulating myelination in the long-term remains unclear (Mei et al., 2013; 
Mitew et al., 2014). Myelin Regulatory Factor (Myrf) is a recently discovered 
membrane-associated transcription factor, which is not only critical for 
mediating oligodendrocytes differentiation, mature oligodendrocyte identity, 
and promotion of new oligodendrocytes in adulthood, but also for myelin 
generation, and myelin related gene maintenance (Bujalka et al., 2013; 
Emery et al., 2009; Koenning et al., 2012; Liu & Zhou, 2013; McKenzie et al., 
2014). Other transcription factors required for oligodendrocyte differentiation 
(reviewed by Mitew et al., (2014)) are Olig1 (Xin et al., 2005), Nkx2.2 (Qi et 
al., 2001), Zfp191 (Howng et al., 2010)) and Ascl1/Mash1 (Nakatani et al., 
2013; Parras et al., 2007; Sugimori et al., 2008).  
Extracellular cues such as chemotactic proteins, growth factors, nuclear 
receptor ligands, and intracellular signaling, are also required for OPC 
differentiation into oligodendrocytes (Nave & Werner, 2014; Valny et al., 
2017). Other mechanisms revealed to regulate different stages of 
oligodendrocyte differentiation and maturation include chromatin remodeling 
and histone modification (Copray et al., 2009; Marin-Husstege et al., 2002; 
Shen, Li, & Casaccia-Bonnefil, 2005), DNA methylation (Coelho et al., 2009), 
and post-translational-modifications through regulation of microRNAs 
(Svaren, 2014).  
Oligodendroglial lineage markers 
Several immunohistochemical markers are used for identification of each 
stage of oligodendroglial development. OPCs express high levels of 
gangliosides, which bind to PDGFRα (Pringle & Richardson, 1993) and 
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proteoglycan NG2 (Levine et al., 1993; Nishiyama et al., 1996), whereas 
these markers are not expressed in neural stem cells. As OPCs mature and 
undergo differentiation they can be detected by the oligodendrocyte antigen 
O4 and O1 (Sommer & Schachner, 1981), and cease to express NG2 and 
PDGFRα. As they begin to differentiate into premyelinating, or immature, 
oligodendrocytes, 2’,3’-cyclic-nucleotide 3’-phosphodiesterase (CNP) and the 
myelin lipid galactocerebroside are amenable to detection (Pfeiffer, 
Warrington, & Bansal, 1993; Zhang & Jiao, 2015). Premyelinating 
oligodendrocytes further mature into myelinating oligodendrocytes that 
express Glutathione S-transferase (GST-pi), and myelin membrane proteins, 
such as myelin basic protein (MBP), proteolopid protein (PLP), myelin-
oligodendrocyte glycoprotein (MOG), and myelin-associated glycoprotein 
(MAG) (Nishiyama et al. (2009); Figure 1.1) 
 
 
 
Figure 1.1 Development stages of oligodendrocytes 
Adapted from Nishiyama et al. (2009), Nature Reviews Neuroscience  
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Multiple roles of oligodendrocytes 
Newly developed fate-mapping techniques investigate proliferation and 
differentiation of oligodendrocytes from OPCs using transgenic mice 
expressing inducible Cre, under the regulation of OPC or oligodendrocyte 
specific genes, including Ng2, Pdgfrα, Plp, Cnp, Myrf (Clarke et al., 2012; 
Kang et al., 2010; Rivers et al., 2008; Young et al., 2013; Zhu et al., 2011). 
Recent studies from the Richardson lab have provided evidence that 
production of new myelinating oligodendrocytes and active myelination is 
required during adulthood for skill learning (McKenzie et al., 2014; Xiao et al., 
2016). Other work has recently revealed that oligodendrocytes also provide 
crucial trophic support through the production of brain derived neurotrophic 
factor (BDNF), glial-derived neurotrophic factor (GDNF), insulin-like growth 
factor (IGF-1), nerve growth factor (NGF) and neutrotrophin-3 (NT-3) (Dai et 
al., 2003; Nave, 2010; Wilkins et al., 2003). Finally, oligodendrocytes also 
provide metabolic support via the lactate monocarboxylate transporter 1 
(MCT1) which maintains axonal mitochondrial energy metabolism 
(Fünfschilling et al., 2012; Lee et al., 2012; Saab, Tzvetanova, & Nave, 
2013). 
1.2.3. Myelin and adaptive myelination 
Structure of myelin  
Approximately 70-85% of myelin membrane by dry-weight is composed of 
lipids, while the remaining 15-30% being protein. Lipid composition is not 
myelin specific, and consists of a high content of cholesterol, galactolipids, 
and other lipids, such as glycosphingolipids, and plasmalogens (Chrast et al., 
2011). The compact myelin proteins MBP and PLP are among the most 
abundant specific myelin related proteins (Boggs, 2006). MBP is localized on 
the intracellular surface of the membrane, and is critical for myelin formation, 
compaction and stability (Min et al., 2009). PLP, in turn, is a more 
preponderant transmembrane protein, and is involved in consolidating 
adjacent myelin layers during the myelin wrapping process (Klugmann et al., 
1997), as well as the enrichment of cholesterol in myelin (Werner et al., 
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2013). The uncompacted myelin proteins, MOG, MAG, and CNP account for 
most of the remaining proteins. In the myelin membrane, MAG is located in 
the periaxonal layer, while MOG is present on the external surface; however, 
both proteins are also expressed in oligodendrocytes (Pham-Dinh et al., 
1993). MOG is believed to play a key role in modulating stability of 
microtubules (Johns & Bernard, 1999), while MAG is crucially involved in 
myelinated axon maintenance (Yin et al., 1998). Myelin lipids are critical for 
regulating conduction along axons, whereas proteins have important roles in 
production and maintenance of myelin itself, as well as mediating axon-glial 
interaction (Simons & Nave, 2015).  
Transcription factors of myelination 
In terms of transcription factors required for myelination, OLIG1 was shown 
to be critical for the initial myelination onset, since Olig1 knock out (KO) mice 
were capable of generating highly branched CNP+O4+ oligodendrocytes (Li 
et al., 2007; Xin et al., 2005). SOX10 is also critical for myelination as it acts 
at the MBP promoter (Li et al., 2007; Stolt et al., 2002) similarly to OLIG1, 
and interacts directly with Myrf (Hornig et al., 2013). MYRF drives immature, 
premyelinating oligodendrocytes to a maturation and myelination stage 
(Emery et al., 2009), whereas absence of Myrf leads to loss of myelin genes, 
and subsequent demyelination (Koenning et al., 2012). Additional 
transcription factors for myelin gene expression and myelination include the 
zinc finger proteins, ZFP488 (Soundarapandian et al., 2011) and ZFP191 
(Howng et al., 2010), although their mechanisms of action have not yet been 
elucidated (Mitew et al., 2014). 
Axonal cues to myelin formation and OPCs differentiation 
Myelin thickness, and length between each myelin segment (i.e. internode), 
varies markedly within a single axon, and across axons (Micheva et al., 
2016; Tomassy et al., 2014). Axonal diameter (i.e. caliber), which also varies 
greatly across axons in the CNS, has been identified as a key property 
influencing myelin sheath length, thickness and internode length 
characteristics (Butt, Ibrahim, & Berry, 1998; Hildebrand et al., 1993; Almeida 
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et al., 2011), all of which play a crucial role is shaping the conduction velocity 
of each axon (Rushton, 1951). This variability in myelin organization 
suggests there to be an inherently wide range of axonal conduction velocities 
in the CNS, which may be important to the timing and regulation of neuronal 
networks (Bechler et al., 2017; de Hoz & Simons, 2014).  
Oligodendrocytes have been shown, using microfiber cultures, to have an 
intrinsic program for generation of myelination, where newly generated 
myelin sheaths exhibited similar properties to myelin sheaths present in the 
brain. These properties included increased sheath length with increased 
axonal fiber diameter, generation of compact and multilamellar membranes 
of similar lengths to those observed in vivo, and, notably, a minimal axonal 
diameter threshold of 300nm for myelination to be initiated (Bechler, Byrne, & 
Ffrench-Constant, 2015; Lee et al., 2012; Rosenberg et al., 2008). 
Additionally, Pten knock-out (KO) from cerebellar granule cells, and thus 
ablation of PTEN signaling inhibition, led to altered gene expression in-vivo, 
and an increase in diameter size of axons previously under this myelination 
threshold, resulting in these axons being myelinated (Goebbels et al., 2017). 
Increased proliferation and differentiation of OPCs was also observed, 
suggesting newly differentiated oligodendrocytes may have contributed to 
this myelination (Goebbels et al., 2017). Taken together, these studies 
suggest a minimal axonal diameter required for oligodendrocytes to sense 
and initiate myelination, but fall short of explaining why many axons in the 
CNS with supra-threshold diameters for myelination remain unmyelinated 
(Almeida et al., 2011). This could be partly due to a cell-type specific 
dependency in myelination-related characteristics, with recent work in the 
mouse showing parvalbumin-expressing cells to be the only GABAergic 
interneuron population to be myelinated in the cortex (Micheva et al., 2016). 
Interestingly, differential cell-type specific myelination could represent a 
trade-off between space and energy demands with signal transduction 
benefits of myelination (Harris & Attwell, 2012; Osso & Chan, 2017). 
OPCs and oligodendrocytes can also be receptive of axonal cues and 
promote selection of that axon through differentiation and myelination, 
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respectively (Osso & Chan, 2017). OPCs express a number of 
neurotransmitter receptors, including glutamate and GABA receptors, and 
receive synaptic input from neurons (Larson, Zhang, & Bergles, 2016; 
Maldonado & Angulo, 2015). In turn, increased neuronal activity promotes 
OPC proliferation and oligodendrocytes differentiation (Gibson et al., 2014), 
and modulates myelin sheath characteristics (Hines et al., 2015; Gautier et 
al., 2015; Gibson et al., 2014; Wake et al., 2015). Furthermore, 
oligodendrocytes processes that enwrap non-active axons are more likely to 
retract their processes compared to those enveloping highly active axons 
(Hines et al., 2015).  
Adaptive and plastic myelination 
Elegant studies have demonstrated that myelination is a highly adaptive and 
plastic process, and undergoes substantial remodeling throughout life as a 
result of combination between intrinsic and extrinsic factors (Bechler et al., 
2017; Bercury & Macklin, 2015; Snaidero & Simons, 2014). Most of the 
evidence available to support adaptive myelination is from studies 
investigating myelination during brain development (Wake, Lee, & Fields, 
2011; Hines et al., 2015; Mensch et al., 2015). In humans, intra-cortical 
myelination persists until the third decade of life, and is stable until the fifth 
decade of life, after which it begins to decline (Grydeland et al., 2013). 
Contrastingly, in mice, most of the myelination process takes place during 
the first two postnatal months, although it also occurs later in life (Young et 
al., 2013). A newly proposed property of adult myelination in the CNS is that 
myelin synthesized in adulthood is associated with thinner sheaths relative to 
axon diameter and shorter internodes, compared to myelin synthesized in 
adolescence (Young et al., 2013). However, others have suggested that this 
observation may be more simply explained by the protracted and on-going 
process of myelin production (Karttunen et al., 2017).  
An interesting model for CNS myelination proposed by (Bechler et al., 2017) 
suggests that initiation of myelin is enacted by an oligodendrocyte intrinsic 
program, while later adaptations and alterations are driven by environmental 
cues and neuronal activity. In keeping with this, optogenetic activation of 
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neurons has been shown to promote increased myelination (Gibson et al., 
2014). Furthermore, neuronal signaling related factors such as matrix 
receptors of the integrin family, Neuregulin-1 (NRG1), or NMDA glutamate 
receptors in the myelin sheath, all contribute to myelination and its 
maintenance, and, while these may not be required for its initiation, they may 
serve important roles in adaptive myelination (Brinkmann et al., 2008; 
Câmara et al., 2009; Saab et al., 2013); also discussed in (Bechler et al., 
2017). Neuronal NRG1 is a member of the NRG superfamily of epidermal 
growth factor-like ligands and it binds to the cell surface ErbB receptor on 
oligodendrocytes (Taveggia et al., 2007). Conditional KO mice lacking 
neuronal NRG1 were not associated with differences in myelination 
formation, but overexpression of neuronal NRG1 led to thicker myelination, 
particularly in small diameter axons that are not usually myelinated 
(Brinkmann et al., 2008; Taveggia et al., 2007). Interestingly, reduced 
expression of NRG1 during social isolation in juvenile mice was shown to 
result in hypomyelination and thinner myelin sheaths in axons of the PFC 
(Makinodan et al., 2012). These findings suggest that while NRG1 signaling 
may not be required for establishing myelination in CNS, it likely plays an 
important role in behavioural-dependent myelination. 
Interestingly, several new findings suggest a small window of time for newly 
differentiated oligodendrocytes to myelinate, such as ~5 hours in the 
zebrafish, and ~12 hours in rodent-derived myelinating cultured cells 
(Watkins et al., 2008; Czopka, Ffrench-Constant, & Lyons, 2013). A window 
of myelination was also described in relation to the capacity of myelin to 
respond to environmental manipulation and behavioural experience, with 
more flexibility during adolescence, but not young adulthood, in rodents 
(Makinodan et al., 2012). Others, however, have demonstrated myelin 
alterations in adulthood with longer periods of environmental manipulation 
(Liu et al., 2012). Further effects of environmental manipulation on 
myelination are described in greater detail in the following sections. 
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1.2.4. Imaging tools for myelin characterisation 
Myelination can be visualized and characterised through high-resolution 
imaging of ultra-thin sections of brain tissue using electron microscopy (EM). 
Properties such as myelinated and unmyelinated axonal population 
distribution, myelin thickness, and ultrastructure, can be obtained using EM. 
Myelin thickness can be quantified and compared using the g-ratio measure, 
which is calculated as the inner axonal diameter divided by the outer 
diameter (axonal diameter plus myelin lamellae; Friede & Miyagishi, 1972). 
Accordingly, smaller g-ratios are associated with thicker myelin sheaths and 
the g-ratio of unmyelinated axons is equal to unity. The optimal g-ratio for the 
rat CNS has been suggested to be around 0.77 (Chomiak & Hu, 2009), 
although values can vary in the literature.  
Imaging white matter microstructure in humans is achieved using diffusion-
weighed imaging (DWI) and diffusion-tensor imaging (DTI) magnetic 
resonance imaging (MRI) (Bihan et al., 1986). These imaging techniques rely 
on fractional anisotropy (FA) to infer axonal fiber density, axonal diameter 
and myelination. Several studies have reported myelination plasticity by 
observing increased FA values, associated with an increase in axonal 
diameter and myelin thickness, as a result of skill training (Scholz et al., 
2009). 
1.2.5. White matter of the CNS – with focus on the corpus 
callosum (CC) and prefrontal cortex (PFC) 
The white matter of the CNS consists of myelinated and unmyelinated axons, 
and glial cells. Axons are most abundant, followed by oligodendrocytes, 
astrocytes, OPCs, and microglia (Walhovd, Johansen-Berg, & Káradóttir, 
2014). Myelination in white matter tracts is not homogenous and not all 
axons are myelinated (Dangata, Findlater, & Kaufman, 1996; Sturrock, 1980; 
Young et al., 2013). Furthermore, as described previously, many axons are 
known to possess non-uniform myelin distributions along their length, termed 
‘intermittent myelination’ (Micheva et al., 2016; Tomassy et al., 2014). 
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Human white matter volume increases during childhood, adolescence, and 
into adulthood (Westlye et al., 2010). 
Myelinated tracts ensheathe the axons of the cortex, and the inter- and intra-
hemispheric connecting fibres of the corpus callosum (CC), internal and 
external capsule, the cingulum, and the anterior commissure (Zatorre, Fields, 
& Johansen-Berg, 2012). The CC is the largest white-matter structure of the 
brain, and it facilitates inter-hemispheric communication, playing a critical 
role in the relay of cognitive, motor and sensory information between cortical 
regions. Callosal fibers arise from cortical pyramidal neurons and are 
topographically structured as they project through the CC (Innocenti, 1994). 
The human CC is segmented into five regions based on functional and 
anatomical connectivity: the lamina rostralis, the genu, the body, the isthmus, 
and the splenium, from frontal to caudal (Hofer & Frahm, 2006; Raybaud, 
2010). In rodents, however, different regions of the CC are typically classified 
according to three main areas, the genu, mid-body and splenium. The genu 
and the body of the CC transfer information from the prefrontal cortex, the 
premotor, primary motor and supplemental motor cortex, whereas the 
splenium integrates connections from posterior parietal cortex, and the 
temporal and occipital lobes (Raybaud, 2010). Interestingly, despite the CC 
being one of the most highly myelinated structures in the brain, it also 
contains a high proportion of unmyelinated axons following the 
developmental peak in myelination (Sturrock, 1980; Young et al., 2013). 
Some of these unmyelinated axons become myelinated in adulthood, 
possibly leaving room for plasticity required for skill learning (Fields, 2008; 
Zatorre et al., 2012). Indeed, of the total number of oligodendrocytes in the 
CC of 8 month old mice, about 30% are generated after 7 weeks of age 
(Rivers et al., 2008; Zhu et al., 2011).  
In addition, the PFC is also highly enriched in myelinated fibres, and 
myelinates late into adulthood in both humans and animals (Fuster, 1996; 
McKenzie et al., 2014; Miller et al., 2012). The PFC has been linked to higher 
cognitive functions, such as planning, executive tasks and working memory, 
and plays a key role in personality expression and social behaviour 
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(McEwen, 2013; Miller & Cohen, 200); Yang et al., 2009; Yuan & Raz, 2014). 
Interestingly, the rate of OPCs differentiation into oligodendrocytes is faster 
in the cortex than other white matter regions, such as the spinal cord and 
optic nerve (Young et al., 2013), highlighting the potential importance of 
myelination in this brain region. Particularly during development, myelination 
in the PFC is more plastic and sensitive than other regions, to experience, 
environmental and social factors (Hoban et al., 2016a; Liu et al., 2012; 
Makinodan et al., 2012; Tomlinson, Leiton, & Colognato, 2016a). 
1.2.6. White matter abnormalities in Huntington disease  
Oligodendrocytes and myelin are vital for axonal function and survival, while 
dysfunction of this population, along with defects in myelination, may play 
important roles in the development and severity of neurodegenerative 
diseases (NDDs) such as HD (Ettle, Schlachetzki, & Winkler, 2016; Huang et 
al., 2015a; Liu & Zhou, 2013).  
Accompanying the well-studied neuronal degeneration in the basal ganglia, 
white matter (WM) atrophy and myelination defects have been identified as 
an early feature of the HD phenotype in both patients and animal models 
(Bartzokis et al., 2007; Ciarmiello et al., 2006; Fennema-Notestine et al., 
2004; Novak et al., 2014; Rosas et al., 2003; Tabrizi et al., 2009; Xiang et al., 
2011). Progressive reduction in WM volume and alterations in WM tracts 
have been reported by longitudinal studies in pre-symptomatic HD gene 
carriers (Tabrizi et al., 2009; Tabrizi et al., 2013; Shaffer et al., 2017), and 
indicate loss of connectivity between cortical and sub-cortical regions, which 
may underpin early clinical symptoms. White matter alterations were found in 
the corpus callosum (CC) and prefrontal cortex (PFC) of pre-symptomatic 
and symptomatic HD gene carriers (Bourbon-Teles et al., 2017; Matsui et al., 
2013; Matsui et al., 2015; Rosas et al., 2006). Furthermore, striatal cell death 
follows a dorsal-to-ventral progression in HD (Hedreen, 2003; Vonsattel, 
2007), and, similarly, altered diffusivity in WM of the dorsal PFC-striatal 
pathway was observed in a pre-symptomatic HD group (Matsui et al., 2015). 
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HD animal models recapitulate WM related alterations in humans. Our group 
has explored the molecular and ultrastructural features of WM abnormalities 
in HD mouse and rat models (Garcia-Miralles et al., 2016; Teo et al., 2016). 
Using diffusor tensor imaging (DTI) imaging, WM microstructural 
abnormalities were revealed prior to neuronal loss in the CC of the YAC128 
mouse model and the BACHD rat model (Teo et al., 2016). In addition, 
thinner myelin sheaths and lower levels of myelin related gene transcripts 
were seen in these animals compared to healthy animals (Teo et al., 2016). 
Others have also reported microstructural abnormalities in the R6/2 and 
HdhQ250 mouse model, and reduction in myelin sheaths thickness, as well 
as decreased expression of myelin related genes in the BACHD and 
HdhQ250 mouse models (Jin et al., 2015; Xiang et al., 2011).  
While HTT expression in glial cells has long been recognised (Hebb, 
Denovan-Wright, & Robertson, 1999), more recent studies have observed 
mutant HTT aggregates in glial cells, including astrocytes, in addition to 
neuronal cells (Faideau et al., 2010; Shin et al., 2005). Myrf knock-out in 
adult mice, and selective expression of mutant HTT in oligodendrocytes of 
transgenic mice, led to similar oligodendroglia related impairments, such as 
demyelination, reduction in myelin gene expression, along with progressive 
motor impairments, seizures, metabolic impairments and reduced survival 
(Koenning et al., 2012; Huang et al., 2015a). Furthermore, mutant HTT was 
found to be spatially restricted to oligodendrocyte-rich brain regions such as 
the CC (Huang et al., 2015a). 
 
1.3. Environmental manipulation 
Through molecular, cellular, structural and functional alterations, the plastic 
brain responds to cognitive, sensory, physical or social stimulation, in 
interaction with the enriched or deprived environment (Galani et al., 2007; 
Keiner et al., 2017; Okuda et al., 2009; Qiu et al., 2012; Segovia et al., 2008; 
Viola et al., 2009). Environmental manipulation by either enrichment or 
deprivation was shown to be involved in modulation of myelination and 
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oligodendroglia population and precursor cells (Komitova et al. 2006; Liu et 
al., 2012; Liu et al., 2016; Magalon et al., 2007; McKenzie et al., 2014; 
Tomlinson, Leiton, & Colognato, 2016a; Wang & Young, 2014). 
1.3.1. What is a standard housing condition in rodents 
Laboratory animals, with particular reference to rodents, are generally kept in 
what is referred to as ‘standard housing’ conditions. Standard housing can 
vary between laboratories, and are often poorly described in literature. In 
general, standard cages are one level, relatively small (~ 30cm x 20cm x 
15cm), and usually include sparse bedding material, and in some cases 
small plastic shelter boxes, with free access to water and food pellets 
(Nithianantharajah & Hannan, 2006). These conditions restrict rodents from 
natural exploratory behaviours, and could have detrimental effects and 
interfere with treatment effects, especially when a neurodegenerative 
disease model is investigated. Mice housed in cages containing wheels run 
between 4-10km per day (Ransome & Hannan, 2013), illustrating the 
potential impact of a simple running wheel were it to be added to a standard 
cage. Animals in standard housing are usually held in groups of two to five 
per cage, but can on some occasions find themselves as the last and single 
animal in the cage during experimental studies. This leads to other issues, 
such as social isolation, which have been shown to be detrimental to normal 
development and behaviour (Liu et al., 2012; Makinodan et al., 2012; 
Makinodan et al., 2016; Potter et al., 2010). As a result, housing of animals in 
‘standard’ cages was previously suggested to be equivalent to ‘deprived’ 
housing, whereas the ‘enriched’ housing is closer to natural environments 
(Mo, Renoir, & Hannan, 2015b). However, others argue that standard 
housing can be considered a form of mild enrichment, since it can promote 
exercise, play and social interactions (Crofton, Zhang, & Green, 2015). 
1.3.2. How to create an enriched environment for laboratory 
rodents 
Enrichment in animal studies has been defined by several components such 
as: (1) larger than standard housing conditions, often built on several levels; 
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(2) enhanced housing conditions, by introduction of objects of different 
shapes, and materials; (3) appropriate sheltering and complex bedding 
material; (4) increased social housing; and (5) exercise stimulating objects 
such as running wheels, platforms or stairs (Olsson & Dahlborn, 2002; 
Nithianantharajah & Hannan, 2006; Singhal et al., 2014). Additionally, 
cognitive or physical training were also included in some study designs 
(Keiner et al., 2017; Pang et al., 2008; Van Dellen et al., 2008). Unless 
investigating aging or late progressive neurodegeneration, most rodents 
have been allocated to enriched housing immediately post-weaning, and 
were maintained in such from 1 day to several months, depending on the 
interest of the researcher. Benefits were shown to usually be augmented with 
more complex EE interventions, such as those that combine sensory, 
cognitive, physical and social stimulation, and eliminate stress (Hannan, 
2014; Mo, Hannan, & Renoir, 2015a; Mo, Renoir, & Hannan, 2015b). The 
strength of such effects are also dependent on the duration of the enrichment 
paradigm, the animal’s age at intervention onset, the genetic background, 
and the sex of the animals (Hannan, 2014; Leger et al., 2015; Pang & 
Hannan, 2012; Singhal et al., 2014; Tomlinson, Leiton, & Colognato, 2016a). 
Enrichment protocols vary greatly between laboratories, and there is no 
standardised paradigm used. Thus, the enrichment components described 
above used either individually, or combination, and to different complexities, 
have sometimes yielded inconsistent or conflicting results. 
1.3.3. Beneficial effects of enrichment in rodents 
Long-lasting effects of animals weaned in enriched environments, as well as 
enrichment of middle-aged, old or diseased animals, were shown to have 
beneficial effects on behavioural performance by multiple studies 
(Nithianantharajah & Hannan, 2006). Early studies pioneering environmental 
manipulation research demonstrated the susceptibility of the adult brain to 
enrichment or deprivation. Rats allocated to enriched housing had greater 
cognitive abilities, thicker cortical layers and a more complex dendritic 
arborisation compared to isolated rats (Diamond, Krech, & Rosenzweig, 
1964; Renner & Rosenzweig, 1987). Another early study showed that spatial 
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memory was enhanced concomitantly with increased neurogenesis in the 
dentate gyrus of the hippocamus as an effect of enrichment (Kempermann, 
Kuhn, & Gage, 1997), an effect subsequently confirmed by later studies 
(Doulames et al., 2015; Lazic et al., 2006; Novkovic, Mittmann, & Manahan-
Vaughan, 2015; Okuda et al., 2009). A more recent study demonstrated that 
young rats held in enriched cages for 10 weeks post-weaning showed long-
lasting improvements in several behavioural tests, indicating better stress-
coping strategies, increased motor activity and improved information 
processing and vigilance (Mosaferi et al., 2015). Performance of middle-aged 
rats was improved in the Morris Water Maze Task after 4 months of enriched 
housing (Zhao et al., 2011). In addition, EE was used as rehabilitation 
therapy following brain injury in rodents, and was demonstrated to positively 
influence motor, cognitive and psychiatric recovery. For example, enriched 
rats following experimental stroke exhibited improved functional recovery 
(Komitova et al., 2006), attenuated cognitive deficits (Hicks et al., 2007), and 
reversed learning impairment (Dahlqvist et al., 2004), compared to standard 
housing animals. Both enriched housing and reaching training improved 
sensorimotor capabilities in the impaired forelimb of rats with induced stroke 
(Keiner et al., 2008). Furthermore, enhanced performance in learning and 
memory tasks was observed in enriched middle-aged and aged rats (Zhao et 
al., 2012), and Alzheimer Disease (AD) mouse models (Arendash et al., 
2004; Herring et al., 2010; Jankowsky et al., 2005; Mirochnic et al., 2009; 
Valero et al., 2011). Motor function recovery also improved in enriched 
mouse models of Parkinson Disease (PD) (Faherty et al., 2005; Jadavji, 
Kolb, & Metz, 2006; Tajiri et al., 2010; Tillerson et al., 2003). Exploratory 
behaviour improved in young and old PD mice after 3 weeks of exposure to 
EE (Goldberg, Haack, & Meshul, 2010). Therefore, enrichment effects have 
been explored as a possible preventive, non-drug based therapy, or in other 
cases, as an ameliorative therapy during disease progression. 
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1.3.4. Enrichment effects on myelin plasticity and 
oligodendroglial population dynamics in humans and 
rodents 
There is evidence to suggest that the majority of axons in the cortex and 
corpus callosum remain unmyelinated into adulthood, indicating that such 
axons can be myelinated during later stages in life (Sturrock, 1980; Tomassy 
et al., 2014; Waly et al., 2014). The plastic properties of myelination, and its 
sensitivity to behavioural and environmental experience, have been 
observed in humans through use of magnetic resonance imaging (MRI). For 
example, DTI MRI revealed microstructural white matter (WM) changes 
following balance training in both healthy young adults (Taubert et al., 2011), 
and young adults with traumatic brain injury (Drijkoningen et al., 2015). Other 
imaging studies demonstrated plasticity of myelination through increased 
fractional anisotropy (FA) as a result of juggling (Scholz et al., 2009), abacus 
training (Hu et al., 2011), extensive piano practice (Bengtsson et al., 2005; 
Han et al., 2009), long-life musical training (Schmithorst & Wilke, 2002), 
working memory training (Takeuchi et al., 2010), reasoning training (Mackey, 
2012), and meditation training (Tang et al., 2012). However, to be noted, that 
decreased FA has been observed in balancing skills training (Taubert et al., 
2011).  
Recent work using animal models has revealed promising effects of 
behavioural experience, enriched housing and voluntary exercising on 
adaptive myelination and oligodendroglial population dynamics in several 
regions of the brain (Tomlinson, Leiton, & Colognato, 2016a). 
Oligodendrocyte precursor cells (OPCs), such as NG2-positive cells, were 
also shown to respond to environmental manipulation. In a recent study, 
(Keiner et al., 2017) assigned 10-12 weeks old male rats to 3 experimental 
conditions (standard housing, enriched housing, and standard housing with 
daily skilled reaching training of the dominant forelimb) for either 10 or 42 
days. Injections of the proliferation marker, BrdU, were given to all animals 
from days 2-6 of the experimental condition. Interestingly, young rats 
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exhibited a shift in the distribution of oligodendroglial population in 
sensorimotor cortex, but not in the CC, between short- and long-term 
enrichment. Compared to standard housing, short-term enriched rats showed 
differentiation of OPCs into mature oligodendrocytes; however, after long-
term enrichment, OPCs and mature GST-pi positive oligodendrocyte 
populations appeared comparable to the standard housing condition. 
Additionally, the number of myelinating CNP-positive cells increased in the 
motor cortex after short-, as well as, long-term enrichment (Keiner et al., 
2017). These findings suggest regional differences in myelin and 
oligodendroglial population exposed to enrichment. Effects of enrichment 
have also been observed in older rats. Four months of enrichment of middle-
aged and old-aged male and female rats led to increased axon volume, 
myelin sheath volume and the length of myelinated fibres, although no 
changes were observed in mean axonal diameter or myelin sheath thickness 
in white matter tracts (Yang et al., 2013). The authors ascribed the increase 
in myelinated fibres as a result of enrichment to ongoing remyelination (Yang 
et al., 2013). Consistently, no differences were observed after 1-2 months of 
enrichment in the numbers of myelinated axons of the CC in 4 months old 
rats (Markham et al., 2009). A 10% increase in the splenium of the CC was 
observed after enrichment, but this was attributed to increase in the number 
of astrocytes branching rather than thicker myelin sheaths (Markham et al., 
2009). Increased total corpus callosum (CC) volume, increased myelinated 
fibre and myelin sheath volume, as well as increased total length of 
myelinated fibres, were observed specifically in the CC of enriched aged rats 
(Zhao et al., 2012). Oligodendroglial population related changes were also 
observed in middle-aged enriched rats, such as an increased number of 
myelinating CNP-positive oligodendrocytes in the CC (Zhao et al., 2011). 
The same period of enrichment in middle-aged rats was also shown to 
increase the total volume of myelinated fibres in sub-cortical, grey matter 
areas, such as the hippocampus, which was significantly correlated with 
improvements in spatial learning (Qiu et al., 2012). 
In contrast, few studies have provided support for oligodendrogenesis in 
many cortical regions, or the amygdala, although evidence for increased 
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numbers of OPCs have been reported (Ehninger & Kempermann, 2003; 
Ehninger et al., 2011; Makinodan et al., 2012). In adult mice enriched for 40 
days, increased number of proliferative OPCs, but no differences in 
CNPase+ labelled cells (i.e. myelinating oligodendrocytes), were observed in 
the amygdala compared to control mice (Ehninger et al., 2011). Similarly, no 
changes in oligodendrocyte density or morphology, nor myelin transcript 
levels, were found in the prefrontal cortex (PFC) of juvenile male mice which 
expressed green fluorescent protein (GFP) under the proteolipid protein 
promoter (PLP) and were enriched for 1.5 months (Makinodan et al., 2012). 
Besides the effects observed under physiological conditions, EE was also 
demonstrated to drive post-insult oligodendroglial differentiation (Keiner et 
al., 2008; Klaissle et al., 2012; Komitova et al., 2006; Simon, Götz, & Dimou, 
2011; Steiner et al., 2006). For example, following induction of local cortical 
infarcts, rats placed for ten days in EE showed a small transient increase in 
immature oligodendrocytes proliferation; however, no differences were 
observed in MBP positive cells within the perilesional region (Keiner et al., 
2008). 
1.3.5. Enrichment effects in HD animal models 
Environmental enrichment was first demonstrated to have a positive 
influence in delaying motor symptoms in a genetic mouse model of HD (van 
Dellen et al., 2000). Enrichment for 18 weeks in post-weaning R6/1 mice 
increased novel object exploration, delayed motor coordination impairments, 
suppressed seizures, and increased striatal and cortical volume by 22 weeks 
of age, compared to R6/1 mice allocated to standard housing (van Dellen et 
al., 2000). Since this pioneering study, physiological and cognitive 
improvements as a result of environmental enrichment have been also 
demonstrated in several others HD mouse models, including the R6/2 and 
N171-82Q lines (Hockly et al., 2002; Schilling et al., 2004; Wood et al., 
2010). For example, R6/1 mice were associated with ameliorated motor 
symptoms and rescue of decreased body weight, specific brain-derived 
neurotrophic factors (BDNF) in the striatum and hippocampus, and the 
dopamine signaling cortical regulator, DARP-32, after four months of 
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enrichment (Spires, 2004). The same period of enrichment also showed 
improved levels of the presynaptic marker synaptophysin, in frontal cortex 
and hippocampus, and elevated levels of the postsynaptic glutamatergic 
signaling protein density 95 (PSD-95) in the hippocampus of the R6/1 mouse 
(Nithianantharajah et al., 2008). Longer life expectancy, along with improved 
hippocampal neurogenesis and longer neurites in newly born neurons, were 
observed in the 25 weeks-old enriched R6/1 group compared to control 
(Lazic et al., 2006). Behavioural and cognitive enrichment-driven 
improvements in the R6/1 HD model also included reduced spatial memory 
deficits and delayed cognitive deficits (Nithianantharajah et al., 2008), and 
amelioration of depressive- (Du et al., 2012a) and emotion- related 
phenotypes (Renoir et al., 2012). Although complex enrichment provides 
enhanced benefits, minimal improvements in housing conditions have also 
been shown to have some positive effects in other models. Indeed, addition 
of nesting materials and tunneling areas (Hockly et al., 2002), and improving 
access to food (Carter, Hunt, & Morton, 2000), has also been demonstrated 
to be beneficial for juvenile R6/2 mice models of HD.  
Interestingly, negative outcomes of enrichment have also been reported in a 
handful of studies. Post-symptomatic 8-week-old R6/2 male mice exposed to 
a playground overnight, while spending daytime hours in standard cages, 
had a lower rate of survival than control animals (Skillings, Wood, & Morton, 
2014; Wood, Glynn, & Morton, 2011). This could be related to the 
accelerated HD mouse model employed in these studies. On the other hand, 
the stress caused by daily transfer from home to playground may also be a 
potential confound, a point acknowledged by both the authors and others 
(Mo, Renoir, & Hannan, 2015b). 
1.3.6. Enrichment inspired therapies in HD patients 
Although animal studies have shown positive and exciting results in terms of 
the beneficial effect of enrichment and exercise, it is important to note that 
these animal models do not fully recapitulate the human disease phenotype. 
In addition, humans already live in what can be considered an ‘enriched 
environment’, making the extrapolation and translation from cage to the clinic 
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a difficult task. Nevertheless, multi-disciplinary long-term interventions have 
highlighted the positive returns of rehabilitation and occupational therapies in 
neurodegenerative disease (Quinn et al., 2017; Reetz, Werner, & Schiefer, 
2015). Several studies have now demonstrated that combining active 
lifestyle, including physical, social and cognitive stimulation factors could 
protect against dementia and Alzheimer Disease (Baker et al., 2010a; Baker 
et al., 2010b; Fratiglioni, Paillard-Borg, & Winblad, 2004). Furthermore, both 
short- and long-term multidisciplinary rehabilitation may benefit patients 
suffering of multiple sclerosis (Asano & Finlayson, 2014; Khan et al., 1996; 
Khan, Amatya, & Turner-Stokes, 2011), Parkinson Disease (Frazzitta et al., 
2015; van der Marck & Bloem, 2014; van der Marck et al., 2013), and 
Huntington Disease (Cruickshank et al., 2015; Piira et al., 2013; Thompson 
et al., 2013; Zinzi et al., 2007).  
To date, reports of multi-disciplinary rehabilitation interventions to slow and 
improve symptoms in HD patients have been sparse and mostly exploratory, 
many of them lacking a control group altogether. In addition, most, if not all, 
interventions have targeted early- to mid-stage HD patients, with little known 
of the impact at pre-symptomatic and late-stages of the disease. The first 
evaluation of multi-disciplinary rehabilitation in HD patients was carried out 
only ten years ago, and examined the effects of a two-year high-intensity 
program at an early- to mid-stage of the disease, and involved three 
sessions per year, each including six in-patient days (Zinzi et al., 2007). 
Despite the high dropout rate (approximately 1/3rd of patients), the 
intervention improved both physical function, such as gait, balance, and 
swallowing, as well as social function, such as better mood and social 
relations (Zinzi et al., 2007). The few studies of this type that followed also 
looked at the therapeutic potential of long-term interventions in early- to mid-
stage HD patients. A nine-month program in a small cohort showed HD 
intervention patients to exhibit reduced motor and posture deficits, as well as 
increased fat-free mass and strength, relative to controls (Thompson et al., 
2013). In addition, minor improvements in cognition, depression and quality 
of life were also observed (Thompson et al., 2013). A second, more 
extensive and carefully designed program, consisted of a one year 
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intervention, including three admissions of three weeks each, and focused on 
a combination of physical exercise, teaching sessions and social activities 
(Piira et al., 2013). The study revealed improved motor function, related to 
gait and balance, as well as improved general physical quality of life, and 
Body Mass Index (BMI) (Piira et al., 2013). Additionally, these patients 
showed decreased anxiety and depressive symptoms. However, a significant 
decline was identified in the Symbol Digit Modalities Test (SDMT; Smith, 
1982), which measures patient attention, concentration and speed of 
information processing (Piira et al., 2013). These findings highlight the 
importance of targeted cognition related tests when applying these types of 
interventions, and raise the possibility that certain types of processing-related 
deficits may be improved by non-pharmacological methods alone. A further 
exploratory long-term rehabilitation intervention, consisting of supervised 
clinical exercise (aerobic and strength exercises), home-based exercise (fine 
motor training and strength exercise) and occupational therapy sessions, in 
patients with manifest HD, revealed increased grey matter volume in the 
dorsolateral PFC and right caudate through MR imaging, which was 
accompanied by improvements in memory and verbal learning (Cruickshank 
et al., 2015). Finally, 18 months of individualised outpatient multidisciplinary 
intervention, prescribed after consultation with a team of specialists, was 
well-tolerated and found to be feasible and beneficial by HD patients and 
their carers (Veenhuizen et al., 2011). Therefore, this study indicates that, 
besides the efficacy of such interventions, HD patients are likely to engage 
and be highly appreciative of such multi-disciplinary programs. 
1.3.7. How to create a socially deprived environment for 
laboratory animals 
Social deprivation in the laboratory involves housing animals individually in 
standard cages with minimal or no enrichment (Heidbreder et al., 2000). 
Once isolated, minimal contact or handling is made, with the exception of 
when bedding requires changing. Although studies have examined the 
effects of isolation in adult and aged rodents, isolation has more prominent 
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and long-term effects during the critical period of brain development, in 
adolescence (Fone & Porkess, 2008).  
1.3.8. Social isolation effects on rodent models of health 
and disease  
Rodents are social creatures, similar to humans, such that post-weaning 
social isolation leads to significant behavioural, cognitive and neurochemical 
abnormalities. Behavioural and cognitive effects of social isolation in rodents 
include increased depressive-like behaviour (Brenes, Rodríguez, & 
Fornaguera, 2008a), aggressive-like behaviour (Matsumoto et al., 2005), 
anxiety-like behaviour (Ieraci, Mallei, & Popoli, 2016), irritability and 
hyperactivity (Ieraci et al., 2016), impaired spatial attention and long-term 
memory  (Okada et al., 2015; Ouchi et al., 2013), and reduced social 
affiliation and conditioned fear (Okada et al., 2015). Detrimental effects of 
isolation on the central nervous system (Fone & Porkess, 2008) include 
shrinkage of hippocampal volume (Pereda-Pérez et al., 2013), decreased 
neurogenesis (Stranahan, Khalil, & Gould, 2006), altered synaptic plasticity 
(Djordjevic et al. , 2009), and down-regulation of transcription factors related 
to synaptic plasticity, such as Egr-1, c-Fos and Arc (Ieraci et al., 2016; 
Matsumoto et al., 2012; Okada et al., 2015). Furthermore, social isolation 
was also associated with decreased PFC and hippocampal BDNF levels 
(Ieraci et al., 2016; Scaccianoce et al., 2006), reduced levels of 
norepinephrine in the ventral striatum (Brenes, Rodríguez, & Fornaguera, 
2008a), abnormal GABAergic and glutamatergic activity (Harte et al., 2007; 
Ieraci et al., 2016; Levine et al., 2007; Matsumoto et al., 2003; Melendez et 
al., 2004), alteration of the dopaminergic and cholinergic system (Okada et 
al., 2015), and altered electrophysiological properties of neuronal activity 
(Peters & O'Donnell, 2005; Roberts & Greene, 2003).  
Negative effects of social isolation have also demonstrated in animal models 
of neurodegenerative disease although the literature is sparser. For example, 
in the aged APP/PS1 Alzheimer Disease (AD) mouse model, three months of 
isolated housing enhanced cognitive deficits, and promoted Aβ plaque 
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accumulation in the hippocampus (Huang et al., 2015b). In turn, social 
isolation of young adult mice led to early onset of the disease-like phenotype 
(Hsiao, Chen, Chen, & Gean, 2011; Hsiao, Kuo, Chen, & Gean, 2012). 
Similarly, in the N17182Q transgenic mouse model, of HD which presents 
with motor deficits from 11 weeks of age, showed early disease onset, 
impairments in motor behaviour, and a reduction in striatal volume when 
housed individually in standard cages with a running wheel from pre-
symptomatic age (Potter et al., 2010). On the other hand, past studies 
demonstrated that the combination of physical stress and corticosterone 
administration can accelerate onset of specific deficits in HD mice (Mo et al., 
2014a; Mo, Renoir, & Hannan, 2014b; 2014c; Mo, Renoir, Pang, & Hannan, 
2013). Therefore in the Potter et al. (2010) study, because of the 
manipulation of two factors, exercise and isolation, which can both impact 
disease progression, it is unclear which one of the two, or whether the 
combination of both, contributed to the effects reported.  
1.3.9. Social isolation effects on myelin plasticity and 
oligodendroglial population 
One of the earliest studies linking white matter abnormalities with 
behavioural experience demonstrated that male rhesus monkeys, raised 
individually from 2-12 months of age, had significantly decreased corpus 
callosum (CC) sizes compared to monkeys raised in groups, as shown by 
MRI (Sánchez, Hearn, Do, Rilling, & Herndon, 1998). This decrease was 
most evident in the posterior CC, and was significantly correlated with the 
several cognitive deficits observed in these animals. The CC reduction 
persisted 6 months after animals were socially reintegrated, whereas no 
differences were identified in the anterior comissure, cerebellum or 
hippocampus (Sánchez, Hearn, Do, Rilling, & Herndon, 1998). In healthy 
rodents, social isolation was demonstrated to induce alterations in 
oligodendroglial population development and maturation, as well as in myelin 
sheaths characteristics, with many studies focusing on the known inherent 
plasticity of the prefrontal cortex (PFC) with respect to environmental 
manipulation (Forbes & Gallo, 2017; Liu et al., 2012; Liu et al., 2016; 
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Makinodan et al., 2012; Makinodan et al., 2016; Mount & Monje, 2017). 
Interestingly, a critical window for oligodendrocyte maturation and capacity 
for myelination was identified as a result of social isolation studies. These 
demonstrated that atypical oligodendroglial morphology and myelination 
deficits, along with long-term abnormal mPFC-mediated behaviour, occurred 
in healthy mice exposed to social isolation from pn21, for only two weeks, 
after which they were returned to standard housing until pn65 (Makinodan et 
al., 2012). The same effect was observed in mice kept in isolation from pn21 
for four weeks, but not in mice where isolation was initiated after pn35. 
Furthermore, the complexity of oligodendrocytes morphology was shown to 
be mediated by neuregulin through ErbB3 receptors on oligodendrocytes 
(Makinodan et al., 2012). These findings highlight the importance of social 
interaction during juvenile periods when oligodendrocytes undergo 
maturation and further axonal myelination (Makinodan et al., 2012). 
Reduction of myelin sheath thickness in the PFC of healthy juvenile mice 
was observed following two, four or eight weeks of post-weaning isolation 
(Cao et al., 2017; Liu et al., 2012; Makinodan et al., 2012).Two weeks of 
social deprivation was sufficient to cause thinning of myelin sheaths, and 
was paralleled by decreased expression of myelin basic protein (MBP) and 
myelin-associated glycoprotein (MAG), but not alterations of axonal 
diameters, in the medial PFC (mPFC); in contrast, no myelin related 
differences were identified in the motor cortex of juvenile mice (Makinodan et 
al., 2012). Additionally, isolation led to alteration of oligodendrocytes 
morphology, including shorter processes, fewer branches and fewer 
internodes per cell (Makinodan et al., 2012). Moreover, isolation-induced 
changes in myelin were observed in sub-cortical areas of juvenile male CD1 
mice reared in isolation for 8 weeks post-weaning, such as thinner myelin 
sheaths in the hippocampus, as well as decreased heterochromatin 
formation and reduced levels of MBP expression (Cao et al., 2017). 
Adaptive myelination was suggested to be highly sensitive to environmental 
manipulation particularly during infancy and adolescent periods, with several 
studies finding no changes in myelin sheath thickness of adult mice. Nine-
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week old mice exhibited no alterations in myelin thickness within layer V of 
the mPFC after 4 weeks of isolation (Makinodan et al., 2016), while 24-week 
old mice also showed no differences in myelin sheaths of the anterior 
commissure, the nucleus accumbens, or the cerebellum, after 2 or 8 weeks 
of isolation, when compared to standard housing controls (Liu et al., 2012). 
However, following 8 weeks of isolation, 24 week old adult mice exhibited 
hypomyelination, paralleled by decreased myelin related gene transcripts in 
the PFC, and reduction in the expression of some oligodendrocyte specific 
paranodal genes, while nodal length was not affected (Liu et al., 2012). In 
addition, oligodendrocytes in isolated mice were associated with immature 
nuclear chromatin and decreased nuclear heterochromatin, associated with 
decreased transcripts for enzymes regulating histone acetylation and 
repressive histone methylation (Liu et al., 2012). This was ascribed to 
reduced oligodendrocyte differentiation in socially isolated mice (Wang & 
Young, 2014). In contrast, a shorter period of 2 weeks of social deprivation 
had mild effects on myelin sheath thinning in this region of the brain, but a 
notable decrease in the proportion of heterochromatin in oligodendrocytes 
(Liu et al., 2012). Interestingly, social reintegration reversed the negative 
effects observed as a result of social deprivation when isolation took place in 
adulthood (Liu et al., 2012), but not in juvenile mice (Makinodan et al., 2012). 
Detrimental effects were also partially reversed, in selective regions of the 
brain, such as the hippocampus, but not the PFC, of juvenile isolated 
animals concurrently exposed to an enriched housing (Cao et al., 2017). 
1.3.10. Detrimental effects of social isolation in humans 
The translational value of investigating social isolation in preclinical models 
lies in the fact that social interaction in humans is a critical factor for 
development of normal social and cognitive function, while childhood social 
isolation or neglect can cause long-term alterations in normal adult behavior, 
cognition and neurophysiology (Bos et al., 2011; Chugani et al., 2001; 
Egeland, Sroufe, & Erickson, 1983; Polak & Saini, 2015). Notably, neglect, 
social isolation or rejection in children and adolescents can lead to long-term 
alterations in myelination of prefrontal cortex (PFC) (Chugani et al., 2001; 
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Egeland et al., 1983; Eluvathingal et al., 2006), and reduced corpus callosum 
area (Mehta et al., 2009; Teicher et al., 2004). Furthermore, individuals 
experiencing isolation, or loneliness, are more susceptible to cognitive 
decline (Badcock et al., 2015; Cacioppo & Hawkley, 2009), depression 
(Cacioppo et al., 2006), stroke (Avendano et al., 2006), faster progression 
and greater risk of late-life Alzheimer disease (AD) or other forms of 
dementia (Dong & Csernansky, 2009; Holwerda et al., 2014; Wilson et al., 
2007), and faster onset of schizophrenia (Jiang et al., 2013). In PD, for 
example, progressive symptoms were shown to impact quality of life, which 
in turn had an effect on social interaction, leading to social isolation from 
society (Pell, Cheang, & Leonard, 2006; Schrag, Jahanshahi, & Quinn, 
2001). In individuals with diagnosed mild AD, social isolation and loneliness 
experiences were significantly correlated with increased hallucinations 
experiences, and were more prevalent compared to elderly, healthy controls 
(Haj et al., 2016). These studies show how social isolation can not only 
hasten disease onset, but also be a by-product and catalyst of the disease 
progression itself, and emphasize the importance of investigating social 
isolation in controlled animal models of neurodegenerative disease. 
Interestingly, the effect of social isolation in individuals with Huntington 
disease (HD), as in animal models, remains unclear, and may be significant 
given that isolation was previously reported as being one of the features that 
arise with the diagnosis of the disease, along with avoidance, anxiety and 
depression (Silva, Lindau, & Giacheti, 2015).  
 
1.4. Microbiota manipulation and the gut-brain axis 
The human diet has changed drastically over the last several decades due to 
rise in global urbanization (Drewnowski & Popkin, 1997; Popkin, 2001). 
Developed, as well as developing countries, have changed the way they eat, 
drink and produce their food (Kearney, 2010; Popkin, Adair, & Ng, 2012). 
Urbanization has brought changes in the living environment, and large 
swathes of the population are not exposed to the same microbes as they 
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were in the past (Round & Mazmanian, 2009). Changes in diet and 
environment have had a direct negative influence on our health, including 
increased preponderance of diabetes (Aune, Ursin, & Veierød, 2009; Hu, 
2011), obesity (Bäckhed et al., 2007; Popkin et al., 2012), risk of developing 
allergies (Kim & Sampson, 2012; Penders et al., 2007), chronic disease 
(Nishida et al., 2004), chronic fatigue syndrome (Lakhan & Kirchgessner, 
2010), and anxiety (Ohland et al., 2013). Furthermore, emerging evidence 
has begun to elucidate the impact of environmental and dietary factors on 
neurodevelopmental, neuropsychiatric and neurodegenerative disorders 
(Lauer, 2010). Although the interaction between the central nervous system 
(CNS) and the gastrointestinal (GI) tract has been explored and discussed 
since the mid-1800s (Aziz & Thompson, 1998), research on these two 
systems have been mostly conducted independently of each other. However, 
an intriguing bi-directional communication between both systems was 
recently revealed and has become a topic of intense research (Cryan & 
O’Mahony, 2011; Mayer, Tillisch, & Gupta, 2015; McLean et al., 2012; 
Stilling, Dinan, & Cryan, 2013). Interestingly, recent findings have suggested 
that dietary and environmental interventions in combination with 
pharmacological treatments can significantly ameliorate and even prevent 
aging related disorders (Fontana & Partridge, 2015; Ghosh, Sinha, & 
Raghunath, 2016; Holzer et al., 2015). 
1.4.1. The microbiome and microbiota 
The mammalian GI tract is home to between 10-100 trillion microbes 
(Whitman, Coleman, & Wiebe, 1998). These microbial communities, known 
collectively as the gut microbiota (Frank & Pace, 2008; Turnbaugh et al., 
2007) predominantly include bacteria, but also viruses, (eukaryotic, bacterial 
(bacteriophages), and archaeal viruses), fungi and other eukaryotic 
organisms (Frank & Pace, 2008; Minot et al., 2011; Qin et al., 2010). 
Microbiota form several types of relationships with their host, including 
symbiosis, parasitism, mutualism or commensal (Gevers et al., 2012; Lloyd-
Price, Abu-Ali, & Huttenhower, 2016; Round & Mazmanian, 2009; Stilling et 
al., 2013). There are over 1,800 genera and about 40,000 species of gut 
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bacteria (Forsythe & Kunze, 2012; Frank & Pace, 2008). The main bacterial 
phyla in the human gut are Bacteroidetes and Firmicutes; whereas less 
dominant phyla include Cyanobacteria, Proteobacteria and Actinobacteria 
(Qin et al., 2010). Approximately 25-33% of microbiota phylotypes are 
believed to be shared between individuals, although estimations vary 
between studies due to technical and biological variability (Qin et al., 2010; 
Salonen et al., 2012). 
The population of genes associated with the gut microbiota is known as the 
microbiome, and thought to number about 3.3 million genes (Zhu, Wang, & 
Li, 2010); over 100 to 150 times more genes than the human genome  
(Bäckhed et al., 2005; Ley, Peterson, & Gordon, 2006; Qin et al., 2010). The 
gut microbiota contributes to pathogen defense (Artis, 2008; Chow & 
Mazmanian, 2010; Rakoff-Nahoum et al., 2004), synthesis of vitamins 
(Hooper, Midtvedt, & Gordon, 2002), breakdown and absorption of nutrients 
(Besten et al., 2013), fortification of intestinal epithelial barriers (Banati et al., 
2013; Hooper et al., 2001; Maes et al., 2012; Severance et al., 2013), and 
intestinal permeability (Camilleri, Lasch, & Zhou, 2012; Matricon et al., 2012), 
and motility (Cani, Everard, & Duparc, 2013). In addition, they play an 
important role in host physiology (Forsythe & Kunze, 2012; Marchesi & 
Shanahan, 2007; Sudo et al., 2004) and immune system development 
(Hughes et al., 2014; Mazmanian et al., 2005; Ringel & Maharshak, 2013; 
Round & Mazmanian, 2009). 
Initial research suggested that first contact with microbiota occurs at birth, 
during which the digestive tract of the newborn is colonised by 
microorganisms from within the birth canal and the environment where the 
birth takes place (Hooper et al., 2001; Vallès et al., 2014). More recent work 
(Lauder et al., 2016) has, however, provided evidence supporting prenatal 
microbiota contact via placental and/or amniotic fluid (Aagaard et al., 2014; 
DiGiulio, 2012; Gomez de Agüero et al., 2016; Kuperman & Koren, 2016; 
Vallès et al., 2012; Zheng et al., 2017). Bifidobacteria is the most 
preponderant microbiota phyla within healthy individuals during early life 
(Bäckhed et al., 2015), although microbiota make-up undergoes significant 
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and more complex changes throughout life and can swell to between 1100 to 
3100 phylotypes (Claesson et al., 2011). Various internal and external 
factors (Moya & Ferrer, 2016), such as host genetics (Goodrich et al., 2016), 
diet (David et al., 2014), hygiene (Wang & Kasper, 2014), antibiotics (Bercik, 
Collins, & Verdu, 2012; Gacias et al., 2016; Minter et al., 2017), infections 
and disease, as well as age (Claesson et al., 2011; Salazar et al., 2014), all 
play an important role on GI microbiota variability, stability and health. 
1.4.2. Bi-directional microbiota-gut–brain communication 
Communication and influence between the microbiota, the GI tract and the 
CNS is bidirectional and reciprocal, and several systems, as well as direct 
and indirect pathways, have been revealed (reviewed in Wang and Kasper, 
2014). The interaction takes place between the CNS, the hypothalamic-
pituitary axis (HPA) axis, the autonomic nervous system (ANS), including the 
sympathetic and parasympathetic divisions, the enteric nervous system 
(ENS), and the immune system. The CNS exerts its influence on the gut and 
its microbial community through the sympathetic and parasympathetic 
pathway via efferent neurons, through the endocrine pathway via the HPA 
axis, and through satiation signaling peptides. Indirect control is also 
obtained through activation of the immune pathway. The reverse 
communication, from microbiota and gut to the CNS, also involves several 
pathways: neural, metabolic, endocrine and immune. The neural pathway 
works through activation of vagal afferent nerves (de Lartigue, La Serre, & 
Raybould, 2011; Perez-Burgos et al., 2013) and neurons of the ENS, which 
in turn, are stimulated by microbially associated molecular patterns 
(MAMPs), and cytokines. The metabolic pathway involves synthesis by gut 
microbes of neuro-active molecules (such as GABA, tryptophan metabolites 
etc.) (Holmes et al., 2011). MAMPs, such as lipopolysaccharides (LPS), 
short-chain fatty acids (SCFA), and bacterial lipoprotein (BLP) also contribute 
to the metabolic pathway. Endocrine influence is gained, in part, via 
enteroendocrine cells (EEC), present in the gut epithelium, which secrete 
signaling peptides and neurotransmitters. The immune pathway is mediated 
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by the effect of microbes, and MAMPS on the auto-reactivity of peripheral 
immune cells to the CNS, and by systemic circulation. 
The gut microbiota produces a diverse range of metabolites, 
neurotransmitters and neuromodulators, which act on the gut-brain axis via 
the metabolic pathway. Among them, generated short-chain fatty acids 
(SCFAs) are metabolites produced in large amounts by Bacteroidetes 
through microbial fermentation of non-digestible carbohydrates. SCFAs 
include acetate, butyrate and propionate and make up between 90-95% of 
the total population. The remaining population consists of branch-chained 
SCFAs produced by proteins that are not absorbed in the small intestine. 
SCFAs are involved in multiple functions related to the immune system 
(reviewed by (Corrêa-Oliveira et al., 2016), which include provision of 
energetic substrates for epithelial cells in the gut (Donohoe & Bultman, 
2012), regulation of epithelial cell signaling (Iraporda et al., 2015), alteration 
of neutrophil differentiation, recruitment and survival (Rodrigues et al., 2016), 
modulation of T lymphocytes (Arpaia et al., 2013; Gurav et al., 2015), 
dendritic cells (Millard et al., 2002; Singh et al., 2010) and macrophages 
(Cox et al., 2009; Vinolo et al., 2011), and contribution to epithelium 
homeostasis (Kelly et al., 2015). In addition, gut-brain communication is 
influenced by SCFAs via several mechanisms, including altered 
catecholamine (Nankova et al., 2014), dopamine, serotonin and GABA levels 
(Bravo et al., 2011; El-Ansary, Ben Bacha, & Kotb, 2012), and regulation of 
microglia maturation and function (Erny et al., 2015; Sampson et al., 2016), 
glial homeostasis (Huuskonen et al., 2004), and tyrosine hydroxylase gene 
expression (DeCastro et al., 2005; Parul Shah et al., 2006).  
Among neuroactive substances produced by gut microbes, GABA is 
synthesized by specific strains of Bifidobacterium and Lactobacillus (Hiraga 
et al., 2008; Komatsuzaki et al., 2008). Other neuroactive products include 
catecholamines (such as dopamine (Asano et al., 2012) and noradrenaline), 
histamine, serotonin (Desbonnet et al., 2014), melatonin, and acetylcholine. 
GI bacteria can also synthesize tryptophan metabolites (such as kynurenine, 
5-hydroxytreptamine (5-HT), indole and tryptamine) and precursors, as well 
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as cytokines released during the immune response (Bailey et al., 2011; Lyte, 
2013). These microbiota-derived substances can signal either via cells and 
receptors in the gut lumen, or via neurocrine or endocrine pathways and 
mechanisms. Release of endocrine factors, such as 5-HT, and peptides, 
including leptin, gastrin, orexin and galanin, which modulate the endocrine 
pathway, have been suggested to play a key role in stress, depression, 
addiction, anxiety, arousal and circadian rhythms, and act at the border of 
the blood brain barrier (BBB) in the area postrema (reviewed in Wang & 
Kasper, 2014).  
1.4.3. Experimental approaches to investigate the influence 
of the microbiota on the brain 
Antibiotic treatment 
Treatments using a combination of antibiotics can partially decrease the 
microbial population in the gut (Reikvam et al., 2011), and alter microbiota 
make-up and diversity (Bercik et al., 2011; Puhl et al., 2012). The time-scale 
of the effect of antibiotic treatment on microbiota appears to be dependent on 
the age of the subject, and produces transient effects on adult mice, but 
long-term effects on neo-natal mice (Cho et al., 2012; Cox et al., 2014). 
Recent studies have revealed complex effects of antibiotic treatments on 
metabolism (Cox et al., 2014), as well on behavioural changes in diabetic 
mice (Gacias et al., 2016), neuro-inflammation and amyloidosis in an AD 
mouse model (Minter et al., 2017), and susceptibility to experimental 
autoimmune encephalomyelitis (Yokote et al., 2010). 
Germ-free animal model 
Germ-free environments provide a method to deplete gut microbiota to a 
greater degree than antibiotic treatments. Although the concept of germ-free 
animals was first proposed and debated in the late 1880’s, by Louis Pasteur 
and Marceli Nencki, it was not until the 1950s that the tools required for 
laboratory investigations were made commercially available (Luckey, 1963). 
Several approaches are available to interrogate host-microbe interactions in 
animal models, including germ-free (GF), ex-germ free (exGF), gnotobiotic, 
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specific pathogen free (SPF), or conventional (CON) environments. Germ-
free animals are born and live in aseptic isolated units, where food water and 
air are sterilised, such that these animals are free of all ‘detectable’ microbes 
and microorganisms (Luckey, 1963; Wostmann, 1981; Yi & Li, 2012). Ex-
germ-free animals are born, and live in GF conditions for a limited time, after 
which they are ‘conventionalised’ by being introduced to microbe-populated 
environments. Gnotobiotic animals, in turn, are GF animals colonised with 
one or more known strains of bacteria (Fritz et al., 2013; Smith, McCoy, & 
Macpherson, 2007). Similarly, SPF animals are those colonised with a 
mixture of eight bacterial strains, known as Schaedler flora (Dewhirst et al., 
1999). Finally, conventional animals are those born and housed under 
normal, or conventional, laboratory conditions (Norin & Midtvedt, 2010). 
Importantly, the effects observed as a result of an absence of microbiota are 
partially reversed through targeted pathogen recolonization of the microbiota 
(Braniste et al., 2014; Sudo et al., 2004). 
1.4.4. Microbiota modulation of CNS plasticity 
Both physical and psychological stress induces changes in normal gut 
function (Porter & Rettger, 1940), and alters microbiota composition (Bailey 
& Coe, 1999). Conversely, commensal microbiota is involved in the 
development of the HPA axis through its interaction with the serotonergic 
system. The HPA axis, part of the limbic system, regulates anxiety and 
stress responses to environmental stimuli (Tsigos & Chrousos, 2002). The 
link between brain plasticity and microbiota was first demonstrated in a 
seminal study where GF animals had different HPA responses to stress 
compared to SPF animals, whereas re-colonization of the gut with microbes 
partially reversed the effects (Sudo et al., 2004). Subsequent studies 
confirmed and extended this finding, by demonstrating an increased HPA 
axis response and reduced anxiety related behaviours in GF animals (Clarke 
et al., 2013; Gareau et al., 2011; Neufeld et al., 2011). Furthermore, anxiety-
related behaviours induced by Lactobacillus rhamnosus were reduced in 
vagotomised mice, revealing a key role for the vagal pathway in mediating 
the effect of microbiota on stress (Bravo et al., 2011). 
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Other behavioural effects of a germ-free environment include modulation of 
risk-taking ( Clarke et al., 2013), social (Desbonnet et al., 2014), hyperactivity 
(Heijtz et al., 2011), depressive-like, and anxiety-like, behaviours (Bercik et 
al., 2011; Bravo et al., 2011; Clarke et al., 2012; Heijtz et al., 2011; Neufeld 
et al., 2011; Savignac et al., 2014). Reduced memory, as measured using a 
novel object test, has also been ascribed to GF relative to SPF animals 
(Gareau et al., 2011). 
In terms of brain neurochemistry, GF mice exhibit changes in neurotrophic 
factors (such as BDNF) (Bercik et al., 2011; Heijtz et al., 2011; Sudo et al., 
2004), GABAA and GABAB receptor subunits (Bravo et al., 2011), NMDA 
receptor subunits, and serotonin (Neufeld et al., 2011) and tryptophan, the 
precursor of serotonin (Clarke et al., 2013).  
The contribution of a healthy BBB is essential for normal brain development. 
However, a recent study revealed increased BBB permeability in GF animals 
that manifested in intrauterine life and persisted throughout their lives. This 
was associated with reduced levels of endothelial tight junction proteins, 
occludin and claudin-5, in the frontal cortex, striatum and hippocampus of GF 
mice compared to SPF (Braniste et al., 2014). Interestingly, when GF 
animals were colonised with Clostridium tyrobutyricum or B. thetaiotaomicron 
(SPF microbiota) BBB permeability properties were restored to SPF levels 
and occludin and claudin-5 levels were upregulated. This study suggests that 
early dysbiosis in the gut could lead to neurodegeneration, through 
extravasation of neuro-inflammatory substances as a result of increased 
BBB permeability.  
1.4.5. Microbiota effects on myelination  
Genome-wide transcriptome profiling of the prefrontal cortex showed 
upregulation of genes linked to myelination and myelin plasticity, as well as 
upregulation of genes related to neural activity induced-pathways in germ 
free animals compared to SPF control (Hoban et al., 2016b). In addition, 
increased mRNA levels of several myelin related gene transcripts and 
regulatory factors (MBP, Mobp, MAG, MOG, PLP1) were reported in the 
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PFC, but not in the frontal cortex, hippocampus, cerebellum, amygdala or 
striatum of GF mice compared to SPF (Hoban et al., 2016b). Increased 
expression levels of myelin related genes (MAG, MOG, MBP, PLP1, and 
MOBP) were also reported in the medial PFC in antibiotic treated compared 
to vehicle treated non-obese diabetic mice. However, this increase was not 
observed in healthy controls following antibiotic treatment (Gacias et al., 
2016). Interestingly, only oral administration of antibiotics showed this effect, 
whereas subcutaneous administration failed to induce changes in microbiota 
composition or myelin differences related to it (Gacias et al., 2016). 
Transcriptional changes in myelin related genes were confirmed by 
hypermyelination of prefrontal cortex axons in GF animals compared to 
conventional animals (Hoban et al., 2016b). Increased myelin thickness was 
also seen in the mPFC of healthy mice recipients of the microbiota of 
diabetic mice treated with antibiotics, as opposed to recipients of the 
microbiota of non-treated diabetic mice (Gacias et al., 2006). 
1.4.6. Microbiota in neurodegenerative disease 
Emerging evidence suggests that neurodegenerative, psychiatric, or 
autoimmune brain disorders can be directly influenced by the microbiota-gut-
brain axis. Levels of probiotic bacteria, such as Fecalibacterium and 
Butyricoccus, associated with the SCFA butyrate production and 
inflammation inhibition, were found to be lower in a group of cognitively 
impaired elderly subjects (Bajaj et al., 2016). In addition, levels of 
Lactobacillales (comprising of Streptoccaceae, Carnobacteriaceae and 
Lactobacillaceae) were correlated with better performance on memory tests 
in elderly patients (Bajaj et al., 2016). The Alzheimer Disease (AD) mouse 
model of Aβ amyloidosis showed alteration in the composition of microbiota 
during long-term antibiotic treatment, which coincided with a reduction in 
amyloid plaque deposition and increased levels of soluble Aβ (Minter et al., 
2016). Analysis of the fecal microbiome showed that the 5xFAD aggressive 
AD mouse model exhibited 10-15% lower levels of Firmicutes, and 2-15% 
greater levels of Bacteroidetes when compared to healthy controls 
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(Brandscheid et al., 2016). Motility abnormalities associated with bacterial 
overgrowth have also been observed in Parkinson disease (PD) patients 
(Fasano et al., 2015; Gabrielli et al., 2010).  
Several studies have recently found altered microbiota in the gut of 
individuals suffering from multiple sclerosis (MS), one of the most prevalent 
human demyelinating inflammatory disorders (Cantarel et al., 2015; Chen et 
al., 2016; Jangi et al., 2016). Interestingly, outside of the gut, microbiota 
composition in white matter of MS patients was found to exhibit reduced 
diversity of the most preponderant phylum, Proteobacteria (Branton et al., 
2016). MS was suggested to be caused by the interaction between complex 
environmental and genetic factors, and often follows a relapsing-remitting 
pattern. The relapsing–remitting (RR) mouse model of spontaneously 
developing Experimental Autoimmune Encephalomyelitis (EAE), 
recapitulates the main characteristic of this disorder (Baxter, 2007; 
Constantinescu et al., 2012; Pöllinger et al., 2009). The SPF RR-EAE mouse 
model is known to develop EAE within 3 to 8 months, but mice bred in a 
germ free environment were protected from the disease throughout their 
lives, although ex-GF RR animals developed EAE immediately after they 
were re-colonised with microbiota (Berer et al., 2011). Moreover, GF animals 
mono-colonised with the gut microbe, Segmented Filamentous Bacterium 
(SFB), showed increased severity of EAE (Ivanov et al., 2009; Lee et al., 
2011), and a cocktail of the probiotic Lactobacillus strains given to C57BL/6 
mice prevented and delayed EAE (Lavasani et al., 2010).  
Epsilon toxin (ε-toxin) is secreted in the intestinal lumen by Clostridium 
perfringens, and thought to play a key role in MS. 10% of MS diagnosed 
patients were found to harbour ε-toxin in their CSF as opposed to 1% of 
control individuals (Rumah et al., 2013). This toxin targets oligodendrocytes 
in the CNS, causing selective death of these cells, while sparing other cell 
types, such as neurons, glia or astrocytes, and inducing demyelination in a 
dose and time dependent manner (Linden et al., 2015). Raised levels of 
hormones of the gut-brain-axis, such as leptin, have been observed in CNS 
lesions (Sanna et al., 2003) and CSF (Matarese, Moschos, & Mantzoros, 
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2005) of MS patients, and leptin deficient mice did not go develop EAE 
(Matarese et al., 2001).  
Notably, despite the compelling evidence supporting a key role for microbiota 
in debilitating neurodegenerative diseases, including myelination-related 
disorders such as MS, research into the role of microbiota in Huntington 
disease is sparse. The work presented herein will endeavor to address this 
research gap.  
 
1.5. Thesis aim, structure and summary of findings  
There is growing evidence for white matter (WM) deterioration early in 
Huntington disease (HD) that is correlated to disease progression. However, 
little is known about the mechanisms and dynamics of WM changes and their 
precise role in HD pathogenesis. Elucidating these unanswered questions 
can provide novel insights into the pathophysiology and clinical manifestation 
of the disease, and help identify possible treatment strategies. This thesis 
describes three studies whose aims were to employ environmental and 
microbiota manipulations to perturb and interrogate white matter plasticity, 
and examine behavioural changes, in the YAC128 and BACHD mouse 
models of Huntington disease, and wild-type (WT) controls. These aims were 
accomplished through use of a battery of behavioural tests, and a range of 
techniques to examine white matter changes in structure and function, 
including transmission electron microscopy, immuno-histochemistry, and 
immunoblotting.  
Chapter 2 provides details of the methodologies employed in the studies 
described in this thesis. Chapters 3 and 4 describe the effects of 
environmental enrichment and deprivation, respectively, on behaviour and 
motor performance, and white matter structure and function in the posterior 
corpus callosum (CC) of the YAC128 mouse model of HD, and WT controls. 
In turn, Chapter 5 reports our findings with respect to the most novel aspect 
of this thesis, namely, the effects of microbiota manipulation on white matter 
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structure and function in the prefrontal cortex (PFC) and CC of the BACHD 
mouse model of HD, and WT controls. Finally, Chapter 6 endeavours to 
provide a detailed discussion and overarching interpretation of all results, 
with reference to available, and occasionally limited, literature, before 
concluding with an overview of possible future work.  
Of note, environmental enrichment was associated with slight improvements 
in behaviour and motor performance across WT and HD mice, while 
environmental deprivation elicited minor deficits. Interestingly, a reduction in 
myelin thickness was observed in WT mice independently exposed to both 
forms of environmental manipulation, while in YAC128 animals this effect 
was only seen in response to environmental enrichment. Environmental 
enrichment was associated with a higher number of small and mid-range 
diameter axons across genotypes, while environmental deprivation was 
associated with higher number of large diameter axons in WT animals, but a 
decrease in YAC128 mice. Both forms of environmental manipulation had no 
effect on mature oligodendrocyte numbers across genotypes. Germ-free 
(GF) BACHD mice exhibited an increase in number of regular-shaped 
myelinated axons, a decrease in irregular shaped myelinated axons, and an 
overall increase in myelin sheath thickness, relative to BACHD mice raised 
under control specific pathogen free (SPF) conditions. Myelin basic protein 
(MBP) expression levels were also associated with a significant decrease in 
the prefrontal cortex (PFC) of wild-type (WT) GF mice, with a similar, albeit 
non-significant, effect in BACHD mice. In turn, a reduction in number of 
mature myelinating oligodendrocyte cells in PFC and CC of WT GF mice was 
also observed, compared to WT SPF mice. Furthermore, a reduction in 
mature myelinating oligodendrocyte cells was also seen in the PFC only of 
BACHD GF animals compared to BACHD SPF controls. Intriguingly, we 
found that both germ-free WT and BACHD mice exhibited a significant 
decrease in overall brain weight compared to their SPF housed counterparts. 
These findings, and others, suggest that environmental and microbiota 
manipulation induce complex effects on white matter structure, function and 
development in wild-type and HD mice, which provide novel insights into 
white matter plasticity and white matter abnormalities in HD. 
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2.1. Environmental manipulation studies 
2.1.1. Experimental groups 
All animals were bred and housed in the Biological Resource Centre, at the 
Biomedical Science Institute, A*STAR, Singapore. All experimental 
procedures were approved by and conducted in accordance with the ethical 
guidelines of the animal care committee at our institution. 
A total of 67 YAC128 transgenic (HD model) and wild-type (WT, control) 
mice were used in this study (Table 2.1). Both males and females were 
included in all experimental groups, unless stated otherwise. Sexing and 
genotyping of animals were carried out at 3 weeks of age. Mice were 
weighed on a bi-weekly basis. Animals were sacrificed and their brains 
harvested at 18 weeks of age. 
Table 2.1 Total number of animals used for the environmental 
manipulation studies 
Number of animals per experimental group categorised per sex (WT=Wild Type, 
YAC128-HD transgenic model, F=female, M=male, EH=enriched housing, 
SH=standard housing, DH=deprived housing). 
 WT YAC128 
Sex F M Total F M Total 
EH 5 5 10 5 5 10 
SH 7 6 13 5 6 11 
DH 5 6 11 4 8 12 
 
 
2.1.2. Housing manipulation details  
Mice were housed under standard conditions with food ad libitum, in an 
inverted light-dark cycle until 4 weeks of age. Subsequently, they were 
placed into their allocated caging conditions, consisting of enriched 
environment housing (EH), standard housing (SH) or deprived housing (DH). 
Animals were kept in their allocated condition for a total of 14 weeks (Figure 
2.1).  
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Figure 2.1 Experimental timeline for environmental manipulation 
studies 
Animals were sexed and genotyped at post-natal day (pn) 21, and allocated to 
experimental conditions at pn day 28. Behavioural testing was started after 12 
weeks in their allocated housing conditions, when animals were 112 days old. Tests 
were carried out for 2 weeks, after which tissue was harvested. Animals were 126 
days (i.e. 18 weeks) old when sacrificed.  
 
2.1.3. Behavioural tests description  
Behavioural tests were carried for the environmental manipulation 
(environmental enrichment and deprivation) studies. Mice were subjected to 
a battery of behavioural tests following 12 weeks of housing according to 
their experimental condition. All behavioural tests were started at least one 
hour after the start of a new dark cycle. All animals were moved to the testing 
room and left to acclimatize for one hour before the start of the experiment. 
All testing was conducted under dim white-light illumination (about 150 lux) in 
a sound attenuated room. All behavioural tests run over the course of this 
study are described below and listed in Table 2.2. 
Table 2.2 List of behavioural tests and their interpretation 
Behavioural test: Analysis of: 
Spontaneous activity Motor function and habituation 
Open field activity Anxiety and habituation 
Elevated plus maze Anxiety 
Climbing test Neuromuscular function 
Rotarod training 
Rotarod test 
Motor function / 
learning / cognitive 
 
 
pn112 pn126 pn28 pn21 pn0 
Behavioural testing 
Environmental manipulation 
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Spontaneous activity (SA) 
The spontaneous activity (SA) test was used to measure both gross and fine 
locomotive movements in mice (Figure 2.2A). Four animals were tested 
simultaneously in a Mouse Open Field Arena (Med Associates, USA) with 
the 48 Channel IR Controller for Open Field Activity. The arena dimensions 
were 27.3cm L x 27.3cm W x 20.3cm H, and consisted of four separated 
arenas. One mouse at a time was placed in the centre of one of the four 
arenas, which was automatically activated, and activity started being 
monitored. Each arena was activated independently of each other. Animals 
were allowed to explore their allocated arena during this test for 30 minutes. 
The Activity Monitor software (Med Associates, USA) was used to record 
horizontal activity (distance travelled, ambulatory counts, ambulatory 
episodes, velocity), vertical activity (rearing, jumping) and stereotypy in 
activity. 
Open field (OF) activity  
The open field (OF) test was used to measure each animal’s habituation to a 
new environment, as well as levels of anxiety, and consisted of measuring 
the time spent by animals in the centre versus outer area of an arena (Figure 
2.2B). An in-house built open field arena, measuring 50cm L x 50cm W x 
50cm H, was used. Four animals were tested simultaneously in the arena 
and their activity was recorded using EthoVision (Noldus, Singapore) video 
tracking software. Animals were allowed to explore the arena for 10 minutes 
during which the time spent in the centre of the arena relative to the time 
spent in the periphery was noted and recorded. 
Elevated plus maze (EPM) 
The EPM is a well-established test of anxiety (Figure 2.2C). The testing 
arena is shaped like a “+”, with two open arms and two arms having tall 
enclosing walls. One animal was tested per trial and allowed 5 minutes in the 
EPM. Recordings were again made using the EthoVision video tracking 
software. The number of entries into, and time spent, in the open and 
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enclosed arms, as well as the total number of arm entries, for each animal 
were noted and recorded. 
Climbing test  
The climbing test was used to assess motor impairment in mice (Figure 
2.2D). Four mesh cylinders were placed on a table and separated by a 
plastic board so animals were not visible to each other. One animal was 
placed in each cylinder sequentially. Each trial was video recorded using 
Sony HDR-CX130 camera for 6 minutes, with the first minute excluded from 
subsequent analysis The number of times each animal attempted to climb 
(defined as having placed all four paws onto the mesh) was noted and 
recorded, as was the latency to the first climbing attempt, and each attempt’s 
climbing time (until any paw was rested back onto the table-top). An animal 
was excluded from the test if it remained stationary on the table-top during 
the duration of test, whereas if the animal was mobile but did not attempt to 
climb, the latency to climb was scored as the maximum duration of the test 
(i.e. 300s), and climbing time was set to null (i.e. 0s). 
Rotarod test (RR) 
The rotarod (RR) test was used to assess motor co-ordination and balance in 
mice, by testing their ability to remain on a rotating rod (Figure 2.2E). The 
test consisted of 3 days constant-speed rotarod training and one day of 
testing on an accelerating rotarod. For training, mice were placed on the 
rotarod in the direction of motion whilst the rotarod turned at 18 revolutions 
per minute (rpm). Each rotarod contained four lanes that enabled four 
animals to be trained simultaneously (i.e. one per lane). Animals were 
returned to the rotarod after each fall during the 300s training period, and 
every animal underwent two training trials for the first day, and three training 
trails for the subsequent two days, separated by 2hour intervals. The latency 
for each mouse to first fall off the rotarod, and the number of falls during 
training, was noted and recorded. For testing, animals were placed in their 
respective lanes and allowed to walk on the rotarod (rotating at 5rpm) for a 
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few seconds in order to gain stability. The rotarod then increased in speed 
from 5-40rpm over the course of the 300s test duration. 
The latency for each mouse to the first fall off the accelerating rotarod was 
noted and recorded, and the mouse returned back to its home cage after its 
first fall. Each mouse underwent three test trials on the same day with a two-
hour rest-time in between each. Overall performance in the accelerating 
rotarod test was calculated as the mean of the latency to first fall across the 
three test trials.  
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Figure 2.2 Illustrations of behavioural tests 
(A) Spontaneous activity (SA); (B) Open field activity (OF); (C) Elevated plus maze 
(EPM); (D) Climbing test; (E) Rotarod test (RR). 
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2.2. Microbiome manipulation study 
2.2.1. Experimental groups 
All mice were bred and housed in the animal facility of the Singapore 
General Hospital Unit (SGH), Singapore. All experimental procedures were 
approved by, and conducted in accordance with the ethical guidelines of the 
animal care committee at our institution. Mice were housed under standard 
laboratory housing conditions with food ad libitum, in an inverted light-dark 
cycle. 
Wild-type (WT) and BACHD transgenic mouse models of HD were raised 
under specific pathogen free (SPF) and germ-free (GF) laboratory conditions 
(Figure 5.1). Each experimental group (N=4) included between 10-13 
animals per condition per sex (Table 2.3).  
Table 2.3 Total number of animals used for the microbiome study 
Number of animals per experimental group categorised per sex (WT=wild type, 
BACHD=transgenic model of HD, GF=germ free, SPF=specific pathogen free, 
F=female, M=male). 
 WT BACHD 
Sex F M Total F M Total 
GF 11 12 23 10 14 24 
SPF 11 13 24 10 13 23 
 
 
Animals were genotyped at 3 weeks of age. All animals were weighed at 3 
months of age, prior to being sacrificed. Brains were harvested, and weighed 
comparisons were carried out for both males and females, however, due to 
cost and time constraints, only males were included in subsequent 
investigation for the study described in this thesis.  
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2.3. Tissue harvesting and processing  
For all three studies, all brains were segmented through the mid-sagittal 
plane, and the left hemisphere used for immunohistochemical procedures, 
while the right hemisphere was microdissected into cortex, prefrontal cortex, 
striatum, hippocampus, cerebellum and olfactory bulb, and placed in cryo-
tubes on dry ice to be used for immunoblotting procedures.  
In addition to the brains harvested for immunostaining and immunoblotting, 
three to four animals in each experimental condition were perfused and 
harvested, to investigate axonal and myelin related characteristics (i.e. 
axonal shape and size, and myelin thickness) using transmission electron 
microscopy (TEM) (Section 2.4). 
 
2.4. Transmission electron microscopy (TEM)  
2.4.1. Tissue extraction fixation and storage 
Mice were anesthetized with Ketamine (150mg /Kg) and Xylazine (10 
mg/Kg), and then transcardially perfused via a catheter inserted through the 
left ventricle and connected to a pump set to 0.1ml /min. Perfusion was 
performed with 25ml of ice cold phosphate buffer solution (PBS, made in-
house, Table 2.8), followed by transmission electron microscopy (TEM) 
fixative solution comprising of 25ml of ice cold 2.5% paraformaldehyde (PFA, 
Sigma-Aldrich, USA, see Appendix A) and 2.5% glutaraldehyde (GlutAH). 
Following perfusion, all brains were segmented through the mid-sagittal 
plane, and the right hemisphere placed in 5ml of TEM fixative solution in 
preparation for TEM. The tissue was stored at 4oC overnight. The following 
day, brains were washed 3 times in 1xPBS (5-10min per wash; Table 2.8) 
and stored in 5ml sucrose (5% sucrose, 1st Base, Singapore, & 0.1% sodium 
azide (NaN3, Merck, Germany) at 4
oC. 
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2.4.2. Pre-processing and microdissection 
The corpus callosum (CC) was microdissected one day before sample 
preparation for TEM. The mid-sagittal sectioned brain was placed in a 
mouse-specific stainless steel matrix (Roboz Surgical Instrument Company, 
Inc. Gaithersburg, MD), and the intersection between the CC and fornix used 
to determine the region where a 1mm coronal section would be segmented 
using a commercial blade. For the environmental manipulation studies, the 
posterior CC (splenium) was microdissected (~Bregma -1.82 to -2.70mm, the 
equivalent of region 5 as described by Barazany et al. (2009) (Figure 3.11 
and Figure 4.9); whereas, for the microbiome study, the anterior mid-body 
region of the CC was microdissected (~Bregma -0.8 to 0 mm) (Figure 5.2). 
The microdissection was carried out in a petri dish filled with 1xPBS (Table 
2.8), and visualised under a dissecting microscope (Figure 2.3). The samples 
were cut in the shape of a rectangular cuboid in order to determine the 
direction of the fibres for TEM. Tissue samples were washed in 1xPBS and 
left overnight at 4oC before sample preparation the next day. 
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Figure 2.3 Corpus callosum microdissection for TEM 
(A) Microdissection of the posterior (splenium) CC viewed under the microscope. 
(B) Sagittal map (adapted from Paxinos and Franklin, 2012) indicating (red circle) 
splenium, and (blue circle) anterior mid-body of the CC. 
 
 
2.4.3. Sample processing and embedding 
On the first day, samples were post fixed in 1% osmium tetroxide (OsO4, 1g 
of osmium in 100ml PBS (Table 2.8), pH 7.4) for 1 hour at room temperature 
under a fume hood, and then washed twice in deionised water for 5-10min. 
The next process was dehydration through an ascending ethanol series, at 
room temperature: 
a) 25% ethanol (Merck, Germany)– 5 minutes; 
b) 50% ethanol – 10 minutes; 
c) 75% ethanol – 10 minutes; 
d) 95% ethanol – 10 minutes; 
B 
A 
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e) 100% ethanol – 10 minutes; 
f) 100% acetone – 10 minutes – 2 changes. 
The final process on day 1 was infiltration, using acetone and resin. Resin 
was prepared from Araldite (90g), DDSA (80g) and DMP-30 (2.4g) (all 
purchased from Sigma Aldrich, Singapore). The following two steps were 
followed: 
a) 100% acetone:resin (1:1) for 30 minutes at room temperature; 
b) 100% acetone:resin (1:6) overnight at room temperature; 
On the second day, three incubation sessions with resin were used: 
a) First change of fresh resin – for 20 minutes at room temperature; 
b) Transfer to oven (40 OC – 50 OC) for 30 minutes;  
c) Two changes of fresh resin for 1 hour each (45 OC and 50 OC 
respectively); 
d) Finally, samples were aligned and placed in a cavity embedding 
mould (1 or 2 samples per block, Zivic Instruments, USA), and 
embedded in fresh resin to polymerise at 60O C for 24 hours. 
2.4.4. Ultramicrotome trimming and sectioning  
Cavity embedding mould was removed from the oven after 24 hours and 
samples were taken for sectioning. 
Each sample was isolated from the resin by trimming prior to ultra-thin 
cutting. The samples were visualised through the resin due to their black 
colour as a result of osmication. Samples were revealed by trimming the 
resin manually using a commercial razor blade and subsequently aligned 
and positioned in the ultra-microtome (Reichert-Jung ultracut E) block holder 
for further trimming using an in-home built glass knife. Glass knives were 
obtained by cutting glass strips under a Leica EM KMR2 microscope. Cutting 
speed was set to 1.5 mm/sec and cutting thickness was set to 0.5μm. Semi-
thin sectioning was performed and several sections stained with toluidine 
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blue dye so as to visualise tissue network under the microscope, and confirm 
target region and viability of the sample.  
Following confirmation of the target region, ultra-thin sectioning was 
performed using a diamond knife with a boat (Diatome, Ultra45, 3mm length, 
USA). Cutting speed was set to 1.5 mm/sec and cutting thickness was set to 
90nm. At this thickness the samples, which form a ribbon, are seen as a gold 
colour when visualised under the microscope. The golden colour indicates an 
appropriate thickness (see figure of colour band – ultra-microtome). After 
securing the ribbon on a 200-mesh grid (Ellipsiz DSS Pte Ltd, Singapore), it 
was left to dry and placed in a plastic capsule.  
2.4.5. Axonal (fibre) staining 
When enough grids were collected (5-6 per animal), fibres were stained at 
room temperature using lead citrate (Reynolds lead citrate, composed of 
lead nitrate and sodium citrate, 3%) for 8 minutes, followed by thorough 
washing in deionised water. The grids were dried with filter paper, placed on 
a different filter paper and left to dry for several minutes before being 
returned to the plastic capsules housing. 
2.4.6. TEM viewing, image capturing, and analysis 
Samples were viewed using a Tecnai G2 Spirit Twin/ Biotwin model (FEI, 
USA) trasnimission electron microscope. Representative micrograph of 
callosal axons is illustrated below, in Figure 2.5A. Two grids were chosen 
based on the quality of the ribbons and 10-12 images were taken from each 
grid. A total of 12 images per animal were chosen to be analysed using 
ImageJ software (version 2.0.0, National Institutes of Health, USA). An 
unbiased frame was randomly selected using the rectangular tool and 
superimposed on each image. Conversion of image magnification was 
performed using the line tool in ImageJ. Axonal myelin thickness was 
calculated using g-ratio analysis, in which the inner and outer diameter of 
regular shaped axons were measured using the line tool in ImageJ, and the 
ratio between both values calculated (Friede, 1972; Figure 2.4). Between 25-
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40 axons per image, giving a total of 300 to 480 values per animal, were 
measured. The results were exported to Matlab (Matlab, USA), where the g-
ratios were calculated.  
 
 
Figure 2.4 Calculation of g-ratio diagram 
The g-ratio, used as measure of myelin thickness, was calculated as the inner 
diameter over the outer diameter (i.e. higher g-ratios are associated with reduced 
myelin thickness). 
 
For axonal counting, all unmyelinated axons within the selected unbiased 
frame were counted. In addition, myelinated axons were classified as 
‘regular’ or ‘irregular’ shaped axons based on their circular properties. Thus, 
axons with quasi-, circular or elliptical shapes were counted as ‘regular’ 
axons, whereas remaining axons were categorised as ‘irregular’ shaped 
(Figure 2.5B). 
 
Myelin 
Axon 
g =  
ID 
OD 
ID OD 
Higher g-ratio = thinner myelin sheath 
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Figure 2.5 Representative micrographs of myelinated and 
unmyelinated axons in the posterior corpus callosum of the 
mouse brain 
(A) Representative micrograph of callosal axons as viewed using transmission 
electron microscopy (Tecnai G2 Spirit Twin microscope). Scale bar at 10μm. 
(B) Myelinated axons were classified as regular (filled circles) and irregular (black 
crosses). Unmyelinated axons are denoted by triangles. 
 
 
2.5. Immunohistochemistry and immunofluorescence  
2.5.1. Tissue extraction, fixation and storage  
Mice were placed in a CO2 gas chamber for 5 minutes after which they were 
euthanized by cervical dislocation. Brains were carefully extracted, 
segmented through the mid-sagittal plane, and the left hemisphere placed in 
5ml of 4% PFA solution (4g in 100ml 1xPBS; see Appendix for PFA recipe) 
x 
x 
x 
x 
x 
x 
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B 
A 
  
 
87 
at 4oC overnight. The next day, brains were washed 3 times in 1xPBS (5-
10min per wash) and stored in 5ml sucrose (30% sucrose & 0.1% NaN3 in 
1xPBS) at 4o C until further processing.  
2.5.2. Cyrosectioning 
Left hemispheres were removed from the sucrose solution and dried on filter 
paper. Prior to cryosectioning, brains were cryopreserved in dry ice and 
isopentane (2-methylbutane) to preserve structurally intact cells and tissues. 
The cryopreserved brains were embedded onto chucks using optimum 
cutting temperature (OCT) compound (VWR, USA). Coronal slices were 
sectioned at a thickness of 25µm, at -20o C using a cryostat (Thermo 
Scientific, USA). Collection began when the forceps minor of the corpus 
callosum (fmiCC) became visible during sectioning. Following sectioning, 
brain slices were placed in 1xPBS and 0.1% NaN3 solution in a 24 well plate. 
The slice corresponding to the location where the fmiCC from each 
hemisphere meet to form the genu (gCC) of the corpus callosum (~ 
Interaural 4.98-4.90 mm and ~Bregma 1.18-1.10 mm) was visually identified. 
A mark was made on the well where this section was placed. 
2.5.3. Immunohistochemistry staining  
The well to be stained was chosen based on the mark of the gCC on the well 
plate. All sections (4-5 per well) were removed from each of the selected 
wells and placed into 12-well plate in NetWell inserts (one well per animal 
and one well for as a negative control for each condition) and placed in 
1xPBS. Brain sections were then: 
1) Incubated in 2ml/well phenylhydrazine solution (Sigma-Aldrich, USA, 
10µl phenylhydrazine / 1ml 1xPBS) and left for 45 minutes at room 
temperature (RT) on a rocker to block endogenous expression of 
peroxidase. This was followed by 3 washes in 1xPBS for 10 minutes 
per wash. 
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2) Incubated in blocking solution (1xPBS: 5% Normal Goat Serum - 
NGS, Sigma-Aldrich, USA; 5% BSA, GE Lifesciences, USA; 0.1% 
Triton, OmniPur, USA) for 30 minutes at RT on a rocker.  
3) Immersed in the primary antibody and incubated with 5% NGS and 
0.2% Triton, in 1xPBS overnight at 4ºC.  
4) The following day, sections were washed 3 times in 1xPBS for 10 
minutes per wash. This was followed by incubation in biotinylated 
secondary antibody for 1.5 hours at RT. Secondary Antibody Solution 
was prepared in 1xPBS: 1% NGS, 0.2% Triton and 1:200 ABC 
Vectastain Kit solution (rabbit kit, Vector Laboratories, USA). Post-
incubation, sections were washed 3 more times in 1xPBS for 10 
minutes per wash.  
5) Incubated in ABC solution for 2 hours at RT on the rocker. ABC 
reagent was prepared in 1xPBS: 1:100 of solution A and 1:100 of 
solution B. Post-incubation, sections were washed 3 times in 1xPBS 
for 10 minutes per wash.  
6) Finally, sections were stained using DAB (1:40, chromogen:buffer; 
Vector Laboratories, USA,). After staining, sections were returned to 
1XPBS, mounted on a glass slide (Biomedia, Singapore) and allowed 
to dry. Once dry, a coverslip with DPx Mountant (Sigma-Aldrich, USA) 
was placed over the brain section. 
2.5.4. Immunofluorescence staining 
Immunofluorescence (IF) staining was performed using platelet-derived 
growth factor receptor alpha (PDGFRα) antibodies. The well to be stained 
was chosen based on the mark of the gCC on the well plate. All sections (4-
5) were removed from each of the selected wells and placed into 12-well 
plates in NetWell inserts (one well per animal and one well as a negative 
control for each condition) and placed in 1xPBS. Sections were first pre-
treated in hydrochloric acid (HCl) based solution (stock of 1N and 2N was 
prepared from 37% HCl solution), an antigen retrieval reagent, to break 
protein cross-links formed by formalin fixation and uncover hidden antigenic 
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sites, was conducted. Sections were subsequently incubated in the following 
manner whilst being agitated using an orbital shaker: 
1) 10 min on ice in 1N HCl in pre-cooled wells  
2) 10 min at RT in 2N HCl  
3) 20 min at 37o C in 2N HCl in pre-warmed wells 
4) 10 min at RT in 0.1M borate buffer solution, (pH 9) 
A standard staining protocol was then followed where sections were 
sequentially: 
5) Washed 3 times in 1xPBS for 10min per wash. 
6) Incubated for 90-120 min in blocking solution (5% normal donkey 
serum - NDS, Sigma-Aldrich, USA; 0.2% Triton; in PBS) 
7) Incubated in primary antibody solution (1% NDS, 0.2% Triton, in PBS) 
overnight at room temperature. 
8) Washed 3 times in 1xPBS for 10min per wash the following day 
9) Incubated in secondary antibody 1:500 in PBS (0.2% Triton in PBS) 
for 2 hours, and well plates covered with aluminium foil to prevent 
fluorochrome bleaching. 
10) Washed 3 times in 1xPBS for 10min per wash. 
11) Finally mounted on a glass slide and allowed to dry.  
2.5.5. Stereology  
Cell counting was blind to the experimental conditions, as new IDs were 
randomly assigned to all animals prior to the start of staining. An upright 
microscope (Olympus, Japan) was used to view the stained brain sections 
and Stereo Investigator software (MBF Bioscience, USA) was used for 
imaging and analysis. Section cut thickness was set to 25 µm, whereas the 
section evaluation interval was 12 (since each section was 12 wells apart 
from the next). The coronal navigation of the mouse brain atlas (Paxinos and 
Franklin, 2001) was used as reference to draw contours for the regions of 
interest: prefrontal cortex (PFC, Bregma 1.18 to -0.94 mm), corpus callosum 
(CC, Bregma 1.18 to 0.86 mm). The grid size was set to 100 for the PFC, 
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and 50 for the CC. A total of 15 counting frame sites were selected for 
counting cells in both regions. Areas that contained no cell bodies or were 
outside the contour were omitted. After counting from all the selected sites 
for each specific region, a results file containing several variables was 
generated by the software. The Gundersen and Schmizh-Hof coefficient of 
errors were used to decide whether enough sites were counted for each 
section. 
The estimated cell population was exported to excel and each animal was re-
assigned to its corresponding experimental group. Statistical analysis was 
performed in Prism (see Section 2.7). 
 
2.6. Western blot processing     
2.6.1. Tissue extraction, fixation and storage  
The right hemisphere of each brain was microdissected into cortex, 
prefrontal cortex, striatum, hippocampus, cerebellum and olfactory bulb, and 
placed in cryo-tubes on dry ice. The cryo-tubes were stored at -80oC to be 
later used for immunoblotting procedures.  
2.6.2. Tissue lysis 
Microdissected cortex tissue was removed from -80° C and placed on dry 
ice. The first step of the protocol involved preparing the lysis buffer on ice 
(see Table 2.4). 
Table 2.4 Lysis buffer recipe for western blot 
Solutions Stock Final Vol to add to 
1ml 
Company 
RIPA NA NA 944 Sigma-
Aldrich 
PMSF 100mM 1mM 10 Sigma-
Aldrich 
PI cocktail 25x 1x 40 Roche 
Z-VAD 5mM 5µm 1 Promega 
NaVan 700mM 1mM 5 Sigma 
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The steps below were followed for the tissue lysis process:  
1) Tissue was lysed in the prepared buffer using a tissue homogenizer 
glass. 
2) Tissue lysates were incubated on ice for 20 minutes. 
3) After incubation, tissue lysates was spun in a 4°C pre-cooled 
centrifuge at 15,000rpm, for 20 minutes, to remove cell debris. 
4) Supernatant was transferred into newly labeled 1.7mL tubes and kept 
on ice. 
2.6.3. Bradford and protein quantification 
Bradford Standards was prepared using bovine serum albumin (BSA) (Table 
2.5). BSA stock was prepared by dissolving BSA Fraction V powder in sterile 
PBS to a final concentration of 2mg/mL (Table 2.8) and syringe filter (0.2μm).  
Table 2.5 Bradford standards for western blot 
 PBS 
(µL) 
BSA standard 
(µL) 
Final concen-tration 
µg/ml 
Final volume 
(µL) 
A 400 - 0 400 
B 325 325 of C 125 325 
C 375 375 of D 250 375 
D 325 325 of F 500 325 
E 175 175 of G 750 350 
F 325 325 1000 325 
G 125 375 1500 325 
H 0 300 2000 300 
In addition, 1xBradford dye (Bio-Rad, USA) was prepared in deionised water 
from stock (Table 2.7A) and stored on ice. 
The following steps were then followed: 
1) Samples were diluted in strip tubes up to 10-fold in RIPA buffer (9µL 
of RIPA buffer: 1µL of protein sample) and vortexed. 
1µL of Bradford standards and 1µL of diluted protein samples were aliquoted 
in triplicate into 96-well clear flat bottom plates (Table 2.6). 
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Table 2.6 Plate reader format for the Microplate Reader 
 
2) 1x Bradford dye was added into the reagent reservoir. 200µL of 1x 
Bradford dye was added to each well using a multichannel pipet. 
3) The plates were incubated in the dark for 15 minutes and agitated 
using a rotary shaker. 
4) The plates were then placed in the Microplate Reader (BMG Labtech, 
Germany) 
5) Omega MARS (BMG Labtech, Germany) software was used to 
measure absorbance of the samples. 
6) The obtained results were then exported to excel where the protein 
concentration was calculated. See Table 2.7B for protein calculation 
formulas.  
7) An amount of desired protein was chosen – between 30µg and 20µg. 
A final volume of 20µL of sample was chosen.  
8) The following items were calculated for the gel sample preparation: 
a. The volume of protein (Vp) sample to be loaded (Table 2.7C). 
b. The Loading Dye (NuPAGE LDS Sample Buffer, Novex, USA) 
and reducing buffer (NuPAGE Sample Reducing Agent, Novex, 
USA) volume (Table 2.8). 
c. Volume of lysis buffer (Vlb) to be added (Table 2.7D). 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12
A
B
C
D
E
F
G
H
Sample 13
Sample 17
Sample 18
Sample 19
Sample 20
Sample 21
Sample 23
Sample 24Sample 16
Sample 15
Sample 14 Sample 22
Sample 12
Sample 11
Sample 10
Sample 9Sample 1
Sample 2
Sample 3
Sample 4
0 μg/mL
125 μg/mL
250 μg/mL
500 μg/mL
750 μg/mL
1500 μg/mL
2000 μg/mL
Sample 5
Sample 6
Sample 7
Sample 8
1000 μg/mL
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Table 2.7 Western blot calculations 
 Calculations Abbreviations and notes 
A) Bradford 
dye 
𝑉𝑏𝑑 = (𝑠𝑡 + 𝑠𝑝) 𝑥 3 𝑥 200µ𝐿 Vbd = volume Bradford dye; st = no. of 
Bradford standards; sp = no. samples; 3 = 
triplicates. 
 
 
B) Protein 
concentration 
𝑦 = 𝑚 × 𝑥 + 𝑐 →  𝑥 =
(𝑦 − 𝑐) ÷ 𝑚 ; 
Final 𝐶 = 𝑥 ∗ 10 
y = absorbance measurement, m = 
gradient of curve; x = concentration; c = 
the y-intercept; 10 is the dilation factor. 
 
C) Volume 
protein 
sample to be 
loaded 
 
 
𝑉𝑝 = 𝑆𝑝 ÷ 𝐶 
 
Vp = volume protein; Sp = amount of 
desired protein; C = concentration of 
protein sample. 
 
 
D) Final 
volume of 
lysis buffer 
𝑉𝑙𝑏 = 𝑉𝑠 − 𝐿𝐷𝑆 𝑆𝐵 − SRA −
Vp  
 
 
Vlb = volume lysis buffer; Vs = volume 
sample, LDS SB = LDS sample buffer; 
SRA = sample reducing agent; Vp = 
volume protein. 
 
2.6.4. Sample preparation and gel running 
The final volume per sample was 20µL and included protein samples, 
NuPAGE LDS Sample Buffer, NuPAGE Sample Reducing Agent and lysis 
buffer. This was aliquoted into strip tubes according to the Bradford Sheet 
calculations. The strip tubes were vortexed and spun, followed by 10 minutes 
boiling at 70°C.  
While samples were boiling, the Precision Plus Protein All Blue Standards 
ladder (Bio-Rad, USA) was thawed at room temperature and a 20X MES 
Running Buffer (Novex, USA) was prepared. A 10 well, 12% Bis-Tris protein 
gel (Novex, USA) was used. The protein gel tank (Novex, USA) was 
configured and the gel comb carefully removed without disrupting the wells. 
MES Running Buffer was poured into the tank. 
10µL of protein ladder was first loaded in the first well, and 5µL added to the 
tenth well. Once boiled, samples were vortexed and spun and then loaded 
into the gel (20µL per well). Finally, the gel tank was plugged into PowerPac 
and the gel was run for 3-4 hours at 100V.  
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2.6.5. Western transfer 
1X Western Transfer Buffer (1L) was prepared using 10X Transfer Buffer 
(100mL), 100% Methanol (200mL, Merck, Germany) and deionised water 
(700mL), and cooled at 4°C before use. 
Transfer tank was set up using the following steps: 
1) Transfer buffer was poured into the assembly tray. 
2) 1x gel holder cassette, two foam pads and four filter papers were 
soaked in the transfer buffer. 
3) Transfer membrane was then activated. Nitrocellulose (Bio-Rad, USA) 
– Transfer Buffer; PVDF – 100% Methanol. 
4) The gel holder cassette was placed in the assembly tray with the 
black side facing down and the transparent side against the slope of 
the assembly tray. 
5) A pre-soaked foam pad was placed on the black side of the gel holder 
cassette and the roller used to remove any bubbles. 
6) Two pre-soaked filter papers were placed on top of the foam pad and 
removed of any bubbles. 
7) The protein gel cassette was opened to release gel. 
8) The end of the gel was trimmed off. 
9) The gel was placed on top of filter paper from step 6.  
10) Transfer membrane was soaked in transfer buffer before placing over 
the gel. 
11) Two pieces of pre-soaked filter paper were placed on top of transfer 
membrane and any bubbles gently rolled out using the roller. 
12) Another foam pad was placed on top of the filter papers in step 11 
and any bubbles gently rolled out using the roller. 
13) The clamp on the transparent side of the gel holder cassette was 
locked to secure all components. 
14) The gel holder cassette was placed into trans-blot central core. 
15) Trans-blot central core was placed into mini trans-blot cell. 
16) A frozen ice-pack was placed in the trans-blot cell. 
17) The gel was run at 120V for 1.5hours. 
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Table 2.8 Agents concentrations 
Agent Stock 
concentration 
Final 
concentration 
Company 
BSA  2 mg / ml  
Bradford Dye 5X 1X Bio-Rad 
NuPAGE LDS Sample Buffer 4X 1X Novex 
NuPAGE Sample Reducing 
Agent 
10X 1X Novex 
NuPAGE MES SDS Running 
Buffer 
20X 1X Novex  
Tris-Glycine Transfer Buffer 10X 1X Made in-
house 
PBS 10X 1X  
Tween (PBS-T) 100% 0.1% In-house 
 
2.6.6. Western blot – LiCor System 
1X PBS-T was prepared from 10X in-house made PBS in deionised water 
and adding 100% Tween-20 (OmniPur, USA) for a final concentration of 
0.1%. Endogenous control used for primary antibodies were rabbit anti-
Calnexin (90kDa) or mouse anti-β-actin (42kDa). Primary antibodies included 
MBP (Millipore, USA), MAG (Millipore, USA), PLP (Abcam, USA) and Ermin 
(Merck, Germany) (Table 2.x). 
Secondary antibodies were diluted at a concentration of 1:10,000, and 
included: Alexa-Fluor goat anti-rabbit 680 (Life Technologies, USA) Alexa-
Fluor goat anti-mouse 800 (Life Technologies, USA) and Alexa-Fluor goat 
anti-rat 800 (Life Technologies, USA). 
The following steps were involved: 
1) Approximately 10mL of LiCor Blocking Buffer (LiCor, USA) were 
added to containers labelled with their corresponding ID. 
2) Membrane from transfer cassette was placed into the container with 
Blocking Buffer and incubated for 1 hour shaking at RT. 
3) Blocking buffer was removed and primary antibody was added to the 
container containing the membrane. This was placed at 4°C on the 
shaker overnight. 
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4) The next day the membrane was washed 1x30 minutes, 1x15minutes, 
1x10min and 1x5min at room temperature. 
5) All subsequent steps were conducted in the dark to prevent the 
fluorophore from degrading. The membrane was incubated in 
secondary antibody for 1 hour at RT. 
6) The membrane was then washed 1x15minutes and 3x5minutes in 
PBS-T. 
7) A LiCor Imaging System (LiCor, USA) was used to scan and visualize 
the blots. 
2.6.7. Membrane imaging 
The membrane was imaged using the LiCor Imaging System and Odyssey 
V3.0 software (LiCor, USA). LiCor system can only detect 700 and 800 
wavelengths. The intensity was adjusted for the 700 and 800 channels 
individually. The image curves were adjusted after the membrane was 
scanned. The image was then saved and exported as TIF files.  
2.6.8. Western blot analysis 
Scanned images of the blots were imported to Image Studio Lite (ver 5.2). 
The image intensity was adjusted using the software adjust tool. Relevant 
channels were selected based on the secondary antibodies used. A 
rectangle was drawn over the largest band representing one of the samples 
tested, and the same rectangle was copied and pasted over the other bands 
for each of the samples. Thus, the area of interest for each sample was 
equal within one gel. This was followed by drawing a rectangle over the 
control bands (i.e. Calnexin). The background average was selected 
overlying, or adjacent to, the bands, or both. Each band was then labeled 
with its corresponding condition name. Signal intensity and background 
values for each band was then automatically calculated and exported to 
Excel (Microsoft, USA). Here, the total signal of the protein of interest (i.e. 
MBP) was normalised to the corresponding total signal of the control protein 
(i.e. Calnexin) for each sample. The resulting values were then normalised to 
the average of all the values of the control condition for that comparison. For 
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example, in the case where SPF animals were compared to GF animals, the 
SPF group was used as control, and GF data normalised to that of SPF. 
Results were then exported to Prism (GraphPad, USA) for statistical 
analysis. 
Table 2.9 Primary antibodies details 
Antibodies Isotope 
MW 
(kda) Application 
Dilution DAB 
(min) 
Source 
GST-π rabbit  IHC 1:3000 2.5 
Scientific Hub 
Services 
Olig2 rabbit  IHC 1:300 6.5 Merck Milipore 
Olig2 rabbit  IF 1:750 - Merck Milipore 
MBP rat 18-20 WB 1:1000 - Milipore 
PLP rabbit 26.3 WB 1:1000 - Abcam 
 
 
2.7. Statistical analysis 
All statistical analysis was run using GraphPad Prism (version 6.07). 
Student’s t-test, two-way ANOVA with Sidak’s correction for multiple 
comparisons, and repeated measures ANOVA with Tukey’s correction for 
multiple comparisons were used to observe whether differences between the 
groups were statistically significant. Any p-values above 0.05 were not 
considered statistically significant. Variables are reported as mean ± SEM 
unless otherwise stated. 
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3.1. Summary 
Enriched laboratory environments (EE) have been shown to improve, or 
delay, motor and cognitive deficits in several neurodegenerative animal 
models. It is becoming increasingly apparent that environmental conditions 
are closely linked to myelination and oligodendrogenesis. White matter 
abnormalities have been revealed to be dysfunctional starting from early 
stages of Huntington disease (HD). Therefore, in the current study we 
investigated the extent to which the status of the environment could 
modulate myelination in the posterior corpus callosum (CC) of the early 
manifest YAC128 mouse model of HD. Animals of mixed genotype were 
allocated to either enriched housing (EH) or standard housing (SH) 
conditions from 4 to 18 weeks of age. Results revealed an overall reduction 
in myelin thickness, and a larger number of small diameter axons in both EH 
groups, regardless of genotype, compared to their corresponding SH 
controls. As previously reported, no changes in the number of mature 
oligodendrocytes were observed in the CC. We propose that environmental 
enrichment could conceivably prolong the ‘window of myelination’, and 
thinner myelin sheaths could be explained by an increase in number of newly 
myelinated axons, a previously suggested possible property of adult 
myelination. Furthermore, on a battery of behavioural tests, we observed, 
first, that animals housed in enriched conditions, regardless of genotype, 
exhibited decreased overall locomotor activity. Second, our findings suggest 
a marginal effect of an enriched environment on motor learning and motor 
performance in the WT group, and minor beneficial effects on motor learning, 
but not motor performance in the YAC128 mouse. And third, we observed an 
evident effect of enrichment on female body weight in the YAC129 mouse 
model, and a minor effect on the body-weight of WT females and males. Our 
findings indicated a lack of profound effects of enrichement on behavioural 
performance in this HD model, possibly due to the mild disease phenotype 
associated with the YAC128, which may have not progressed significantly 
over the course of this study.  
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3.2. Introduction 
Recent studies have demonstrated the beneficial effects of enriched 
environments (EE) on both healthy and disease animal models. These pre-
clinical insights have been partially translated to the clinic in patients 
suffering from psychiatric or neurodegenerative disorders. While Huntington 
disease (HD) is an autosomal-dominant genetic disorder, other highly 
prevalent human neurodegenerative disorders arise from the complex 
interaction between environmental and genetic factors. Thus, animal models 
of HD have become important tools to investigate the interplay between 
progressive physical, cognitive and psychiatric decline, and environmental 
components (Mo, Hannan, & Renoir, 2015a).  
Environmental enriching was first found to have a positive influence in 
delaying motor symptoms in a genetic mouse model of HD (van Dellen et al., 
2000). Since then, physiological and cognitive improvements with 
environmental enrichment have been demonstrated in several HD models, 
including the R6/1, R6/2 and N171-82Q (Hockly et al., 2002; Schilling et al., 
2004; Wood et al., 2010). These improvements have included reduced brain 
atrophy (Spires, 2004), improved spatial memory deficits (Nithianantharajah 
& Hannan, 2006), improved hippocampal neurogenesis (Lazic et al., 2006), 
delayed cognitive deficits (Nithianantharajah et al., 2008), and amelioration 
of depressive- (Du et al., 2012b) and emotion-related phenotypes (Renoir et 
al., 2012).  
Additionally, myelination has been demonstrated to be a plastic process and 
to undergo remodeling throughout adult life (Waly et al., 2014), with several 
animal studies demonstrating the effects of behavioural experience, enriched 
housing and voluntary exercising on adaptive myelination and 
oligodendroglial population dynamics in a variety of brain regions (Forbes & 
Gallo, 2017; Mount & Monje, 2017; Tomlinson, Leiton, & Colognato, 2016a). 
After four months of enrichment, middle-aged and old-aged rats showed 
increased axon and myelin sheath volume (Yang et al., 2013), while middle-
aged rats had an increased number of myelinating CNPase+ 
oligodendrocytes in the corpus callosum (CC) (Zhao et al., 2011). 
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Interestingly, young rats exhibited a shift in the distribution of oligodendroglial 
population in sensorimotor cortex between a short-term (10 days) and long-
term (42 days) period of enrichment (Keiner et al., 2017). Specifically, 
compared to standard housing, rats showed a decreased number of 
oligodendrocyte precursor cells (OPCs; labeled BrdU+NG2+) and an 
increase in the number of mature oligodendrocytes (labeled 
BrdU+NG2+GST-pi+) cells after 10 days of enrichment reflecting 
differentiation of OPCs into mature oligodendrocytes (Keiner et al., 2017). 
However, after 42 days of enrichment, OPCs and mature oligodendrocyte 
populations appeared comparable to the standard housing condition. 
Additionally, the number of newly differentiated myelinating 
oligodendrocytes, as labeled by BrdU+CNPase+, was increased after 10 
days, and remained increased following 42 days of enriched housing, relative 
to the standard housing condition (Keiner et al., 2017). However, other 
studies have provided little support for oligodendrogenesis in some cortical 
regions, or the amygdala, although evidence for increases in OPC 
populations was found (Ehninger et al., 2011; Ehninger & Kempermann, 
2003; Makinodan et al., 2012). In adult mice enriched for 40 days, increased 
number of proliferative OPCs (BrdU+NG2+S100b- labeled) were observed in 
the amygdala, but no differences were seen in CNPase+ labelled cells (i.e. 
myelinating oligodendrocytes) in this region compared to control mice 
(Ehninger et al., 2011). Similarly, no changes in oligodendrocyte density or 
morphology, or myelin transcript levels were found in prefrontal cortex (PFC), 
of young mice housed for 1.5 months in an EE setup (Makinodan et al., 
2012). 
In this study we aimed to investigate the effects of environmental enrichment 
on myelin plasticity and mature oligodendrocytes in the white matter tracts of 
the posterior corpus callosum of the early manifest YAC128 HD mouse 
model, and healthy littermates (as control). We also evaluated motor function 
and habituation, as well as anxiety- and depressive-like behaviour using a 
battery of behavioural tests. In addition, body weight over time, and brain 
weight were compared between groups.  
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3.3. Methods 
3.3.1. Experimental groups and housing conditions 
A total of 67 YAC128 transgenic (HD model) and wild-type (WT, control) 
mice were used in this study. Both males and females were included in all 
experimental groups. Sexing and genotyping of animals were carried out at 3 
weeks of age. Mice were housed under standard conditions with food ad 
libitum, in an inverted light-dark cycle until 4 weeks of age. Subsequently, 
they were placed into their allocated caging conditions under the same 
inverted light-dark cycle: enriched housing (EH), or standard housing (SH). 
Animals were housed in their allocated condition for a total of 14 weeks. At 
18 weeks (4.5 months) of age, animals were sacrificed, and their brains were 
harvested. Animals were weighed on a bi-weekly basis.  
 
Figure 3.1 Experimental groups for standard and enriched condition 
Four groups were used for these experiments: wild type (WT) groups – standard 
housing (SH) and enriched housing (EH), and YAC128 groups – also SH and EH. 
 
 
WT SH 
YAC128 SH YAC128 EH 
WT EH 
  
mHTT mHTT 
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Figure 3.2 Typical enriched housing 
Enriched cages contained objects, which offered various tactile and visual stimuli in 
terms of material, texture and shape. Objects included a small plastic box (‘my lego 
house’) filled with shredded paper, plastic and carton tunnels, wooden stairs, metal 
and ceramic bowls, cotton play balls, wooden stairs, and plastic toys (‘bear-buddy’ 
and plastic letters). 
 
Several factors were taken into consideration in the design of a suitable 
enriched housing environment (Figure 3.3). Animals allocated to the EH 
group were housed in larger than standard cages (48 × 26 × 21 cm). Five 
animals were housed in a single cage in order to stimulate social interaction. 
Additionally, novelty items that varied in shape, size, and texture were placed 
in the cage (Figure 3.2). This allowed for sensory, cognitive and motor 
stimulation through interaction with the environment. Three mice per cage 
were allocated to the SH condition and were housed in standard mouse 
cages (39 x 19 x 16 cm; Techniplast, Greenline, sealsafe plus mouse, 
GM500). To note that these animals were used as control SH for the 
deprivation study (Chapter 4). 
Plastic 
 shelter 
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Figure 3.3 Study design for an enriched housing conditions in 
laboratory animals 
Several factors were considered for the design of an ideal enriched housing 
condition (adapted from Singhal et al., 2014). Red crosses indicate environmental 
enrichment factors not implemented in the study. 
3.3.2. Overview of behavioural tests 
After 12 weeks of housing in their experimental conditions, several 
behavioural tests (Table 2.2) were carried out. This included evaluation of 
motor function and habituation (spontaneous activity test (SA)); anxiety and 
habituation (open field test (OFT)); anxiety (elevated plus maze (EPM)); 
motor function (climbing test); motor function and motor learning (rotarod test 
(RR)). Details of the behavioural tests are described in Chapter 2 - Materials 
and Methods (Section 2.1.3).  
3.3.3. Tissue harvesting and processing 
All brains were segmented through the mid-sagittal plane, and the left 
hemisphere was used for immunohistochemical procedures (Section 2.5). 
Sections were immunostained for the mature oligodendrocyte marker, 
Glutathione S-transferase (GST)-pi (Table 2.9). Stereo Investigator software 
was used for cell counting in the corpus callosum (Section 2.5.5). 
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Prior to cryosectioning for IHC procedures, the left hemisphere, of both 
males and females, was weighed. Brain weights were recorded and 
compared between the experimental groups. 
In addition to the brains harvested for immunostaining, three to four animals 
in each experimental condition were perfused and their brains harvested, for 
investigation of myelin ultrastructural analysis (i.e. axonal shape and size, 
and myelin thickness). For this study, posterior region (splenium) of the CC 
(~Bregma -1.82 to -2.70, according to the Mouse Brain Atlas, Paxinos and 
Franklin, 2001) was microdissected (Figure 2.3A) to be processed and 
imaged for TEM (Section 2.4). 
3.3.4. Statistical analysis 
The 2x2 factorial design (genotype x housing condition) of the study was 
statistically analysed using two-way independent ANOVA with Sidak’s 
correction for multiple comparisons, and repeated measures ANOVA 
statistical tests with Tukey’s correction for multiple comparisons. P-values 
equal to or greater than 0.05 were not considered statistically significant. P 
values and n values were indicated in the associated figure legends for each 
figure, while mean values are stated in the results section. Variables are 
reported as mean ± SEM unless otherwise stated.  
 
3.4. Results 
3.4.1. Behavioural tests results 
3.4.1.1. Spontaneous activity results  
Over the 30 minutes duration of the SA test, comparisons in the distance 
travelled using two-way ANOVA revealed no significant interaction between 
genotype and housing condition (F (1, 40) = 0.11, p > 0.05), significant main 
effect of housing condition (F (1, 40) = 12.81, p < 0.001), but no effect of 
genotype (F (1, 40) = 2.5, p > 0.05). Sidak’s correction for multiple 
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comparisons post-hoc tests revealed that wild-type enriched-housed (WT 
EH) animals (6240±522.9 cm) travelled less than wild-type standard-housed 
(WT SH) (10377±1793 cm, p < 0.05; Figure 3.4A). YAC128 EH (4926±207.4 
cm) mice also showed a trend towards decreased activity levels compared to 
their SH controls (8344±502.2 cm). Additionally, over the 10 minutes duration 
of the OF test, total distance travelled was compared using two-way ANOVA 
showing no significant interaction between genotype and housing condition 
(F (1, 40) = 3.97, p > 0.05), however, a significant main effect of housing 
condition (F (1, 40) = 6.46, p < 0.001), but no effect of genotype (F (1, 40) = 
0.35, p > 0.05). Sidak’s correction for multiple comparisons post-hoc tests 
revealed reduced distance travelled in WT EH animals (5995±721.8 cm) 
compared to SH controls (10509±1586 cm, p < 0.05; Figure 3.4F). Other 
measures of activity levels taken during the SA test included resting time, 
vertical (rearing) and jump counts, and average velocity. For all these 
measures, two-way ANOVA revealed no significant interaction between 
genotype and housing condition, a significant main effect of housing 
condition, but no effect of genotype. Sidak’s correction for multiple 
comparisons post-hoc tests revealed that EH mice of both genotypes 
showed increased levels of mean resting time (WT: 1010±28.24 s; YAC128: 
1066±17.51 s) when compared to their SH control group (WT: 846.6±48.96 
s; p < 0.01; YAC128: 880.6±24.57 s; p < 0.001; Figure 3.4B). Additionally, 
averaged vertical counts (Figure 3.4C), jump counts (Figure 3.4D), and 
velocity (Figure 3.4E) were significantly decreased in the YAC128 EH group 
compared to its SH control (vertical counts: EH 461.5±20.44, SH 
659.2±37.76, p < 0.01; jump counts: EH 499±48.42, SH 754.3±82.1, p ≤ 
0.05; average velocity: EH 34.16±0.75, SH 37.94±0.98, p ≤ 0.05).  
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Figure 3.4 Comparison of spontaneous activity measures in YAC128 
and WT mice under standard and enriched housing conditions 
(C) Total distance travelled during the SA test was lower in EH groups compared to 
SH groups, regardless of genotype. 
(D) Resting time was significantly higher in the EH groups compared to their SH 
controls, regardless of genotype. 
(E) Vertical counts were significantly lower in the YAC EH group compared to YAC 
SH controls, and a similar non-significant trend was observed in the WT groups’ 
comparison. 
(F) Number of jumps were also significantly lower in the YAC EH group compared 
to YAC SH control, but no significant differences were seen in WT SH/EH 
comparisons. 
(G) Average velocity was significantly lower in YAC EH group compared to YAC SH 
control. 
(H) Distance travelled during the OFT test was significantly lower in the YAC EH 
compared to YAC SH control, but no significant differences were seen in the WT 
EH compared to WT SH. 
 
The SA test was run over 30 minutes, while OFT was run for 10 minutes. All readouts were 
obtained from the video tracking software associated with each test. n = 10-12 animals of 
mixed sex per condition; bar graphs represent mean ± SEM. Two-way ANOVA, with Sidak’s 
correction for multiple comparisons. *p < 0.05; **p < 0.01. Abbreviations: SA, spontaneous 
activity; OF, open field test. 
 
3.4.1.2. Anxiety-like behaviour results  
When comparing the total time spent in the centre of the arena during the 10 
minutes OF test of anxiety, two-way ANOVA revealed no significant 
interaction between genotype and housing condition (F (1, 39) = 0.09, p > 
0.05), no significant main effect of housing condition (F (1, 39) = 0.14, p > 
0.05), and no effect of genotype (F (1, 39) = 0, p > 0.05) between 
experimental groups (Figure 3.5A). Additionally, no significant differences 
were seen between any of the groups of interest in the total time spent in the 
open arms of the maze during 5 minutes of the EPM test of anxiety (two-way 
ANOVA, interaction (F (1, 36) = 3.2, p > 0.05); housing condition (F (1, 36) = 
0.16, p > 0.05); genotype (F (1, 36) = 0.4, p > 0.05); Figure 3.5B).   
 
  
 
109 
 
Figure 3.5 Comparison of anxiety-like behaviour in YAC128 and WT 
mice housed under standard and enriched conditions 
(A) No significant differences were observed between groups in percentage time 
spent in the centre of the arena in the OFT. 
(B) No significant differences were observed between groups in percentage time 
spent in the open arms during the EPM test. 
 
The OFT had a duration of 10 minutes, the EPM test was run for 5 minutes. Readouts for 
the OFT and EPM were obtained from the EthoVision, video tracking software. Percentage 
(%) of total time was calculated for each condition. n = 10-12 animals of mixed sex per 
condition; bar graphs represent mean±SEM. Two-way ANOVA. Abbreviations: OFT, open 
field test; EPM, elevated plus maze. 
 
3.4.1.3. Motor function results 
When comparing the latency to climb two-way ANOVA revealed no 
significant interaction between genotype and housing condition (F (1, 40) = 
0.95, p > 0.05), no significant main effect of housing condition (F (1, 40) = 
1.05, p > 0.05), and no effect of genotype (F (1, 40) = 0.01, p > 0.05) (Figure 
3.6A) across experimental conditions. For time spent climbing, two-way 
ANOVA revealed no significant interaction between genotype and housing 
condition (F (1, 40) = 0.31, p > 0.05), however a significant main effect of 
housing condition (F (1, 40) = 9.05, p < 0.05), but no effect of genotype (F (1, 
40) = 0.4, p > 0.05). Sidak’s correction for multiple comparisons post-hoc test 
revealed a significant difference in time spent climbing between YAC128 SH 
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and EH groups (p < 0.05), and a similar non-significant trend was observed 
between WT SH and EH (p > 0.05; Figure 3.6B). For number of climbing 
attempts, two-way ANOVA revealed no significant interaction between 
genotype and housing condition (F (1, 40) = 0.005, p > 0.05), however a 
significant main effect of housing condition (F (1, 40) = 11.62, p < 0.01), but 
no effect of genotype (F (1, 40) = 3.4, p > 0.05). Sidak’s correction for 
multiple comparisons post-hoc test revealed differences in the number of 
climbing attempts between WT EH (8.8±2.08) and WT SH controls 
(15.33±2.05; p < 0.05), and between YAC128 EH (5±1.01) and YAC128 SH 
controls (11.83±2.19, p < 0.05). Both WT and YAC128 animals in the EH 
condition were associated with a lower number of climbing attempts than 
their corresponding SH controls (Figure 3.6C). 
3.4.1.4. Motor function and motor learning evaluation 
The latency to first fall (Figure 3.7) and the number of falls (Figure 3.8) were 
recorded as measures of motor learning performance on the fixed speed 
rotarod training over three days, with three trials per day, except the first day 
when only two trials were recorded. For the latency to fall, repeated 
measures ANOVA revealed a significant main effects of time (F (7,280) = 
2.557, p < 0.05), but no effect of genotype and housing condition (F (3, 40) = 
1.533, p > 0.05), and no effect of the interaction between the two (F (21,280) 
= 0.673, p > 0.05). No significant differences in latency to fall were found 
between experimental groups when corrected for multiple comparisons (p 
>0.05). However, YAC128 EH mice were able to remain on the rotarod for 
longer (increased latency to fall) compared to YAC128 SH mice, during trials 
2-6, although this difference was not significant (Figure 3.7C). When 
averaged over training days, WT EH mice showed a trend towards a slightly 
longer latency to fall compared to the other groups on the first two training 
days, however this also was not significant (two-way ANOVA for each 
training day; p > 0.05, Figure 3.9A). The number of falls, and latency to fall 
was similar across all animal groups and plateaued by trial 6-7 (p > 0.05; 
(Figure 3.7C). 
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Figure 3.6 Comparison of climbing characteristics of YAC128 and WT 
controls housed under standard and enriched conditions  
(A) No significant differences were observed between the latency for the first 
climbing attempt, although there was a trend for WT EH to take longer before 
attempting climbing compared to its SH control. 
(B) No significant differences were observed between the total time spent climbing, 
although there was a trend for both the WT EH and YAC EH to spend less time 
climbing compared to their SH controls. 
(C) Both WT EH and YAC EH performed less climbing attempts compared to their 
corresponding SH controls.  
 
The climbing test had a total duration of 6 minutes, and videos were examined manually. n = 
10-12 animals of mixed sex per condition; bar graphs represent mean±SEM. Two-way 
ANOVA, with Sidak’s correction for multiple comparisons; *p < 0.05. 
 
In terms of number of falls, repeated measures ANOVA revealed significant 
main effects of time (F (7,280) = 3.66, p < 0.001), but no effect of the 
genotype and housing condition (F (3, 40) = 1.952, p > 0.05), and no effect of 
the interaction between the two (F (21,280) = 1.095, p > 0.05). On the first 
trial of training, WT EH mice showed a trend towards falling less (0.1±0.1) 
than YAC128 EH (1±0.39) animals, and WT SH mice also fell less 
(0.33±0.14) than YAC128 SH animals (1.16±0.6). Although, no statistical 
differences were seen between the groups in the number of falls, WT EH 
animals exhibited the smallest number of falls over all training trials (red 
squares), followed by WT SH (black squares) and YAC EH mice (red 
triangles; Figure 3.8A, B, and C). In addition, from trial 1 to 5, the YAC128 
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EH group showed a slightly smaller, non-significant, number of falls 
compared to YAC128 SH controls (p > 0.05; Figure 3.8C). 
The proportion of mice in each experimental group that fell off the rotarod in 
each session was calculated, and averaged over trials for each training day 
(Figure 3.9B). Although not statistically significant, the WT EH group showed 
a trend towards smaller proportion of mice falling off the rotarod compared to 
all the other groups. During the first day of training (2 trials) 10% (±0%) of 
WT EH mice consistently fell off the rotarod compared to 20.83% (±12.50%) 
of WT SH mice, 40% (±20%) of YAC128 EH mice, and 37.5% (±4.17%) of 
YAC128 SH mice. On the second training day (3 trials), as little as 3.33% 
(±3.33%) WT EH mice had fallen off the rotarod, 13.89% (±5.5%) WT SH, 
and 16.67% (±3.33%) YAC128 EH and 27.78% (±2.78%) YAC128 SH mice 
fell off the rotarod. Finally, on the third training day, only 6.67% (±3.33%) WT 
EH mice fell off the rotarod, compared to 13.89% (±2.78%) of WT SH mice, 
23.33% (±3.33%) of YAC128 EH, and 16.67% (±4.81%) of YAC128 SH.  
After three days of training, on the fourth day, the rotarod test was run over 
three trials, at an accelerated speed, and the latency to first fall was taken as 
a measure of motor performance. Repeated measures ANOVA revealed no 
significant main effects of time (F (2,80) = 0.56, p > 0.05), but a main effect 
of genotype and housing condition (F (3,40) = 2.87, p < 0.05), and no effect 
of the interaction between the two (F (6,80) = 0.54, p > 0.05). Tukey’s 
correction for multiple comparisons post-hoc test revealed on the first trial, 
the WT EH group showed longer latency to fall (286.7±8.02 s) compared to 
all the other groups, but significantly different only to YAC128 EH 
(194.2±30.13 s, p < 0.05; Figure 3.10B). When averaged over all three 
testing trials, two-way ANOVA revealed a significant interaction between 
genotype and housing condition (F (1, 40) = 4.19, p > 0.05), no significant 
main effect of housing condition (F (1, 40) = 0.35, p > 0.05), and significant 
effect of genotype (F (1, 40) = 4.83, p > 0.05) between experimental groups. 
WT EH (276.7±10.33 s) animals took significantly longer to fall compared to 
YAC128 EH (215.9±14.72 s, p < 0.05) mice, and a non-significant trend 
towards a higher latency to fall relative to WT SH was also notable 
(238.9±16.02 s, p > 0.05; Figure 3.10A). 
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Figure 3.7 Comparison of latency to fall during fixed speed rotarod 
training for YAC128 and WT mice in SH and EH conditions  
(A) Latency to fall over 8 trials of training in all groups. 
(B) Slightly better performance in WT EH compared to WT SH for several sessions. 
(C) Faster motor learning performance in YAC128 EH mice compared to SH control. 
Latency to fall illustrated in seconds (s). Training was run over 3 days with 2-3 trial sessions 
per day. n = 10-12 animals of mixed sex per condition; error bars represent mean±SEM. 
Repeated measures ANOVA. 
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Figure 3.8 Comparison of number of falls of YAC128 and WT mice 
housed under standard and enriched conditions during fixed speed 
rotarod training  
(A) Number of falls over the 8 trials of training for all groups. 
(B) WT EH had similar number of falls to WT SH with the exception of several trials. 
(C) YAC128 EH mice had less number of falls over 4 trials compared to SH control. 
Error bars represent mean±SEM. Repeated measures ANOVA.  
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Figure 3.9 Session averages of latency to fall and percentage of mice 
fallen for YAC128 and WT mice housed under standard and enriched 
conditions 
(A) Average latency to fall for each day of training shows some trends towards EH 
groups performing slightly better, although no significant differences were found. 
(B) Percentage of mice that fell off the rotarod was (non-statistically significant) 
smaller in the WT EH group compared to the other groups. 
 
Testing was run over 2-3 trials within the same day. n = 10-12 animals of mixed sex per 
condition; bar graphs represent the mean±SEM. Two-way ANOVA, with Sidak’s correction 
for multiple comparisons. Latency to fall illustrated in seconds (s) (A). Proportion of mice that 
fell off the rotarod averaged over trials for each training day (B). 
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Figure 3.10 Comparison of latency to fall in YAC128 and WT mice 
housed under standard and enriched conditions during accelerated 
rotarod test 
(A) WT EH mice outperformed all groups over 3 trials of accelerated rotarod testing 
session. 
(B) Latency to fall was significantly higher in the WT EH group compared to YAC 
EH, and (non-statistically significant) higher than all the other groups over all 3 
trials.  
 
Latency to fall illustrated in seconds (s). Testing was run over 3 trials within the same day. n 
= 10-12 animals of mixed sex per condition; bar graphs represent mean±SEM (A); and, error 
bars represent ±SEM (B). Two-way ANOVA, with Sidak’s multiple comparisons test (A), and 
repeated measures ANOVA, with Tukey’s multiple comparisons test (B). *p < 0.05. 
Comparison symbols: * WT EH vs YAC128 EH. 
 
3.4.2. Ultrastructural analysis of myelin  
The inner (axoplasm) and outer (axoplasm and myelin sheath) diameters of 
regular-shaped axons in the posterior part (splenium) of the CC were 
measured (Figure 2.3). Representative micrographs of callosal axons for 
each experimental group are illustrated below, in Figure 3.11. G-ratios were 
calculated as the inner diameter divided by the outer diameter, and used as 
a measure of myelin thickness (Figure 2.4). 
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G-ratios were first evaluated against inner diameter for each axon to 
examine the variability of myelin thickness at different ranges of axonal 
diameters. WT EH mice exhibited qualitatively higher g-ratios, suggestive of 
thinner myelin sheath, at small axonal diameters (ID < 500nm), and smaller 
g-ratios, suggestive of thicker myelin sheath, at large axonal diameter (ID ≥ 
1000nm) compared to WT SH animals (Figure 3.12A). Cumulative frequency 
analysis confirmed a shift towards overall larger g-ratios, in WT EH animals 
compared to WT SH mice (Figure 3.12B). Similarly, YAC128 EH animals 
showed a trend towards overall larger g-ratios relative to YAC128 SH, 
although not to the same extent as that seen in WT groups (Figure 3.12C 
and D).  
When the g-ratio was averaged over all axonal diameters, two-way ANOVA 
revealed no significant interaction between genotype and housing condition 
(F (1, 2635) = 1.54, p > 0.05), significant main effect of housing condition (F 
(1, 2635) = 37.21, p < 0.0001), and no main effect of genotype (F (1, 2635) = 
2.51, p > 0.05). Both WT and YAC128 EH groups showed higher g-ratios, 
suggestive of thinner myelin sheaths, compared to their respective SH 
controls (Figure 3.13A). Specifically, Sidak’s correction for multiple 
comparisons post-hoc test revealed WT EH (0.798±0.002) animals 
possessed a significantly greater mean g-ratio compared to WT SH 
(0.779±0.003, p < 0.0001), and YAC128 EH (0.798±0.002) showed 
significantly higher g-ratios compared to YAC128 SH (0.786±0.002, p < 
0.0001). 
In addition, g-ratio values were classified, averaged and compared according 
to three inner diameter ranges: small diameter axons (ID < 500nm), mid-
range diameter axons (500 ≤ ID < 1000nm), and large diameter axons (ID ≥ 
1000nm) (Figure 3.13B). At small diameter ranges, two-way ANOVA 
revealed significant interaction between genotype and housing condition (F 
(1, 939) = 18.6, p < 0.0001), significant main effect of housing condition (F 
(1, 939) = 24.45, p < 0.0001), but no main effect of genotype (F (1, 939) = 
0.24, p > 0.05). Sidak’s correction for multiple comparisons post-hoc test 
revealed WT EH (0.765±0.003) showed a significantly higher mean g-ratio, 
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suggestive of thinner myelin sheath, compared to both WT SH (0.727±0.004, 
p < 0.0001), and YAC128 EH animals (0.749±0.004, p < 0.01). In addition, 
YAC128 SH (0.747±0.004) also showed a significantly larger mean g-ratio, 
suggestive of thinner myelin sheath, compared to WT SH (p < 0.01). At mid-
range axonal diameters, two-way ANOVA revealed no significant interaction 
between genotype and housing condition (F (1, 1420) = 0.54, p > 0.05), 
significant main effect of housing condition (F (1, 1420) = 57.05, p < 0.0001), 
and no main effect of genotype (F (1, 1420) = 1.21, p > 0.05). Sidak’s 
correction for multiple comparisons post-hoc test revealed g-ratio of WT EH 
(0.814±0.002) and YAC128 EH (0.819±0.003) animals were significantly 
larger than that of WT SH (0.793±0.003, p < 0.0001), and YAC128 SH 
(0.794±0.002, p < 0.0001) mice, respectively. No differences were observed 
at the mid-diameter range between WT and YAC128, regardless of housing 
condition (p > 0.05). Finally, at large axonal diameters, two-way ANOVA 
revealed significant interaction between genotype and housing condition (F 
(1, 271) = 13.38, p < 0.001), significant main effect of housing condition (F 
(1, 271) = 11.34, p < 0.001), but no main effect of genotype (F (1, 271) = 
0.48, p > 0.05). Sidak’s correction for multiple comparisons post-hoc test 
revealed YAC128 EH (0.883±0.004) showed a significantly higher average g-
ratio compared to both YAC128 SH (0.844±0.005, p < 0.0001), and WT EH 
(0.859±0.005, p < 0.05). However, no significant differences were seen 
between WT SH (0.860±0.005) and WT EH (p > 0.05) at this range.  
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Figure 3.11 Representative TEM images of callosal axons in YAC128 
and WT mice housed under standard and enriched conditions  
Representative micrographs of axons from the posterior (splenium) region of the 
corpus callosum for each experimental group. Scale bar at 2µm. 
WT SH 
YAC128 SH YAC128 DH 
WT DH 
2 μm 
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Figure 3.12 G-ratios and axonal diameters of YAC128 and WT mice 
housed under standard and enriched conditions  
(A) Scatter plot of g-ratio values against inner axonal diameter showed higher g-
ratios at small ID (ID < 500nm), and smaller g-ratio at mid-range and large ID 
(ID ≥ 500) for the WT EH (red) compared to SH group (black). 
(B) Cumulative frequency plot of g-ratios showed an overall shift towards larger g-
ratios for WT EH mice compared to WT SH. 
(C) Scatter plot indicating lower g-ratio values at smaller to mid-range axonal 
diameters (ID < 700 nm), and higher values for mid-range to large axonsal 
diameters (ID > 700nm) for YAC128 EH (red) compared to SH (black).  
(D) Cumulative frequency of g-ratio showed a close overlap of the two curves 
representative of the YAC128 groups, although a small overall shift towards 
larger g-ratios can be observed. 
 
n = 474 - 916 axons per condition (WT SH, n = 474 axons; WT EH, n = 843 axons; YAC128 
SH, n = 782 axons; YAC128 EH, n = 556 axons). 2-4 animals per condition. 
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Figure 3.13 Average g-ratio for YAC128 and WT mice housed under 
standard and enriched conditions 
(A) The EH groups showed significantly smaller g-ratio values for both the WT and 
the YAC128 groups, when compared to their respective SH controls. 
(B) G-ratio values were classified and compared based on their corresponding inner 
diameter ranges (small diameter axons, ID < 500nm; mid-range diameter axons, 
500 ≤ ID< 1000nm; large diameter axons, ID ≥ 1000nm). Note the overall 
increase in g-ratio with increasing axonal diameter, as well as increased g-ratios 
of EH mice compared to SH mice, for both WT and YAC128 groups, at small 
and medium diameter ranges (IDs).  
 
Bar graphs represent mean±SEM. SEM comes from axonal variance. n = 474 - 916 axons 
per condition (WT SH, n = 474 axons; WT EH, n = 843 axons; YAC128 SH, n = 782 axons; 
YAC128 EH, n = 556 axons); 2-4 animals per condition. Two-way ANOVA, with Tukey’s 
multiple comparisons test. *p < 0.05; **p < 0.01; ****p < 0.0001. Inner diameter shown in 
nanometres (nm). Abbreviations: ID, inner diameter, SH, standard housing, EH, enriched 
housing, WT, wild type. 
 
3.4.3. Differences in axonal characteristics 
WT EH animals exhibited a higher number of axons with small axonal 
diameters (300 ≤ ID ≤ 600nm), and a smaller or similar number of axons with 
large axonal diameters (ID ≥ 700nm), compared to WT SH controls (Figure 
3.14A). Cumulative frequency plot of inner diameters showed a close overlap 
of the two curves representative of the EH and SH WT groups, with a small 
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shift towards smaller g-ratios, driven by the aforementioned larger number of 
smaller axonal diameters, for the WT EH group (Figure 3.14B). In addition, 
when the means of the axonal diameters were compared, WT EH animals 
(614.6±8.7) showed significantly higher number of axons with smaller inner 
diameters compared to their WT SH control (652.5±12.6, p < 0.05, (Figure 
3.14C). A higher number of axons with small diameters (100 to 500nm), and 
a smaller number of axons at mid-range axonal diameters (600 to 700nm) 
were observed in the YAC128 EH animals compared to SH controls (Figure 
3.15A). The YAC128 EH cumulative frequency curve also showed a shift 
towards the left, driven by a larger number of small-to mid-range axonal 
diameters, compared to the SH group (Figure 3.15B). In addition, the mean 
axonal diameter of YAC128 EH mice (626.7±11.8) was significantly smaller 
than that of YAC128 SH animals (672.7±10.7, p < 0.01, Figure 3.15C). 
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Figure 3.14 Axonal diameters of WT mice house under standard and 
enriched conditions 
(A) Higher number of axons with a small diameter (300 to 600nm), and a smaller or 
similar number of axons with a large diameters (≥700nm), in WT EH animals 
compared to their WT SH controls. 
(B) Cumulative frequency of axonal diameters showed a small shift towards smaller 
diameters in WT EH mice (red) compared to WT SH (black). 
(C) WT EH animals showed smaller average axonal diameter myelinated axons 
compared to WT SH.  
 
n = 474 - 916 axons per condition (WT SH, n = 474 axons; WT EH, n = 843 axons; YAC128 
SH, n = 782 axons; YAC128 EH, n = 556 axons); 2-4 animals per condition. Relative 
frequency histogram (A) and cumulative frequency (B), bin width = 100nm (A). Unpaired, 
two-tailed t-test, 95% confidence intervals, *p < 0.05; bar graphs represent mean ± SEM (C). 
Abbreviations: ID, inner diameter. 
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Figure 3.15 Axonal diameters of YAC128 mice housed under standard 
and enriched conditions 
(A) Higher number of axons with a small diameter (100 to 500nm), and a smaller 
number of mid-range diameter axons (600 to 700nm), in YAC128 EH animals 
compared to their YAC128 SH controls. 
(B) Cumulative frequency of axonal diameters exhibiting a small shift towards 
smaller diameters for YAC128 EH mice (red) compared to YAC128 SH (black). 
(C) Myelinated axons of YAC128 EH animals possessed a smaller average 
diameter compared to YAC128 SH.  
 
n = 474 - 916 axons per condition (WT SH, n = 474 axons; WT EH, n = 843 axons; YAC128 
SH, n = 782 axons; YAC128 EH, n = 556 axons); 2-4 animals per condition. Relative 
frequency histogram (A) and cumulative frequency (B), bin width = 100nm (A). Unpaired, 
two-tailed t-test, 95% confidence intervals, **p ≤ 0.01; bar graphs represent mean±SEM (C). 
Abbreviations: ID, inner diameter. 
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3.4.4. Mature oligodendrocyte numbers  
Mature oligodendrocytes, as identified by GST-pi staining, were counted in 
all regions of the corpus callosum. No differences were seen between any of 
the four groups (two-way ANOVA, p > 0.05, Figure 3.16).  
 
Figure 3.16 Number of GST-pi positive cells in the CC of YAC128 and 
WT mice housed under standard and enriched conditions 
No significant differences were seen in callosal GST-pi positive cell population 
between the four experimental groups. 
  
Bar graphs represent the average of a total of 7-10 animals per condition; bar graphs 
represent mean±SEM. Two-way ANOVA. Abbreviations: CC, corpus callosum; Glutathione 
S-transferase (GST)-pi.  
 
3.4.5. Brain weight for standard and enriched WT and 
YAC128 animals 
Left hemisphere of the brain was weighed for each animal prior to tissue 
processing. No significant differences were found at 4.5 months between any 
of the groups when comparing the brain weights of mixed sex (Figure 3.17A), 
female (Figure 3.17B), or male (Figure 3.17C) mice (two-way ANOVA). 
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Figure 3.17 Brain weight comparison in YAC128 and WT mice housed 
under standard and enriched conditions 
(A) Mixed sex animals showed similar brain weights regardless of experimental 
condition. 
(B) Female mice had similar brain weights across experimental conditions. 
(C) Male mice also showed similar brain weights across experimental conditions. 
 
Animals’ brains were weighed at 18 weeks (4.5 months) of age. Left hemisphere weight 
shown in milligrams (mg). n = 5-7 males per condition, and 5-7 females per condition; bar 
graphs represent mean±SEM. Two-way ANOVA. 
 
3.4.6. Body weight comparison over time for standard and 
enriched WT and YAC128 animals 
Animals were weighed fortnightly starting from pn50 (~7 weeks) until being 
sacrificed on pn126 (18 weeks). Weight comparisons were evaluated and 
compared separately for females and males.  
In the female groups (Figure 3.18A), repeated measures ANOVA revealed 
significant main effects of age (F (5,90) = 64, p < 0.0001), and experimental 
group (genotype and housing condition) (F (3,18) = 12.62, p < 0.0001), as 
well as a significant effect of the interaction between the two (F (15,90) = 
6.283, p < 0.0001). Female YAC128 EH body weights exceeded those of all 
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other experimental groups between pn50-126. Female YAC128 EH body 
weights (24.72±0.45) at pn64 were significantly larger (p < 0.05) than those 
of WT EH females (21.34±0.46g), and remained so until the day of sacrifice 
(p < 0.0001) (Tukey’s correction for multiple comparisons). The difference in 
YAC128 EH and WT EH body weight increased over time (pn78: WT EH 
22.8±0.72g, YAC128 EH 26.58±0.75g, p < 0.01; pn92: WT EH 22.24±0.79g, 
YAC128 EH 28.80±1.32g, p < 0.0001; pn106: WT EH 22.32±0.83g, YAC128 
EH 27.48±10.4g, p < 0.0001; pn126: WT EH 24.06±0.67g, YAC128 EH 
28.48±0.82g, p < 0.001). Additionally, YAC128 EH (26.58±0.75g) females 
showed increased body weights compared to YAC128 SH (23.16±1.16g) at 
pn78 (p < 0.05), and pn106 (YAC128 EH: 27.48±1.04g; YAC128 SH: 
24.46±1.03g; p < 0.05); whereas YAC128 SH (23.16±1.16g) females showed 
increased body weights when compared to WT SH (20.21±0.54g) at pn78 (p 
≤ 0.05), and pn92 (YAC128 SH: 23.46±1.32g; WT SH: 20.57±0.4g; p < 0.05).  
When comparing male body weights (Figure 3.18B), repeated measures 
ANOVA also revealed significant main effects of time (F (5,90) = 129, p < 
0.0001), and experimental group (genotype and housing condition) (F (3,18) 
= 3.52, p < 0.05), as well as an effect of the interaction between the two (F 
(15,90) = 2.846, p < 0.05). YAC128 SH (29.71±0.8g) males had increased 
body weights compared to WT SH (26.92±1.03g) males at pn92 (p < 0.05), 
and 106 (YAC128 SH: 30.93±0.9g; WT SH: 27.2±1.08g; p < 0.05). 
Additionally, YAC128 EH (32.14±0.65g) males showed increased body 
weight compared to WT EH (29±0.7g) males at pn126 (p < 0.05).  
At the final time point, 18 weeks of age, when weight was taken prior to 
sacrifice, for female mice, two-way ANOVA revealed a significant interaction 
between genotype and housing (F (1, 18) = 5.6, p < 0.05), a main effect of 
housing condition (F (1, 18) = 19.12, p < 0.001), and a main effect of 
genotype (F (1, 18) = 13.42, p < 0.01). Female YAC128 EH mice showed 
significantly increased body weights compared to both WT EH, and YAC128 
SH (with Sidak’s correction for multiple comparisons, p < 0.01; Figure 3.19). 
For male mice, two-way ANOVA revealed no significant interaction between 
genotype and housing (F (1, 18) = 0.6, p > 0.05), no main effect of housing 
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condition (F (1, 18) = 0, p > 0.05), but a main effect of genotype (F (1, 18) = 
8.04, p < 0.05). Sidak’s correction for multiple comparisons revealed that 
YAC128 EH male mice (29±0.69g) showed a trend towards increased body 
weight compared to WT EH mice (32.14±0.65g; p < 0.05).  
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Figure 3.18 Body weight over time for female and male YAC128 and WT 
mice housed under standard and enriched conditions 
(A) YAC128 EH female mice showed increased body weights compared to the other 
groups throughout all time points. 
(B) Male body weights were similar between groups with the exception of later time 
points (>pn92). 
 
Animals were weighed fortnightly: pn 50 (~7weeks) to 126 (18weeks). Body weight 
in grams (g). n = 5-7 mice per sex per condition; error bars as mean±SEM. 
Repeated measures ANOVA, with Tukey’s corrections for multiple comparisons. *p 
< 0.05; **p< 0.01; ***p < 0.001; ****p < 0.0001. Symbols: # WT SH vs WT EH; * WT 
EH vs YAC128 EH; #WT SH vs YAC128 SH; * YAC128 SH vs YAC128 EH. 
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Figure 3.19 Final body weight of female and male YAC128 and WT mice 
housed under standard and enriched conditions 
(A) Female YAC128 mice in the EH condition showed increased body weight 
compared to all the other groups. 
(B) Male body weights were similar across conditions although slightly larger in the 
YAC128 SH/EH groups compared to WT. 
 
Average body weight on sacrifice day, pn 126 (18 weeks). Body weight shown in grams (g). 
n = 5-7 animals of each sex per condition; bar graphs represent mean±SEM. Two-way 
ANOVA, with Sidak’s multiple comparisons test. *p < 0.05; **p < 0.01.  
 
3.5. Discussion 
Enrichment effects on behavioural performance and motor function 
Locomotor activity in enriched mice was decreased across WT and YAC128 
animals, and relative activity levels between both genotypes were broadly 
comparable. These observations are in keeping with previous reports that 
enriched rodents were less likely to exhibit exploratory behaviours (Brenes, 
Rodríguez, & Fornaguera, 2008a; Hellemans, Benge, & Olmstead, 2004; 
Leger et al., 2015; Makinodan et al., 2012; Mosaferi et al., 2015), and that 
early manifest YAC128 mice locomote similarly to WT counterparts (Van 
Raamsdonk et al., 2005). No effect of enrichment on anxiety-like behaviour 
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was observed across genotypes, somewhat consistent with earlier WT 
rodent studies (Brenes, Rodríguez, & Fornaguera, 2008a; Peña et al., 2006; 
Peña et al., 2009), but at variance with others (Galani et al., 2007; Hellemans 
et al., 2004). Increased anxiety-like behaviour was previously seen in 7 
months’ old YAC128 mice (Southwell et al., 2009), raising the possibility that 
our younger YAC128 animals (4.5 months) could have been yet to manifest 
this phenotype. Similarly, climbing characteristics were found to be 
approximately equivalent across genotypes and housing conditions, roughly 
in keeping with a previous report of no changes in climbing performance in 
standard housed YAC128 FVB mice compared to WT controls, across most 
age groups (Menalled et al., 2009). Finally, YAC128 animals housed under 
standard conditions were associated with the weakest rotarod training 
performance, consistent with previous studies reporting motor learning 
deficits in YAC128 SH mice (Franciosi et al., 2012; Lawhorn, Smith, & 
Brown, 2008; Slow et al., 2003; Van Raamsdonk et al., 2005). Furthermore, 
a non-significant improvement in rotarod performance was seen, to a small 
extent, during training and testing in enriched WT mice compared to other 
experimental groups, and, to a greater degree, during rotarod training in 
enriched YAC128 animals, compared to their SH counterparts. These results 
suggest that enrichment marginally improved motor learning in both 
genotypes, and motor function in WT animals. Interestingly, enrichment was 
previously reported to improve rotarod test (i.e. motor) performance in the 
early onset and aggressive R6/2 mouse model of HD (Hockly et al., 2002). 
This disparity in results, as well as the mild effects of enrichment on 
behaviour we observed, may be due to the late onset phenotype associated 
with our YAC128 model, as well as the early stage of disease manifestation 
at which these tests were conducted. 
Enrichment effects on myelination and mature oligodendrocytes 
We observed an overall reduction in average myelin thickness across all 
axons in enriched versus standard-housed animals, across both genotypes. 
Furthermore, enriched mice of both genotypes were associated with an 
increased number of small diameter axons relative to standard-housed 
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counterparts. Environmental enrichment was associated with a decrease in 
average axonal diameter across genotypes. These observations are 
consistent with a previous study reporting an increase in number of small-
diameter axons in enriched aged rats, and that these were associated with a 
decreased myelin thickness (Yang et al., 2013). Since large diameter axons 
are the first axons to become myelinated (Almeida et al., 2011; Hahn et al., 
1987; Matthews & Duncan, 1971), we speculate that myelination may have 
been ongoing (Karttunen, 2017; Powers et al., 2013), such that at the time of 
our analysis smaller diameter axons were still undergoing myelination, with 
these freshly myelinated axons being associated with an intrinsically thinner 
myelin sheath.  
A further notable observation was that of a significantly thinner myelin sheath 
in small diameter axons in YAC128 animals housed under standard 
conditions relative to WT controls. However, while a trend towards thinner 
myelin in YAC128 SH animals, relative to WT SH, was observed across all 
diameter axons, this was not found to be significant. Previous work by our 
laboratory has demonstrated that thinner myelin sheaths in the same brain 
region (i.e. posterior CC) in standard housed YAC128 mice only becomes 
evident after 6 months of age (Teo et al., 2016). Furthermore, our group has 
also previously shown thinner myelin sheaths in the anterior mid-body of the 
CC in the standard housed YAC128 mouse from 1.5 months of age (Teo et 
al., 2016). This suggests that development of myelin-related pathology in the 
posterior region of the CC may be more protracted than in the anterior to 
mid-region, and that our observation at 4.5 months of age took place prior to 
this becoming severe and significant.  
Enrichment was not found to influence the number of GST-pi positive cells 
(i.e. mature myelinating oligodendrocytes) in posterior CC. This observation 
is in keeping a previous report of unchanged oligodendrocyte density or 
morphology, nor in myelin transcript levels, in the PFC of enriched young 
mice (Makinodan et al., 2012). A further study showed that a decrease in 
OPC number, and increase in mature oligodendrocyte number, observed 
after ten days in sensorimotor cortex of enriched rats became absent after 42 
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days (Keiner et al., 2017). Therefore, it is possible that the differentiation of 
OPCs into mature oligodendrocytes, driven by enrichment and behavioural 
experience, could take place within the first week of manipulation, and would 
not be detected at later points (such as those used in our study). 
Enrichment effects on brain and body weight  
Brain weights were comparable in animals across genotypes and housing 
conditions, which may be due to the early recording time point since a 
previous study has demonstrated a 5-10% decrease in the brain weight of 9 
and 12 months old YAC128 mice (Slow et al., 2003). Interestingly, we found 
enriched females of both genotypes to weigh more than their standard 
housed counterparts, an effect which was not as evident in males, although 
reports into the effects of enrichment on body weight are notoriously 
inconsistent, and are sensitive to a variety of factors such as sex, strain and 
enrichment protocol (Tsai et al., 2016). 
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4.1. Summary 
Social isolation has been revealed to contribute to cognitive decline, and 
have negative effects on development and aging. Furthermore, emerging 
evidence supports an association between social isolation and myelination-
related abnormalities. White matter abnormalities have also been recently 
observed during the early stages of Huntington disease (HD) in patients and 
animal models. This suggests that social deprivation could exacerbate these 
pathological features, which could have important implications for the design 
of experimental protocols using animal models of HD, as well as inform on 
factors that could contribute to the clinical progression of the disease. We 
therefore investigated the impact of 14 weeks of social deprivation on 
myelination and mature oligodendrocytes population in the corpus callosum 
of the early manifest YAC128 mouse model of HD. Animals were allocated 
post-weaning to either standard housing (SH) or socially deprived housing 
(DH). Ultrastructural characterization of myelin sheaths and axonal diameter, 
using electron microscopy, revealed thinner myelin sheaths in the deprived 
wild-type (WT) mice compared to their standard housing control; however, no 
change in myelin sheath thickness was observed in YAC128 deprived 
relative to animals reared in standard conditions. No significant differences in 
mature oligodendrocyte numbers, habituation, general locomotor activity or 
anxiety-like behaviour were observed as a result of isolation, regardless of 
genotype. Modest signs of depressive-like behaviour were detected in 
deprived animals compared to their SH controls for both genotypes. 
Deprivation had a minor impact on motor learning and motor performance on 
the early manifest YAC128 mouse at 18 weeks of age. These findings, 
supported by past studies, suggest that isolation alters myelination in healthy 
mice. However, YAC128 mice fail to respond to environmental deprivation in 
the same way as WT animals, pointing to possible dominant effects of the 
disease. 
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4.2. Introduction 
Environmental manipulation in Huntington disease (HD) patients and animal 
models, as described in the previous chapter, has primarily focused on the 
impact of enrichment (Mo et al., 2015b). In contrast, there appears to be little 
research, investigating the effects of environmental and social deprivation on 
the pathological progression of HD. HD patients and animals models exhibit 
myelination related abnormalities that in of themselves can be induced by 
deprivation and isolation. Indeed, emerging evidence indicates that 
myelination is adaptive to environmental and behaviorally-driven experiences 
(Forbes & Gallo, 2017; McKenzie et al., 2014; Mount & Monje, 2017; 
Tomlinson, Leiton, & Colognato, 2016a; Xiao et al., 2016). This suggests that 
environmental or social deprivation could exacerbate HD-driven myelination 
deficits (Mo, Hannan, & Renoir, 2015a; Potter et al., 2010), which could 
hasten the clinical progression of the disease, and be an important 
consideration when employing animal models of HD. 
Social isolation of healthy mice has been shown to induce alterations in 
oligodendroglial population development and maturation, and capacity to 
myelinate axons, particularly in the prefrontal cortex (PFC) (Forbes & Gallo, 
2017; Liu et al., 2012; Liu et al., 2016; Makinodan et al., 2012; Makinodan et 
al., 2016; Mount & Monje, 2017). Two weeks of social isolation was sufficient 
to cause thinning of myelin sheaths and alteration of oligodendrocyte 
morphology, paralleled by decreased expression of myelin basic protein 
(MBP), in the medial PFC (mPFC), but not in the motor cortex, of socially 
deprived juvenile mice (Makinodan et al. 2012). Additionally, decreased 
myelin sheath thickness and MBP expression was also observed in sub-
cortical regions of juvenile mice subjected to 8 weeks of social deprivation 
(Cao et al., 2017). Delayed oligodendrocytes precursor cell (OPC) 
differentiation and abnormal chromatin structure in oligodendrocytes were 
shown to precede disturbances in behavior (Cao et al., 2017; Liu et al., 
2012). Isolated housing was also demonstrated to affect myelination in adult 
mice. Following 8 weeks of isolation, 24 weeks old adult mice exhibited 
hypomyelination, paralleled by decreased myelin related gene transcripts in 
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the PFC; whereas a shorter period of only 2 weeks of social deprivation had 
mild effects on myelin sheath thinning (Liu et al., 2012). However, others 
found no alterations in myelin thickness in the mPFC (Makinodan et al., 
2016), the white matter tracts of the anterior commissure, the nucleus 
accumbens, or the cerebellum of adult mice placed kept in 2-8 weeks 
isolation (Liu et al., 2012).  
Similarly, reduction in myelin sheaths thickness, and lower levels of 
expression of myelin related genes and transcripts have been reported in 
several animal models of HD, reared in standard housing conditions (Garcia-
Miralles et al., 2016; Gatto et al., 2015; Jin et al., 2015; Teo et al., 2016; 
Xiang et al., 2011). Surprisingly, these alterations were reported prior to 
motor deficit onset or neuronal loss in the anterior region of CC of juvenile 
YAC128 mouse (Teo et al., 2016). Additionally, mice expressing mutant 
huntingtin (htt) selectively in oligodendrocytes exhibited locomotor deficits, 
along with progressive demyelination and decreased expression of myelin 
related proteins (Huang et al., 2015a). Such reports of early myelination 
abnormalities in pre-symptomatic HD mouse models underscore the 
importance of understanding how behavioural experience modulates the 
influence of mutant HTT on oligodendrocytes myelination.  
The main focus of the current study was to understand the effects of a 
deprived environment on axonal myelination in the posterior corpus callosum 
of the young, early manifest, YAC128 mouse model of HD, as well as healthy 
controls. In addition, we investigated behavioural alteration and physiological 
effects of deprivation in these animals. 
 
4.3. Methods 
4.3.1. Experimental groups 
The YAC128 transgenic mouse model of HD and wild-type (WT) control 
littermates were used in this study. Both males and females were included in 
all experimental groups. Sexing and genotyping of animals were carried out 
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at 3 weeks of age. Mice were weighed on a bi-weekly basis. Mice were 
housed under standard conditions with food ad libitum, in an inverted light-
dark cycle until 4 weeks of age. Subsequently, they were placed into their 
allocated caging conditions, under the same inverted light-dark cycle: 
standard housing (SH) or deprived housing (DH). Animals were kept in their 
allocated condition for 14 weeks in total. At 18 weeks of age, animals were 
sacrificed and their brains harvested. 
 
Figure 4.1 Experimental groups for standard and deprived housing 
conditions 
Four groups were used for these experiments: wild type (WT) groups – standard 
housing (SH) and deprived housing (DH), and YAC128 groups – also SH and DH. 
Four groups were used for these experiments: wild type (WT) groups – 
standard housing (SH) and deprived housing (DH), and YAC128 groups – 
also SH and DH (Figure 4.1). Mice allocated to the SH condition were 
housed in standard mouse cages (39 x 19 x 16 cm; Techniplast, Greenline, 
sealsafe plus mouse, GM500) with 3 mice per cage. These animals were 
used as SH controls in the enrichment study presented earlier in this thesis 
(Chapter 3). DH condition mice were single housed housed in the same type 
of cage as animals in standard housing. No novelty items were added for 
WT SH 
YAC128 SH YAC128 DH 
WT DH 
  
mHTT mHTT 
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either of these groups; however, cages included bedding material (i.e. 
shredded paper).  
4.3.2. Overview of behavioural testing 
After 12 weeks of housing in their experimental conditions, several 
behavioural tests were carried out: the spontaneous activity test (SA), a 
motor function and habituation test; the open field activity (OF), an anxiety 
test; the elevated plus maze (EPM), also an anxiety test; the climbing test, a 
motor function test; the rotarod (RR) test, a motor function, learning and 
cognition test. Details of behavioural tests were described in Chapter 2 - 
Materials and Methods (Section 2.1.3). 
4.3.3. Tissue harvesting and processing 
Three to four animals in each experimental condition were perfused and their 
brains harvested, to investigate axonal and myelin related characteristics (i.e. 
axonal shape and size, and myelin thickness). For this study, splenium of the 
CC (~Bregma -1.82 to -2.70, Mouse Brain Atlas, Paxinos and Franklin, 2001) 
was microdissected (Figure 2.3A) to be processed and imaged for 
transmission electron microscopy (TEM). Details of TEM processing were 
described in Chapter 2 - Materials and Methods (Section 2.4). 
All brains were segmented through the mid-sagittal plane, and the left 
hemisphere used for immunohistochemical (IHC) procedures. Sections were 
immunostained for the Glutathione S-transferase (GST)-pi Stereo 
Investigator software was used for cell counting in the corpus callosum. 
Details of IHC processing and analysis were described in Chapter 2 - 
Materials and Methods (Section 2.5). Prior to cryosectioning for IHC 
procedures, the left hemisphere of the brain was weighed. Brain weights 
were recorded and compared between the experimental groups. 
4.3.4. Statistical analysis 
The 2x2 factorial design (genotype x housing condition) of the study was 
statistically analysed using two-way independent ANOVA with Sidak’s 
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correction for multiple comparisons, and repeated measures ANOVA 
statistical tests with Tukey’s correction for multiple comparisons. P-values 
equal to or greater than 0.05 were not considered statistically significant. P 
values and n values were indicated in the associated figure legends for each 
figure, while mean values are stated in the results section. Variables are 
reported as mean ± SEM unless otherwise stated.  
 
4.4. Results 
4.4.1. Behavioural tests 
4.4.1.1. Spontaneous activity results  
No housing condition x genotype interaction effect (p > 0.05), housing 
condition effect (p > 0.05), or genotype effect (p > 0.05) was found during the 
spontaneous activity (SA) test or open field (OF) tests (two-way ANOVA, 
Sidak’s correction for multiple comparisons; Figure 4.2). In the SA test, WT 
groups (SH: 10377±1793 cm; DH: 10335±1826 cm) showed a non-significant 
trend towards increased distance travelled compared to YAC128 groups 
(SH: 8344±502 cm; DH: 8652±622 cm; Figure 4.2A). No significant 
differences were observed in the mean resting time (Figure 4.2B), mean 
vertical counts (Figure 4.2C), mean jump counts (Figure 4.2D), or average 
velocity (p > 0.05; Figure 4.2E). In the OFT, no significant differences in 
mean distance travelled were observed between the groups (Figure 4.2F). 
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Figure 4.2 Comparison of spontaneous activity measures in YAC128 
and WT mice under standard and deprived housing  
(A) Total distance travelled over the duration of the SA test was similar between the 
groups, but a non-significant higher travel distance was observed in the WT 
groups. 
(B) No significant differences were found in resting time between groups. 
(C) Mean vertical counts were similar between all groups compared. 
(D) Mean number of jumps was also similar between all the groups. 
(E) Average velocity was comparable between all groups. 
(F) No significant differences were found in distance travelled in the OF test across 
groups. 
 
The SA test was run over 30 minutes, while OFT was run for 10 minutes. All readouts were 
obtained from the video tracking software associated with each test. n = 10-12 animals of 
mixed sex per condition; bar plots and error bars represent the mean±SEM. Two-way 
ANOVA. Abbreviations: SA, spontaneous activity; OFT, open field test. 
 
4.4.1.2. Anxiety-like behaviour results  
There were no significant differences between experimental groups in the 
total time spent in the centre of the arena during the 10 minutes OF test of 
anxiety (two-way ANOVA; p > 0.05; Figure 4.3A). However, there was a non-
significant trend towards decreased proportion of the time spent in the centre 
of the OF arena for WT DH mice (2.56±0.37%) compared to WT SH controls 
(3.709±0.67%). This trend was not seen in the YAC128 groups. Additionally, 
no significant differences were seen in the total time spent in the open arms 
of the maze during 5 minutes of the EPM test of anxiety (two-way ANOVA; p 
> 0.05; Figure 4.3B). WT SH mice spent a decreased proportion of time in 
the open arm of the EPM maze (34.59±4.76%) compared to WT DH animals 
(43.11±4.75%).  
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Figure 4.3 Comparison of anxiety-like behaviour in YAC128 and WT 
mice housed under standard and deprived housing 
(A) No significant differences were observed between the groups in the time spent 
in the centre of the arena of the OFT. 
(B) No significant differences were observed between the groups in the time spent 
in the open arm of the EPM test. 
 
The OFT had a duration of 10 minutes, the EPM test was run for 5 minutes. Readouts for 
the OFT and EPM were obtained using EthoVision video tracking software. Percentage (%) 
of total time was calculated for each condition. n = 10-12 animals of mixed sex per condition; 
bar graphs represent mean±SEM. Two-way ANOVA. Abbreviations: OFT, open field test; 
EPM, elevated plus maze. 
 
4.4.1.3. Motor function results 
When comparing latency to climb, time spent climbing and number of 
climbing attempts two-way ANOVA revealed no significant interaction 
between genotype and housing condition (p > 0.05), however a significant 
main effect of housing condition (latency to climb: F (1, 42) = 7.11, p < 0.05; 
time spent climbing: F (1, 42) = 5.75, p < 0.05; number of climbing attempts: 
F (1, 42) = 4.45, p < 0.05), but no effect of genotype (p > 0.05). Sidak’s 
correction for multiple comparisons post-hoc for the housing effects revealed 
no significant differences in climbing characteristics during the climbing test, 
although both DH groups (WT and YAC128) were associated with an 
increased latency to climb, reduced climbing time, and lower number of 
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climbing attempts compared to their corresponding SH controls (p > 0.05; 
Figure 4.4). Specifically, both WT (96.5±27.9s) and YAC128 (117.3±22.3s) 
animals in the DH group exhibited a higher mean latency to climb than their 
respective SH controls (WT SH: 35.0±16.1s; YAC128 SH: 63.1±20.3s; 
Figure 4.4A). Both DH groups (WT DH: 25.1±3.4s; YAC128 SH: 24.6±4.1 s) 
spent, on average, less time climbing compared to SH controls (WT SH: 
38.2±5.0s; YAC128SH: 37.5±7.5s; Figure 4.4B), regardless of genotype. And 
finally, both DH groups (WT DH: 9.6±1.2; YAC128 DH: 9.3±1.9) had a lower 
mean number of climbing attempts than SH controls (WT SH: 15.3±2.0; 
YAC128 SH: 11.8±2.1; Figure 4.4C).  
  
 
Figure 4.4 Comparison of climbing characteristics of YAC128 and WT 
controls housed under standard and deprived housing  
(A) No significant differences were observed between the latency for the first 
climbing attempt, although there was a trend for both WT DH and YAC DH to 
take longer before attempting to climb compared to their SH controls. 
(B) No significant differences were observed between the total time spent climbing, 
although there was a trend for both DH groups to spend less time climbing 
compared to their SH controls. 
(C) Consistently, both WT DH and YAC128 DH groups attempted climbing to a 
lesser extent than their corresponding SH controls.  
 
The climbing test had a total duration of 6 minutes, and videos were scored manually. n = 
10-12 animals of mixed sex per condition; bar graphs represent mean±SEM. Two-way 
ANOVA, with Sidak’s correction for multiple comparisons post-hoc. 
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4.4.1.4. Motor function and motor learning evaluation 
The latency to first fall (Figure 4.5) and the number of falls (Figure 4.6) were 
recorded as measures of performance on the fixed speed rotarod training 
over three days, with three trials per day, except the first day when only two 
trials were recorded. For the latency to fall, repeated measures ANOVA 
revealed significant main effects of time (F (7,301) = 4.751, p < 0.0001), but 
no effect of the group (genotype and housing condition) (F (3,43) = 1.629, p 
> 0.05), and no effect of the interaction between the two (F (21,301) = 0.975, 
p > 0.05). The significant effect of time reflects improved rotarod 
performance with increased training (Figure 4.5A). Nevertheless, several 
non-significant trends were observed. Firstly, YAC128 DH mice (trial 1: 
65.25±14.77s; trial 2: 68.33±12.16s) remained on the rotarod for the least 
time compared to all the other groups (trial 1: WT DH: 88.81±13.18s; 
YAC128 SH: 84.75±14.26s; WT SH: 93.66±11.54s; trial 2: WT DH: 
100.45±10.4s; YAC128 SH: 91.5±13.92s; WT SH: 110.58±9.41s) during the 
first two training sessions on the first day of the training (Figure 4.5A). 
Secondly, when averaged together over training trials for each day, YAC DH 
mice spent less time on the rotarod on the first and final day of training (day 
1 (trials 1-2): 71.25±13.03; day 3 (trials 6-8): 99.33±8.48) compared to the 
other groups (day 1 (trials 1-2): WT DH: 94.64±10.89; YAC128 SH: 
88.13±12.67; WT SH: 102.1±6.64; day 3 (trials 6-8): WT DH: 115.6±2.41; 
YAC128 SH: 109±5.23; WT SH: 113.1±4.29), although this difference did not 
reach significance (two-way ANOVA, p > 0.05, Figure 4.7A). Thirdly, WT DH 
animals also spent marginally less time on the rotarod compared to WT SH 
animals during most training trials (with the exception of trials 4 and 8). 
In terms of the average number of falls, repeated measures ANOVA 
revealed significant main effects of time (F (7,301) = 3.57, p < 0.001), but no 
effect of group (genotype and housing condition) (F (3,43) = 1.514, p > 0.05), 
and no effect of the interaction between the two (F (21,301) = 0.768, p > 
0.05). The significant effect of time again reflects the effect of more training 
on increased performance (Figure 4.6A). Several non-significant trends were 
observed: firstly, WT SH mice fell the least number of times over most 
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training trials compared to all the other groups, while YAC128 SH mice were 
associated with the most number of falls, compared to all the other groups, 
over the majority of trials (Figure 4.6). 
The proportion of mice in each experimental group that fell off the rotarod 
was calculated and averaged over trials for each training day (Figure 4.7B). 
Two-way ANOVA calculated for each of the training days to identify any 
group differences revealed no significant effect of interaction for day 1 and 3 
(day 1: F (1,4) = 0.36, p > 0.05; day 2: F (1,8) = 6, p < 0.05; day 3: F (1,8) = 
1.36, p > 0.05), no effect of the housing condition (day 1: F (1,4) = 3.83, p > 
0.05; day 2: F (1,8) = 2.66, p > 0.05; day 3: F (1,8) = 0.71, p > 0.05) and no 
effect of genotype (day 1: F (1,4) = 7.07, p > 0.05; day 2: F (1,8) = 2.66, p > 
0.05; day 3: F (1,8) = 2.79, p > 0.05). Interestingly, although not statistically 
significant, YAC128 DH animals fell more often than other groups during the 
first and last day of training. During the first day of training (2 trials), 
58.33±8.33% of YAC128 DH mice fell off the rotarod compared to 
37.5±4.16% of YAC128 SH mice, 31.82±4.54% of WT DH mice, and 
20.83%±12.5% of WT SH mice. On the second day of training, only 25% of 
YAC128 DH mice fell of the rotarod, compared to 27.78%±2.77% of YAC128 
SH mice, and the same proportion of WT DH mice. WT SH mice fell less 
often off the rotarod (13.89±5.56%). Finally, on the last day of training, 
YAC128 DH mice had the highest number of falls (27.78±7.34%) compared 
to YAC128 SH (16.67±4.81%) of mice, WT DH (12.12%±6.06%) and WT SH 
mice (13.89%±2.77%).  
The accelerated rotarod test was performed after three days of training on 
the fixed speed rotarod, and the latency to first fall was recorded as a 
measure of motor performance (Figure 4.8). No significant differences were 
observed between the groups (p > 0.05; two-way ANOVA). However, 
YAC128 DH mice (216.6±21.24 s) showed a trend towards a shorter latency 
to fall compared to other groups, when averaged over all test trials (YAC128 
SH: 236.8±14.19s; WT DH: 242.3±17.63s; WT SH: 238.9±16.02s), although 
variability in this group was relatively high (Figure 4.8A). Latency to fall was 
lowest in YAC128 DH mice during each of the three test trials (Figure 4.8B). 
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Figure 4.5 Comparison of latency to fall during fixed speed rotarod 
training for YAC128 and WT mice housed under SH and DH 
(A) Latency to fall over 8 trials of training in all groups. 
(B) WT DH mice performed poorly compared to WT SH animals on most trials. 
(C) YAC128 DH mice performed poorly or comparably to YAC128 SH animals. 
Latency to fall illustrated in seconds (s). Training was run over 3 days with 2 trials on first 
day and 3 trial sessions on last two days. n = 10-12 animals of mixed sex per condition; 
error bars are ±SEM. Repeated measures ANOVA. 
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Figure 4.6 Comparison of number of falls of YAC128 and WT mice from 
SH and DH conditions during fixed speed rotarod training 
(A) Number of falls over the 8 training for all groups. 
(B) WT DH had increased number of falls compared to WT SH during most trials. 
(C) YAC128 DH showed slight increased number of falls compared to YAC128 SH. 
Training was run over 3 days, with 2 trials on first day and 3 trials on second and third days. 
n = 10-12 animals per condition; Error bars represent ±SEM. Repeated measures ANOVA.  
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Figure 4.7 Session averages of latency to fall and percentage of mice 
fallen for YAC128 and WT mice housed under standard and deprived 
conditions 
(A) Average latency to fall for each day of training showed a trend towards 
decreased performance by the YAC128 DH group, although no significant 
differences were found. 
(B) YAC128 DH mice were more likely to fall off the rotarod compared to any of the 
other groups on the first and last day of training. 
  
Testing was run over 2-3 trials within the same day. n = 10-12 animals of mixed sex per 
condition; Bars graphs represent mean±SEM. Two-way ANOVA, with Sidak’s multiple 
comparisons test. Latency to fall illustrated in seconds (s) (A). Proportion of mice that fell of 
the rotarod averaged over trials for each training day (B). 
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Figure 4.8 Comparison of latency to fall in YAC128 and WT mice 
housed under standard and deprived conditions during accelerated 
rotarod test 
(A) All groups had a similar mean latency to fall over the 3 trials of the testing 
session, although YAC128 DH mice were associated with a shorter time spent 
on the accelerated rotarod compared to other groups. 
(B) No significant differences in latency to fall were found between groups across 
the 3 testing trials, although WT DH animals consistently spent less time on the 
rotarod during each of the testing trials compared to other groups. 
 
Mean latency to fall illustrated in seconds (s). Testing was run over 3 trials within the same 
day. n = 10-12 animals of mixed sex per condition; bar graphs represent mean±SEM (A); 
error bars represent ±SEM (B). Two-way ANOVA, with Sidak’s multiple comparisons test 
(A), and repeated measures ANOVA (B). 
 
4.4.2. Ultrastructural analysis of myelin  
The inner (axoplasm) and outer (axoplasm and myelin sheath) diameters of 
regular-shaped axons in the posterior (splenium) of the corpus callosum 
(CC) were measured (Figure 2.3). G-ratios were calculated as the inner 
diameter divided by the outer diameter, and used as a measure of myelin 
thickness (Friede, 1972; Figure 2.4). Representative micrographs of callosal 
axons for each experimental group are illustrated below, in Figure 4.9. 
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WT DH mice exhibited qualitatively larger g-ratios at small axonal diameters 
(ID < 500nm), and smaller g-ratios at large axonal diameter (ID > 1000nm), 
compared to WT SH animals (Figure 4.10A). Cumulative frequency analysis 
confirmed a shift towards overall larger g-ratios for WT DH mice compared to 
WT SH mice (Figure 4.10B). In contrast, YAC128 DH animals showed 
qualitatively smaller g-ratios at small and mid-range diameter (ID < 1000nm) 
compared to SH controls, while no differences were seen at large diameters 
(Figure 4.10C). Cumulative frequency analysis showed a closer overlap of 
the two curves representative of the YAC128 groups (Figure 4.10D). 
G-ratios were averaged over all axonal diameters for quantitative comparison 
between groups (Figure 4.11A). Two-way ANOVA revealed significant 
interaction between genotype and housing condition (F (1, 2995) = 63.91, p 
< 0.0001), significant main effect of housing condition (F (1, 2995) = 29.65, p 
< 0.0001), and significant main effect of genotype (F (1, 2995) = 28.4, p < 
0.0001). Sidak’s correction for multiple comparisons post-hoc tests revealed 
WT DH animals (0.814±0.002) exhibited a significantly larger mean g-ratio 
compared to all the other groups (WT SH: 0.779±0.003; YAC128 SH: 
0.786±0.002). In contrast, the mean g-ratio in YAC128 DH mice 
(0.779±0.002) was comparable to that of YAC128 SH controls. 
Finally, g-ratios were classified according to their respective inner axonal 
diameter: small diameter axons (ID < 500nm), mid-range diameter axons 
(500 ≤ ID < 1000nm), and large diameter axons (ID ≥ 1000nm) (Figure 
4.11B). There was an overall increase in g-ratio with increasing axonal 
diameter. At small axonal diameters, two-way ANOVA revealed significant 
interaction between genotype and housing condition (F (1, 1007) = 27.98, p 
< 0.0001), significant main effect of housing condition (F (1, 1007) = 13.57, p 
< 0.001), but no significant main effect of genotype (F (1, 1007) = 0.377, p > 
0.05). Sidak’s correction for multiple comparisons post-hoc tests revealed 
WT DH mice possessed larger g-ratio (0.765±0.004) relative to both WT SH 
(0.727±0.004; p < 0.0001) and YAC128 DH (0.740±0.003, p > 0.05) animals. 
Additionally, YAC128 SH mice showed slightly higher g-ratios (0.747±0.004; 
p > 0.05) compared to that of WT SH control. At mid-range inner diameters, 
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two-way ANOVA revealed significant interaction between genotype and 
housing condition (F (1, 1592) = 22.66, p < 0.0001), significant main effect of 
housing condition (F (1, 1592) = 25.06, p < 0.0001), and significant main 
effect of genotype (F (1, 1592) = 19.14, p < 0.0001). Sidak’s correction for 
multiple comparisons post-hoc tests revealed WT DH mice also exhibited 
larger g-ratios (0.821±0.002) than both WT SH (0.793±0.003; p < 0.0001) 
and YAC128 DH (0.795±0.002; p < 0.0001) animals. In contrast, YAC128 DH 
and SH (0.794±0.002) mice had comparable g-ratios. Finally, at large axonal 
diameters, two-way ANOVA revealed no significant interaction between 
genotype and housing condition (F (1, 386) = 1.7, p > 0.05), a significant 
main effect of housing condition (F (1, 386) = 13.52, p < 0.001), and no 
significant main effect of genotype (F (1, 386) = 3.58, p > 0.05). Sidak’s 
correction for multiple comparisons post-hoc tests for housing effect revealed 
both WT and YAC128 DH groups showed an increased mean g-ratio 
compared to corresponding SH groups, regardless of genotype. However, 
only the mean g-ratio of YAC128 DH animals (0.869±0.004) was significantly 
larger than that of YAC128 SH animals (0.844±0.005; p < 0.001), whereas 
the mean g-ratio of WT DH mice (0.872±0.004) was not significantly greater 
than that of WT SH mice (0.860±0.005). 
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Figure 4.9 Representative TEM images of callosal axons in YAC128 and 
WT mice housed under standard and enriched conditions 
Representative micrographs of axons from the posterior (splenium) region of the 
corpus callosum for each experimental group. Scale bar at 2µm. 
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Figure 4.10 G-ratios and axonal diameters of YAC128 and WT mice 
housed under standard and deprived housing  
(A) Scatter plot of g-ratio values against inner axonal diameter (ID) showed higher 
g-ratios at small IDs (< 500nm), and smaller g-ratios at large IDs (> 1000nm) for 
WT DH (red) animals relative to WT SH (black). 
(B) Cumulative frequency plot of g-ratios showed an evident shift towards larger g-
ratios in the WT DH condition compared to WT SH. 
(C) Scatter plot showing lower g-ratio values at small and mid-range axonal 
diameters (IDs < 1000 nm), and higher g-ratios at large axonal diameters (ID > 
1000nm) for YAC128 DH animals (red) compared to YAC128 SH mice (black).  
(D) Cumulative frequency plot of g-ratios showed a close overlap of the two curves 
representative of both YAC128 SH and DH groups. 
 
n = 474 - 916 axons per condition (WT SH, n = 474 axons; WT DH, n = 916 axons; YAC128 
SH, n = 782 axons; YAC128 DH, n = 841 axons); 2-4 animals per condition. 
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Figure 4.11 Average g-ratio for YAC128 and WT mice housed under 
standard and deprived housing 
(A) The WT DH group showed a significantly higher mean g-ratio compared to 
YAC128 DH animals and WT SH controls. 
(B) G-ratio values were classified according to their corresponding inner axonal 
diameter (ID, small diameter axons, ID≤500nm; mid-range diameter axons, 
500<ID≤1000nm; large diameter axons, ID≥1000nm). Overall, there was an 
increase in g-ratio with increasing axonal diameter, as well as an increased g-ratio 
in DH mice compared to SH mice, for WT groups, but not YAC128 groups at small 
and medium axonal diameter ranges. A larger mean g-ratio value was observed at 
large diameters in YAC128 DH animals compared to YAC128 SH controls. 
 
Bar graphs represent mean±SEM. SEM comes from axonal variance. n = 474 - 916 axons per 
condition (WT SH, n = 474 axons; WT DH, n = 916 axons; YAC128 SH, n = 782 axons; 
YAC128 DH, n = 841 axons); 2-4 animals per condition. Two-way ANOVA, with Sidak’s 
multiple comparisons test. *p < 0.05; ****p < 0.0001. Inner diameter shown in nanometres 
(nm). Abbreviations: ID, inner diameter. 
 
4.4.3. Differences in axonal characteristics 
Analysis of axonal diameter revealed a lower number of small diameter 
axons (200 to 400nm), and a comparable or higher number of medium and 
large diameter axons (500 to 1300nm) in WT DH animals compared to WT 
SH controls (Figure 4.12A). Cumulative frequency plots of inner diameters 
showed a close overlap of the two curves representative of both WT groups, 
with a small shift towards larger g-ratios driven by the increased number of 
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large axonal diameters in the WT DH group (Figure 4.12B). Additionally, the 
mean inner axonal diameter was significantly greater in WT DH animals 
(685.6±9.39nm) compared to WT SH (652.5±12.67nm; p < 0.05). On the 
other hand, YAC128 DH animals possessed a larger number of small 
diameter axons (200-500nm), and a similar or smaller number of mid-range 
diameter axons (600-1000nm), compared to YAC128 SH mice (p < 0.001). 
Cumulative frequency analysis of inner diameters revealed a close overlap of 
the two curves representative of both YAC128 SH and DH groups. 
Additionally, the mean axonal diameter of YAC128 DH mice (618.2±9.66nm) 
was significantly smaller than that of YAC128 SH animals (672.7±10.76nm). 
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Figure 4.12 Axonal diameters of WT mice housed under standard and 
deprived conditions 
(A) Smaller number of axons with a small diameter (200-400nm), and a higher or 
similar number of axons with a large diameter (500-1300nm) in WT DH animals 
compared to WT SH controls. 
(B) Cumulative frequency of IDs showed a close overlap of the two curves 
representative of both WT groups. 
(C) WT DH animals were associated with a significantly larger mean axonal 
diameter in myelinated axons compared to WT SH mice.  
 
Average of 2-4 animals per condition; n = 474 - 916 axons per condition (WT SH, n = 474 
axons; WT DH, n = 916 axons; YAC128 SH, n = 782 axons; YAC128 DH, n = 841 axons). 
Relative frequency histogram (A) and cumulative frequency (B), bin width = 100nm (A). 
Unpaired, two-tailed t-test, 95% confidence intervals, *p < 0.05; Bars graphs represent 
mean±SEM (C). Abbreviations: ID, inner diameter 
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Figure 4.13 Axonal diameters of YAC128 mice housed under standard 
and deprived conditions 
(A) Higher number of axons with small diameters (200-500nm), and a smaller or 
similar number of axons at mid-range axonal diameters (600 to 1000nm) in the 
YAC128 DH animals compared to YAC128 SH controls. 
(B) Cumulative frequency of IDs showed a close overlap of the two curves 
representative of the YAC128 groups. 
(C) YAC128 DH animals showed significantly smaller diameter average for 
myelinated axons compared to SH control.  
 
Average of 2-4 animals per condition; n = 474 - 916 axons per condition (WT SH, n = 474 
axons; WT DH, n = 916 axons; YAC128 SH, n = 782 axons; YAC128 DH, n = 841 axons). 
Relative frequency histogram (A) and cumulative frequency (B), bin width = 100nm (A). 
Unpaired, two-tailed t-test, 95% confidence intervals, ***p < 0.001; bar graphs represent 
mean±SEM (C). Abbreviations: ID, inner diameter. 
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4.4.4. Quantification of mature oligodendrocytes  
Mature oligodendrocytes, as identified by GST-pi staining, were counted in 
the corpus callosum. No significant differences in number of GST-pi positive 
cells were seen between any of the four groups (two-way ANOVA, p > 0.05, 
Figure 4.14). However, a trend towards an increased number of GST-pi 
positive cells was observed in WT DH (35,726±4,265) mice compared to WT 
SH (29,406±2,498), and YAC128 DH (32,692±2,420) compared to YAC128 
SH (29,766±4,065), mice. 
 
Figure 4.14 Number of GST-pi positive cells in the posterior corpus 
callosum of YAC128 and WT mice housed under standard and 
deprived conditions 
No significant differences in number of GST-pi cells were seen between any of the 
four experimental groups. Bar graphs represent the average of a total of 8-10 
animals per condition, 6-8 sections per animals; bar graphs represent mean±SEM. 
Abbreviations: CC, corpus callosum; Glutathione S-transferase (GST)-pi. 
 
4.4.5. Brain weights for standard and deprived WT and 
YAC128 animals 
The left cerebral hemisphere of each animal was weighed prior to tissue 
processing. No significant differences were found at 4.5 months between any 
of the groups when comparing the brain weights of mixed sex (Figure 
4.15.A), females (Figure 4.15.B), or males (Figure 4.15C) mice (two-way 
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ANOVA, p > 0.05). However, left hemisphere brain weights for WT and 
YAC128 animals in the DH condition were consistently larger than their SH 
counterparts, regardless of sex (Figure 4.13A-C). 
  
 
Figure 4.15 Brain weight (left hemisphere) in YAC128 and WT mice 
housed under standard and deprived conditions 
(A) No significant differences were seen in the brain weights of mixed sex groups 
across conditions. 
(B) No significant differences were seen in the brain weights of female mice across 
conditions. 
(C) No significant differences were seen in the brain weights of male mice across 
conditions. 
 
Animals’ left cerebral hemisphere were weighed at 18 weeks (4.5 months) of age. Left 
hemisphere weight shown in milligrams (mg). n = 5-8 males per condition, and 5-7 females 
per condition; Bar graphs represent mean±SEM. Two-way ANOVA. 
 
4.4.6. Body weight comparison over time for standard and 
deprived WT and YAC128 animals 
Animals were weighed fortnightly starting from pn50 (~7 weeks) until 
sacrifice, on pn126 (18 weeks). Body weights were evaluated and compared 
separately for females and males. In the female groups (Figure 4.16A), 
repeated measures ANOVA revealed significant main effects of time (F 
(5,85) = 37.33, p < 0.0001), but not of animal group (genotype and housing 
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condition) (F (3,17) = 1.567, p > 0.05), although a significant effect of the 
interaction between the two was observed (F (15,85) = 2.87, p < 0.01). WT 
SH female mice consistently possessed the lowest mean body weight at all 
time-points, followed by WT DH mice, although no significant differences 
were observed between both groups. In turn, YAC128 SH female mice were, 
on average, generally heavier than other groups at most time-points; 
however this only reached statistical significance when compared to WT SH 
at pn78 (YAC128 SH: 23.16±1.165g; WT SH: 20.21±0.54g; p < 0.05). When 
compared at the last time point, no significant differences were observed 
between groups (two-way ANOVA), although a trend towards lower body 
weights for WT SH (22.59±0.52g) compared to all the other groups was 
observed (WT DH: 23.86±0.52g; YAC128 SH: 23.54±0.95g; YAC128 DH: 
24.23±1.09g; Figure 4.17A). On the other hand, in the male comparisons 
(Figure 4.16B), repeated measures ANOVA revealed significant main effects 
of time (F (5,110) = 77.39, p < 0.0001), of animal group (genotype and 
housing condition) (F (3,22) = 4.952, p < 0.01), and a significant effect of the 
interaction between the two (F (15,110) = 2.006, p < 0.05). Significantly 
increased body weights at most time-points were observed in YAC128 DH 
male mice (pn50: 26.21±0.84g; pn78: 28.65±1.03g; pn92: 29.62±1.09g; 
pn106: 30.23±1.18g; pn126: 30.71±1.04g) compared to WT DH male 
animals (pn50: 22.76±0.5g; pn78: 24.78±0.7g; pn92: 25.63±0.86g; pn106: 
25.81±0.74g; pn126: 27.21±0.52g). A further significant difference was seen 
between YAC128 SH (30.92±0.9g) and WT SH (27.2±1.08g) males at 
pn106. Overall, WT DH male mice had the lowest body weights at all time-
points recorded, followed by WT SH mice. The body weights of YAC128 DH 
and SH groups were approximately similar at all-time points. At the final time-
point, two-way ANOVA revealed no significant interaction between genotype 
and housing (F (1, 22) = 0.8, p > 0.05), no main effect of housing condition (F 
(1, 22) = 2.61, p < 0.05), but a main effect of genotype (F (1, 22) = 7.79, p > 
0.05). WT DH male mice (27.22±0.53g) were associated with the lowest 
body weight of all the groups at the final time-point, but this was only 
statistically different to YAC DH mice (30.71±1.04g; Sidak’s multiple 
comparisons, p < 0.05; Figure 4.17B).  
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Figure 4.16 Body weight over time for female and male YAC128 and WT 
mice housed under standard and deprived conditions 
(A) WT SH females had generally lower mean body weights compared to all other 
groups, while YAC128 SH females showed the opposite at most time-points. 
(B) WT DH males had overall lower mean body weights compared to all other 
groups, whereas YAC128 groups were comparable.  
 
Animals were weighed fortnightly starting from pn50 (~7 weeks) until sacrificed at pn126 (18 
weeks). Body weight shown in grams (g). n = 5-8 animals of each sex per condition; Error 
bars represent ±SEM. Two-way ANOVA, with Tukey correction. *p < 0.05; **p<0.01. 
Comparison symbols: * WT DH vs YAC128 DH; #WT SH vs YAC128 SH. 
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Figure 4.17 Final body weight of female and male YAC128 and WT mice 
housed under standard and deprived housing 
(A) No significant differences were observed in female body weights between 
conditions when weighed at the final time point.  
(B) No significant differences were seen in male body weights at the final time point.  
 
Average body weight on sacrifice day, pn126 (18 weeks). Body weight shown in grams (g). n 
= 5-8 animals of each sex per condition; bar graphs represent mean±SEM. Two-way 
ANOVA, with Sidak’s multiple comparisons test.  
 
4.5. Discussion 
Social isolation effects on behavioural performance and motor function 
Social isolation was not found to affect locomotor activity of either WT or 
YAC128 mice, consistent with previous work examining social isolation in 
juvenile and adult mice (Makinodan et al., 2012; Liu et al., 2012). 
Furthermore, and similarly to environmental enrichment, no clear effect of 
social isolation was observed on anxiety-like behaviour. This is at variance 
with other reports of increased anxiety-like behaviour in socially isolated 
adolescent and adult mice (Cao et al., 2017; Lander, Linder-Shacham, & 
Gaisler-Salomon, 2017), and may be due to differing technical approaches to 
induce social isolation. The climbing performance of socially isolated animals 
of both genotypes was poor relative to their standard-house counterparts, 
fe m a le m a le
S H D H S H D H
0
9
1 8
2 7
3 6
B
o
d
y
 w
e
ig
h
t 
(g
)
W T Y A C 1 2 8
S H D H S H D H
0
9
1 8
2 7
3 6
B
o
d
y
 w
e
ig
h
t 
(g
)
W T Y A C 1 2 8
*
A B 
 164 
although this was not found to be significant. Socially isolated YAC128 mice 
were associated with the weakest rotarod performance during training and 
testing across groups, and deprived WT animals were slightly more 
predisposed to falls during the initial stages of rotarod training. These 
observations indicate that environmental deprivation and social isolation had 
a mild negative influence on motor learning and function in both WT and 
YAC128 mice. While our results provide support for the notion that 
environmental deprivation likely confers negative effects on, at least some, 
behaviours in WT rodents, it is challenging to contextualise this with respect 
to HD models, since the associated research is limited.  
Social isolation effects on myelination and mature oligodendrocytes 
Socially isolated WT mice were associated with significantly thinner myelin 
sheaths in the posterior corpus callosum (CC) relative to all other groups, 
and this effect persisted across all axonal diameters when compared to 
standard-housed WT mice. Additionally, environmental deprivation was 
associated with an increase in axonal diameter in WT animals, but a 
decrease in YAC128 mice. This finding is in keeping with an early study 
demonstrating white matter abnormalities in the posterior CC of socially 
isolated male rhesus monkeys (Sánchez et al., 1998). It is also consistent 
with other reports of thinner myelin sheaths in the medial prefrontal cortex of 
juvenile (Cao et al., 2017; Liu et al., 2012; Makinodan et al. 2012), and adult 
mice subjected to social isolation (Liu et al., 2012), and which was lessened 
with shorter periods of isolation. Axonal diameters of WT deprived mice 
were, on average, significantly larger than standard housed WT mice. In 
contrast, social isolation was not seen to have an effect on axonal diameter 
in the medial prefrontal cortex (mPFC) of juvenile mice (Makinodan et al., 
2012), suggesting that the effect of isolation on myelination may be brain 
region and/or age dependent. Interestingly, no differences in myelin sheath 
thickness were observed between socially isolated and standard housed 
YAC128 mice, which suggest a dominant effect of this disease phenotype. 
Finally, we found no significant differences in mature oligodendrocyte 
population in both genotypes as a result of social isolation, in keeping with 
  
 
165 
other work reporting the same in the mPC of juvenile mice (Makinodan et al., 
2012). 
Social isolation effects on brain and body weight  
Brain weights across animals were comparable across genotypes and 
housing condition, as observed during environmental enrichment. 
Furthermore, while social isolation did not significantly affect body weight 
across experimental groups, socially isolated female mice were associated 
with a mild increase in body weight relative to their standard house 
counterparts, with males exhibiting the reverse trend. These observations 
are supported by other studies showing socially isolated female rats to weigh 
approximately 10% more than standard-housed females (Hermes et al., 
2011), and socially isolated male mice to have a decreased body weight 
relative to their standard controls (Lander et al., 2017). However, these 
trends were not observed in YAC128 mice, which is suggestive of an over-
riding effect of the disease phenotype. 
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5.1. Summary 
Structural and molecular myelination deficits occur in the early stages of 
Huntington disease (HD). Recent evidence from germ-free (GF) and 
antibiotic-treated animal models has suggested that gut microbiota 
influences brain development and function. Specifically, microbiota-gut-brain 
bidirectional communication has been shown to be involved in the regulation 
of oligodendrocyte differentiation and myelination. However, little is known 
about the effect of microbiota on white matter in HD. In this study, therefore, 
we aimed to investigate the impact of microbiota on myelination plasticity and 
oligodendroglial populations in the early manifest stage of the BACHD 
mouse model of HD. Three months old specific-pathogen-free (SPF) and GF 
male mice of mixed genotype of each genotype (wild type and BACHD) were 
used here. Ultrastructural analysis of myelin in the anterior mid-body region 
of the corpus callosum indicated contrasting alterations in myelin thickness at 
different axonal diameters in the WT GF group compared to SPF control, 
whereas alterations of myelin thickness particularly at small and mid-range 
axonal diameter were evident in the BACHD GF group. In addition, WT 
animals placed in a germ-free environment exhibited reduction of 
premyelinating and myelinating, cortical and callosal, oligodendrocytes, and 
decreased levels of mature myelin related proteins in the prefrontal cortex. 
Further reductions were observed in cortical myelinating oligodendrocytes 
and callosal oligodendrocytes precursor cells (OPCs) in the BACHD GF 
animals compared to their SPF control. Finally, in a germ-free environment, 
the characteristic body weight gain of BACHD animals is normalised to the 
body weight of WT animals, whereas both genotypes showed decreased 
overall brain weight. Therefore, our results indicate complex effects of 
microbiota on myelin-related characteristics, revealing, further, the adaptive 
properties of myelination in both the BACHD and wild-type animal. 
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5.2. Introduction 
White matter (WM) atrophy has been widely identified as an early feature of 
Huntington disease (HD) in both patients and animal models (Bartzokis et al., 
2007; Ciarmiello et al., 2006; Fennema-Notestine et al., 2004; Novak et al., 
2014; Rosas et al., 2003; Tabrizi et al., 2009; Xiang et al., 2011). Previous 
work in our laboratory explored the molecular and ultrastructural features of 
WM abnormalities in HD mouse and rat models (Garcia-Miralles et al., 2016; 
Teo et al., 2016). Diffusion tensor imaging (DTI) imaging revealed WM 
microstructural abnormalities prior to neuronal loss in the CC of the YAC128 
mouse model and the BACHD rat model (Teo et al., 2016). In addition, 
thinner myelin sheath and lower levels of myelin-related gene transcripts 
were seen in these animals compared to wild-type controls (Teo et al., 2016). 
Others also reported microstructural abnormalities and reduction in myelin 
sheath thickness, as well as decreased expression of myelin related genes in 
the BACHD, HdhQ250 and R6/2 mouse models (Gatto et al., 2015; Jin et al., 
2015; Wade, Jacobs, & Morton, 2008; Xiang et al., 2011). In addition, 
transgenic mice that expressed mHTT selectively in oligodendrocytes 
showed impaired myelination with thinner myelin thickness in the striatum, 
reduction of myelin basic protein gene expression, along with progressive 
motor impairments, metabolic deficits and reduced survival (Huang et al., 
2015).  
Emerging evidence suggests the microbiota-gut-brain axis to be involved in 
modulation of adaptive myelination, and myelin-related characteristics, in the 
rodent brain. An upregulation of genes linked to myelination and myelin 
plasticity was described in the wild-type GF mouse (Hoban et al., 2016b). 
Increased mRNA levels of myelin related genes and transcript factors were 
identified, specifically in the prefrontal cortex (PFC), of wild-type animals 
(Hoban et al., 2016b), as well as in antibiotic treated non-obese diabetic mice 
(Gacias et al., 2016). These transcriptional changes were consistent with 
hypermyelination of PFC axons in GF animals, compared to animals raised 
in conventional laboratory conditions (Hoban et al., 2016b).  
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The PFC and the CC are highly enriched in myelinated fibres, and both 
regions were shown to be affected by environmental manipulation and 
behavioural experience (Hoban et al., 2016b; Liu et al., 2012; Makinodan et 
al., 2012; Sánchez et al., 1998; Tomlinson, Leiton, & Colognato, 2016a). On 
the other hand, the PFC and CC are two of the most affected regions by 
disease pathology in HD patients and animal models (Gatto et al., 2015), and 
several studies reported white matter alterations in the PFC and CC of pre-
symptomatic and symptomatic HD gene carriers (Bourbon-Teles et al., 2017; 
Di Paola et al., 2012; Dumas et al., 2011; Matsui et al., 2013; Phillips et al., 
2014; Poudel et al., 2015; Rosas et al., 2006; Tomassy et al., 2014). 
The findings described above indicate the need for further investigation into 
possible modulating environmental factors of plastic and adaptive 
myelination in HD, particularly with respect to white matter-related 
abnormalities. Therefore, the purpose of our study was to use microbiome 
manipulation as an assay to understand myelination plasticity and 
oligodendroglial population changes in the BACHD mouse model and WT 
controls. Using transmission electron microcopy (TEM), we investigated 
ultrastructural characteristics of myelin in the anterior mid-body region of the 
CC. Cortical myelin-related proteins, such as MBP and PLP, were also 
compared between experimental groups, and oligodendroglial populations in 
the CC and PFC were examined at different stages of maturity in their 
development.  
 
5.3. Methods 
5.3.1. Experimental groups 
Wild-type (WT) and BACHD transgenic mice on the FVB background were 
raised either under normal laboratory conditions (SPF) or in a germ-free 
environment (GF) (Figure 5.1). Every experimental group included between 
10 to 13 animals per condition per sex.  
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Figure 5.1 Experimental groups used for microbiota manipulation study 
Four groups were used for these experiments: wild type (WT) groups – specific 
pathogen free (SPF) and germ free (GF), and BACHD groups – also SPF and GF. 
GF animals were born through caesarean section in aseptic conditions, 
where all incoming air, water and food were sterilised. These animals were, 
therefore, free of all ‘detectable’ microbes and microorganisms. GF pups 
were housed in gnotobiotic isolators with the same strain GF adoptive 
mothers. SPFs were conventional laboratory animals, whose strains of 
bacteria were allowed to acquire microbiota naturally, and were known to this 
specific animal unit.  
Animals were genotyped at 3 weeks of age. All animals were weighed at 3 
months of age, prior to being sacrificed. Brains were harvested from both 
males and females, however, due to time and cost constraints, only males 
brains were included for investigation in the current study.  
5.3.2. Tissue processing 
All brains were segmented through the mid-sagittal plane, and the left 
hemisphere placed in 4% PFA solution to be used for immunohistochemical 
procedures (Section 2.5). Sections were immunostained for the 
oligodendroglia precursor marker, platelet derived growth factor receptor 
alpha (PDGFR), the oligodendroglial lineage marker, Olig2, and the mature 
oligodendrocyte marker, Glutathione S-transferase (GST)-pi (Table 2.9). 
WT SPF  
BACHD SPF  BACHD GF 
WT GF 
mHTT mHTT 
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Stereo Investigator software was used for PFC, CC and striatum cell 
counting and area estimation (Section 2.5.5). 
The right hemisphere was microdissected, and protein extracted from PFC 
tissue and processed for western blot. The samples were probed for myelin 
basic protein (MBP), myelin proteolipid protein (PLP), and Ermin. The blots 
obtained were quantified using Image Studio Lite, and values obtained were 
normalised in Excel (Chapter 2. Materials and methods. Section 2.6). 
Concentration of protein of interest (i.e. MBP) was first normalised to control 
(i.e. Calnexin), and then expressed relative to its experimental control 
condition. The SPF group was taken as the control condition for all 
comparisons between GF and SPF and described in the results section 
below. Each blot included comparisons between two of the four experimental 
conditions, and contained 8 samples (one per animal) in total (Figure 5.11A, 
Figure 5.12A). Box and whiskers plots represent quantification of samples 
from 4 animals per condition (Figure 5.11 and Figure 5.12).  
In addition to the brains harvested for immunostaining and immunoblotting, 
three to four animals in each experimental condition were perfused and 
harvested, to investigate axonal and myelin related characteristics (i.e. 
axonal shape and size, and myelin thickness) using TEM. For this study, 
anterior mid-body of the CC (~Bregma -0.80 to 0 mm, according to the 
Mouse Brain Atlas, Paxinos and Franklin, 2001; Figure 2.3) was 
microdissected (Figure 5.2A) to be processed and imaged for TEM (Chapter 
2. Materials and methods. Section 2.4). 
Prior to cryosectioning for IHC procedures, the left hemisphere, of both 
males and females, was weighed. The brains were weighed again following 
removal of the olfactory bulb (OB) and cerebellum. For the purpose of 
simplicity, the remaining brain is henceforth referred to in the text as 
‘forebrain’ (Figure 5.13D-F). Brain weights were recorded and compared 
between the experimental groups (Figure 5.13). 
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5.3.3. Statistical analysis 
Pairwise comparisons were generated using Student’s two-tailed t tests. 
Two-way ANOVA with Sidak’s correction for multiple comparisons was used 
for the 2x2 study design (genotype x microbiota presence) to observe 
whether differences between the groups were statistically significant, as 
appropriate. P-values equal to or greater than 0.05 were considered not 
statistically significant. P-values and n-values were indicated in the 
associated figure legends for each figure, while mean values were stated in 
the results section. Bar graphs were built based on mean ± SEM unless 
otherwise stated.   
 
5.4. Results 
5.4.1. Ultrastructural analysis of myelin  
Representative micrographs of callosal axons for each experimental group 
are illustrated below, in Figure 5.2. G-ratio values were plotted against inner 
diameter, for each axon, using scatter plots to exhibit variability of myelin 
thickness at different ranges of axonal diameters. Comparison of WT groups 
showed similar g-ratios over all diameter ranges for SPF and GF animals 
(Figure 5.3A). In addition, the cumulative g-ratio frequency plot of both WT 
groups showed a close overlap (Figure 5.3B). In contrast, small axons (ID < 
500 nm) displaying lower g-ratios, and large axons (ID > 1000nm) displaying 
higher g-ratios, were observed in BACHD GF animals compared to BACHD 
SPF animals (Figure 5.3C). Cumulative frequency analysis of g-ratios 
showed an evident shift towards smaller values for BACHD GF compared to 
BACHD SPF (Figure 5.3D).  
G-ratio values were subsequently classified, averaged and compared 
according to three inner diameter ranges: small diameter axons (ID < 
500nm), mid-range diameter axons (500 ≤ ID < 1000nm), and large diameter 
axons (ID ≥ 1000nm) (Figure 5.4B). For small diameter ranges two-way 
ANOVA revealed significant interaction between genotype and microbiota 
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presence (F (1, 1869) = 105.1, p < 0.0001), significant main effect of 
microbiota presence (F (1, 1869) = 6.96, p < 0.01), as well as of genotype (F 
(1, 1869) = 62.15, p < 0.0001). For mid-range diameter axons, two-way 
ANOVA revealed significant interaction between genotype and microbiota 
presence (F (1, 2601) = 17.56, p < 0.0001), significant main effect of 
microbiota presence (F (1, 2601) = 13.36, p < 0.001), as well as of genotype 
(F (1, 2601) = 45.22, p < 0.0001). Whereas, for large diameter axons, two-
way ANOVA revealed no significant interaction between genotype and 
microbiota presence (F (1, 402) = 0.77, p > 0.05), significant main effect of 
microbiota presence (F (1, 402) = 14.52, p < 0.001), as well as of genotype 
(F (1, 402) = 45.22, p < 0.01). Sidak’s correction for multiple comparisons 
post-hoc tests revealed at small diameter ranges WT GF (0.805±0.002) 
animals showed higher mean g-ratio, suggestive of thinner myelin, compared 
to WT SPF (0.782±0.002; p < 0.001), whereas at mid-range diameter no 
significant differences were seen (p > 0.05). On the other hand, when 
comparing between the BACHD groups, the same difference persisted at 
both small (BACHD GF: 0.752±0.003; BACHD SPF: 0.789±0.002) and mid-
range diameters (BACHD GF: 0.824±0.002; BACHD SPF: 0.841±0.001), 
with a smaller mean g-ratio, suggestive of thicker myelin sheath, observed in 
BACHD GF animals compared to BACHD SPF (p < 0.001), which diminished 
at large diameter values, although the same trend was still observed (p > 
0.05). Additional differences in mean g-ratio were seen between WT GF and 
BACHD GF animal at both small (WT GF: 0.805±0.002; BACHD GF: 
0.752±0.003) and mid-range (WT GF: 0.847±0.002; BACHD GF: 
0.825±0.002) axonal diameters, with a smaller mean g-ratio values for 
BACHD GF (p < 0.001). At large diameter ranges, no significant interaction 
between genotype and microbiota presence was observed, however, WT GF 
animals (0.875±0.005) showed a trend towards smaller mean g-ratio, 
suggestive of thicker myelin, compared to WT SPF (0.895±0.002), whereas 
BACHD SPF animals (0.878±0.003) showed a trend towards reduced g-ratio 
compared to WT SPF (0.895±0.002) (p < 0.001). 
 174 
 
Figure 5.2 Representative TEM images of callosal axons in BACHD and 
WT mice housed under SPF and GF conditions 
Representative micrographs of axons from the anterior mid-body region of the 
CC for each experimental group. Scale bar at 2µm. 
 
2 μm 
WT SPF  
BACHD SPF  BACHD GF 
WT GF 
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Figure 5.3 Axonal g-ratios in BACHD and WT mice housed under SPF 
and GF conditions 
(A) Scatter plot of g-ratio values against inner axonal diameter showed similar g-
ratios at all diameter ranges for WT SPF and GF. 
(B) Cumulative frequency plot of g-ratios showed a close overlap of the two curves 
representative of the WT groups. 
(C) Scatter plot indicating lower g-ratio values at small axonal diameters (ID < 500 
nm), and higher values for large axonal diameters (ID > 1000nm), in BACHD GF 
animals (red) compared to BACHD SPF (black).  
(D) Cumulative frequency analysis of g-ratios showed a robust shift towards smaller 
g-rations in the case BACHD GF (red) relative to BACHD SPF (black). 
 
n = 775 - 1440 axons per condition (WT SPF, n = 1440 axons; WT GF, n = 775; BACHD 
SPF, n = 1133; BACHD GF, n = 1028); 3-4 animals per condition.  
 
When averaged over all axons, two-way ANOVA revealed significant 
interaction between genotype and microbiota presence (F (1, 4374) = 121.7, 
p < 0.0001), significant main effect of microbiota presence (F (1, 4374) = 
72.3, p < 0.0001), as well as of genotype (F (1, 4374) = 175.8, p < 0.0001). 
Sidak’s correction for multiple comparisons post-hoc tests revealed WT 
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groups presented with a similar g-ratio (p > 0.05), while the mean g-ratio in 
BACHD GF animals (0.786±0.002) was significantly reduced compared to 
both WT GF (0.834±0.001; p < 0.0001), as well as, when compared to 
BACHD SPF (0.824±0.001; p ≤ 0.0001; Figure 5.4A).  
              
 
Figure 5.4 Mean g-ratio across all axons and different axonal diameters 
in BACHD and WT animals housed under SPF and GF conditions 
(A) BACHD GF animals were associated with a significantly smaller mean g-ratio 
compared to both WT GF, and to BACHD SPF. WT groups had similar mean g-
ratios (p>0.05).  
(B) G-ratios were classified according to inner axonal diameter (small diameter axons, 
ID<500nm; mid-range diameter axons, 500≤ID<1000nm; large diameter axons, 
ID≥1000nm). 
 
Bar graphs represent mean±SEM. Error bars represent SEM from axonal variance. n = 775 - 
1440 axons per condition (WT SPF, n = 1440 axons; WT GF, n = 775; BACHD SPF, n = 1133; 
BACHD GF, n = 1028); 3-4 animals per condition.  Two-way ANOVA, with Sidak’s correction 
for multiple comparisons. ***p < 0.001; ****p < 0.0001. Inner diameter shown in nanometres 
(nm). Abbreviations: ID, inner diameter. 
 
5.4.2. Differences in axonal characteristics 
Axons in the anterior mid-body region of the CC for each animal were 
examined using TEM (Figure 5.2B). Regular and irregular myelinated axons 
were visually categorised based on their shape. Circular or elliptical 
myelinated axons were classified as ‘regular shaped axons’, whereas those 
that deviated from this were classified as ‘irregular shaped axons’ (Figure 
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2.5B). On the other hand, unmyelinated axons were not classified based on 
shape, and are simply referred to as ‘unmyelinated axons’.  
The total number of myelinated axons was similar across conditions (WT 
SPF: 86.38±3.12; WT GF: 82.26±3.02; BACHD SPF: 81.86±4.84; BACHD 
GF: 88.38±1.78; Figure 5.5A). Two-way ANOVA revealed no significant 
interaction between genotype and microbiota presence (F (1, 129) = 2.62, p 
> 0.05), no main effect of microbiota presence (F (1, 129) = 0.13, p > 0.05), 
and no main effect of genotype (F (1, 129) = 0.05, p > 0.05). However, 
further investigation revealed differences in axonal shapes between groups. 
When comparing the number of regular myelinated axons two-way ANOVA 
showed significant interaction between genotype and microbiota presence (F 
(1, 129) = 14.84, p < 0.001), significant main effect of microbiota presence (F 
(1, 129) = 6.04, p < 0.05), but no main effect of genotype (F (1, 129) = 0.76, 
p > 0.05). Sidak’s correction for multiple comparisons post-hoc test revealed 
the number of regular myelinated axons was reduced in the BACHD SPF 
(32.62±2.71) compared to WT SPF (44.18±2.49; p < 0.01). However, no 
significant differences were observed between GF groups, although BACHD 
GF animals were associated with a marginally higher number of axons 
(48.06±1.82) than WT GF controls (40.77±2.62; p > 0.05). No main effect of 
genotype was found however, BACHD GF showed a trend towards a higher 
number of regular myelinated axons compared to BACHD SPF (Figure 
5.5B). When comparing irregular myelinated axons, two-way ANOVA 
showed significant interaction between genotype and microbiota presence (F 
(1, 128) = 4.66, p < 0.05), significant main effect of microbiota presence (F 
(1, 128) = 6.27, p < 0.05), but no main effect of genotype (F (1, 128) = 1.36, 
p >0.05). Sidak’s correction for multiple comparisons post-hoc test revealed 
that WT groups showed similar numbers (SPF, 42.21±1.77; GF 41.48±1.62). 
In contrast, the BACHD SPF group (49.24±3.45) was associated with higher 
numbers of irregular myelinated axons compared to all the other groups, but 
this difference was only significant when compared to BACHD GF 
(39.39±1.33; p < 0.01; Figure 5.5C). Interestingly, unmyelinated axon 
number was comparable across all groups (Figure 5.5D).  
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Figure 5.5 Average number of unmyelinated and myelinated axons per 
selected area in BACHD and WT mice under SPF and GF conditions 
(A) Total number of myelinated axons was similar across all groups. 
(B) Number of regular myelinated axons in the BACHD SPF was smaller 
compared to WT SPF, whereas the BACHD GF group was associated with a 
larger number relative to BACHD SPF. 
(C) Number of irregular myelinated axons was comparable between WT groups. 
The BACHD SPF group possessed a greater number compared to all the 
other groups, but was only significant in comparison to BACHD GF.  
(D) Unmyelinated axon number was similar between all the groups, although GF 
animals were associated with a larger number compared to SPF 
counterparts, regardless of genotype. 
 
Selected area for axonal counting was equivalent to 7.35x10
7
 nm
2
. Bar graphs represent the 
average of a total of 6-12 images per animal, from 3-4 animals per condition; n = 21-39 
images per condition; Bar graphs represent mean±SEM. Error bars represent. Two-way 
ANOVA, with Sidak’s correction for multiple comparisons. *p < 0.05; **p < 0.01; ***p < 0.001. 
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Inner axonal diameter was measured for regular shaped axons using ImageJ 
software (line tool). Relative frequency, cumulative frequency, and bar 
graphs, were plotted to illustrate the differences between inner axonal 
diameters in the four groups. When comparing between WT groups, relative 
frequency distribution showed similar number of axons at all diameter ranges 
(Figure 5.6A). Cumulative frequency plot of inner diameters showed a close 
overlap of the two curves representative of the WT groups (Figure 5.6B). In 
addition, no significant difference was found between WT groups when 
averaging over all inner axonal diameters (p > 0.05; Figure 5.6C). The 
BACHD comparisons, however, showed differences in the relative frequency 
distribution graph. Higher number of axons with small diameter (200 to 
400nm), and smaller number of axons with large diameter (700 to 1000nm), 
was observed in the BACHD GF animals compared to its SPF control (Figure 
5.7A). Cumulative frequency plot of inner diameters showed an evident shift 
towards smaller diameters in BACHD GF compared to BACHD SPF (Figure 
5.7B). Additionally, when all diameter ranges were pooled and averaged for 
each group, BACHD GF animals were associated with a smaller mean 
axonal diameter (525.1nm±7.33) compared to both BACHD SPF 
(647.7nm±7.11; p < 0.0001; Figure 5.7C), and WT GF (619nm±8.9; p < 
0.0001; data not shown). 
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Figure 5.6 Inner axonal diameter in SPF and GF WT animals 
(A) Distribution of inner axonal diameters was similar in WT SPF and GF animals. 
(B) Cumulative frequency plot of inner diameters showed a close overlap of the two 
curves representative of the WT groups. 
(C) No significant difference in mean axonal diameter between WT SPF and WT GF 
groups (p>0.05).  
 
Inner diameter shown in nanometres (nm). n = 775 - 1440 axons per condition (WT SPF, n = 
1440 axons, WT GF, n = 775); 3-4 animals per condition. Relative frequency histogram (A) 
and cumulative frequency (B), bin width = 100 (A). Unpaired two-tailed t-test, 95% 
confidence intervals; Bar graphs represent mean±SEM (C). Abbreviations: ID, inner 
diameter. 
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Figure 5.7 Inner axonal diameter in SPF and GF BACHD animals 
(A) Greater number of axons with a small diameter (200 to 400nm), and a smaller 
number of axons with a large diameter (700 to 1000nm), in BACHD GF animals 
compared to BACHD SPF. 
(B) Cumulative frequency analysis of IDs showed a robust shift towards smaller 
diameters in BACHD GF (red) animals compared to BACHD SPF (black). 
(C) BACHD GF animals possessed a significantly smaller mean axonal diameter 
compared to BACHD SPF.  
 
Inner diameter shown in nanometres (nm). n = 1028 - 1133 axons per condition (BACHD 
SPF, n = 1133; BACHD GF, n = 1028); 3-4 animals per condition. Relative frequency 
histogram (A) and cumulative frequency plot (B), bin width = 100 (A). Unpaired, two-tailed t-
test, 95% confidence intervals, ****p < 0.0001; bar graphs represent mean±SEM (C). 
Abbreviations: ID, inner diameter. 
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5.4.3. Oligodendroglial cell differences in the prefrontal 
cortex and corpus callosum 
No significant differences were observed as a result of microbiota 
manipulation in the number of cortical oligodendrocytes precursor cells 
(OPCs), as labeled by the platelet-derived growth factor receptor α 
(PDGFRα). When comparing groups in the corpus callosum region, two-way 
ANOVA showed no significant interaction between genotype and microbiota 
presence (F (1, 40) = 1.79, p > 0.05), significant main effect of microbiota 
presence (F (1, 40) = 4.15, p < 0.05), but no main effect of genotype (F (1, 
40) = 0.47, p > 0.05). Additionally, when comparing groups in the PFC 
region, two-way ANOVA showed no significant interaction between genotype 
and microbiota presence (F (1, 40) = 0.33, p > 0.05), no significant main 
effect of microbiota presence (F (1, 40) = 1.62, p > 0.05), and no main effect 
of genotype (F (1, 40) = 0.36, p > 0.05). A non-significant trend towards 
increased number of cells was seen in the PFC of WT GF (1,647±248) 
compared to the other experimental groups (WT SPF: 1,283±194; BACHD 
GF: 1,414±177; p > 0.05; Figure 5.8C). In contrast, BACHD SPF (1,133±113) 
showed a non-significant increased number of OPCs in the CC compared to 
the other groups, which was normalised to wild-type levels in the BACHD 
animals held in GF conditions (BACHD GF: 818±64; WT SPF: 941±110; 
Figure 5.8D). 
The number of oligodendrocytes, as labeled by the oligodendroglial lineage 
marker, Olig2, in the PFC and CC region showed no significant differences 
between the groups. When comparing groups in the corpus callosum region, 
two-way ANOVA showed significant interaction between genotype and 
microbiota presence (F (1, 41) = 10.67, p < 0.01), no significant main effect 
of microbiota presence (F (1, 41) = 0.84, p > 0.05), and no main effect of 
genotype (F (1, 41) = 0.58, p > 0.05). Additionally, when comparing groups in 
the PFC region, two-way ANOVA also showed significant interaction 
between genotype and microbiota presence (F (1, 42) = 4.31, p < 0.05), but 
no significant main effect of microbiota presence (F (1, 42) = 0.62, p > 0.05), 
and no main effect of genotype (F (1, 42) = 1.38, p > 0.05). Olig2 population 
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showed a trend towards reduced population in WT GF animals compared to 
SPF controls (WT GF: 8,228±805.9, WT SPF: 8,228±805.9). In addition, WT 
GF also showed a decreased number of Olig2-positive cells compared to 
BACHD GF (13,575±2,283; Figure 5.9B). A similar non-statistically 
significant trend to that in the PFC was observed when comparing the Olig2 
population in the CC of WT GF and SPF animals. The number of Olig2-
positive cells was slightly decreased in WT GF compared to WT SPF 
controls (WT GF, 23,263±2,261; WT SPF, 38,460±4,630; Figure 5.9C). In 
addition, BACHD SPF (23,812±2,632) exhibited a reduced number of Olig2-
positive cells compared to WT SPF. As in the PFC, BACHD GF and SPF 
animals showed a similar number of Olig2-positive cells in the CC.  
When comparing GST-pi positive cells in the corpus callosum region, two-
way ANOVA showed no significant interaction between genotype and 
microbiota presence (F (1, 38) = 3.64, p > 0.05), no significant main effect of 
microbiota presence (F (1, 38) = 0.03, p > 0.05), and no main effect of 
genotype (F (1, 38) = 0.47, p > 0.05). A trend for a decreased GST-pi 
positive cell population was seen in the WT GF compared to its SPF control 
(WT GF, 21,027±2,570, WT SPF, 31,360±5,445; Figure 5.10C). When 
comparing groups in the PFC region, two-way ANOVA also showed no 
significant interaction between genotype and microbiota presence (F (1, 35) 
= 0.68, p > 0.05), but a significant main effect of microbiota presence (F (1, 
35) = 24.46, p < 0.0001), however no main effect of genotype (F (1, 35) = 
0.15, p > 0.05). The GST-pi-positive population was decreased in the PFC of 
both GF groups compared to SPF controls (Figure 5.10B). Sidak’s correction 
for multiple comparisons post-hoc tests for microbiota main effect revealed 
WT GF had significantly less GST-pi positive cells compared to WT SPF (WT 
GF, 3,318±412; WT SPF, 8574±1291; p < 0.001), while BACHD GF GST-pi-
positive population was reduced relative to BACHD SPF (BACHD GF, 
4,430±352; BACHD SPF, 8,180±720; p < 0.05). When comparing within the 
same genotype and between microbiota conditions, both the WT and 
BACHD groups were similar in terms of GST-pi cell numbers (p > 0.05; 
Figure 5.10B).  
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Figure 5.8 PDGFRα positive cell populations in the PFC and CC of 
BACHD and WT mice housed under SPF and GF conditions 
(A) 2.5x magnification of representative image of coronal section labelled for 
PDGFRα.  
(B) 20x magnification of representative image of coronal section of PFC and CC 
labelled for PDGFRα.  
(C) Minor non-significant increase in number of PDGFRα positive cells in the PFC of 
WT GF group compared to the other groups. 
(D) Number of PDGFRα positive cells was significantly decreased in the CC of 
BACHD GF compared to its SPF control.  
 
Bar graphs represent the average of a total of 9-12 animals per condition, and 8-12 sections 
per animal; bar graphs represent mean±SEM. Two-way ANOVA. Abbreviations: CC, corpus 
callosum; PFC, prefrontal cortex. PDGFRα, platelet derived growth factor receptor 
alpha.  
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Figure 5.9 Olig2 positive cell populations in the PFC and CC of BACHD 
and WT mice housed under SPF and GF conditions 
(A) 2.5x magnification of representative image of coronal section labelled for Olig2.  
(B) 20x magnification of representative image of coronal section of PFC and CC 
labelled for Olig2.  
(C) Decreased number of Olig2 positive cells in the PFC of WT GF group compared 
to the other groups. 
(D) Number of Olig2 positive cells was also decreased in the CC of WT GF 
compared to its SPF control. BACHD SPF also showed smaller number of 
Olig2-positive cells compared to WT SPF. 
 
Bar graphs represent the average of a total of 9-12 animals per condition, and 8-12 sections 
per animal; bar graphs represent mean±SEM. Two-way ANOVA. Abbreviations: CC, corpus 
callosum; PFC, prefrontal cortex.  
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Figure 5.10 GST-pi positive cells in PFC and CC of BACHD and WT 
mice housed under SPF and GF conditions 
(A) 2.5x magnification of image of coronal section labelled for GST-pi.  
(B) 20x magnification of representative image of coronal section of PFC and CC 
labelled for GST-pi.  
(C) Decreased number of GST-pi positive cells in the PFC of both WT and BACHD 
GF groups compared to their SPF controls. 
(D) No significant differences in GST-pi positive cells observed in the CC. 
 
Bar graphs represent the average of a total of 9-12 animals per condition, and 8-12 sections 
per animal; bar graphs represent mean±SEM. Two-way ANOVA, with Sidak’s correction for 
multiple comparisons. *p < 0.05. Abbreviations: GST-pi, Glutathione S-transferase; CC, 
corpus callosum; PFC, prefrontal cortex. 
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5.4.4. Expression of myelin related proteins 
Myelin basic protein (MBP) expression levels were decreased in the PFC of 
WT GF (0.547±0.068) compared to WT SPF animals (1±0.132; p < 0.05; 
Figure 5.11B). A similar trend was found in BACHD GF animals 
(0.716±0.149) when compared to SPF controls (1±0.261), however, this did 
not reach statistical significance (p > 0.05; Figure 5.11C).  
Lower levels of PLP expression in the PFC of WT GF animals (0.738±0.050) 
compared to SPF controls (1±0.193) did not reach significance (p > 0.05; 
Figure 5.12B). A similar trend, and absence of significance, was also 
observed between the BACHD groups (SPF: 1±0.382; GF: 0.790±0.213, p > 
0.05; Figure 5.12C).  
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Figure 5.11 MBP levels in the PFC of BACHD and WT mice housed 
under SPF and GF conditions 
(A) Representative western blots of PFC homogenates, immunostained with MBP 
(and Calnexin) in WT groups. 
(B) Representative western blots of PFC homogenates, immunostained with MBP 
(and Calnexin) in BACHD groups. 
(C) MBP levels decreased significantly in the PFC of WT GF compared to SPF 
controls. 
(D) MBP levels decreased in the PFC of BACHD GF compared to SPF controls, but 
was not statistically significant. 
 
Quantification of MBP protein (18-20kDa) concentration was normalised to Calnexin 
(75kDa), and expressed relative to control; SPF was taken as control for each blot. Box and 
whiskers represent quantification of samples from 4 animals per condition; n = 4; whiskers 
represent min to max. Unpaired two-tailed t-test, 95% confidence intervals; *p < 0.05. 
Abbreviations: MBP, myelin basic protein. 
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Figure 5.12 PLP levels in the PFC of BACHD and WT mice housed 
under SPF and GF conditions 
(A) Representative western blots of PFC homogenates, immunostained with PLP 
(and Calnexin) in WT groups. 
(B) Representative western blots of PFC homogenates, immunostained with PLP 
(and Calnexin) in BACHD groups. 
(C) Non-significant lower levels of PLP in the PFC of GF WT compared to SPF WT.  
(D) Non-significant difference between the BACHD groups, but similar trend to the 
WT groups. 
 
Quantification of PLP protein (26.3kDa) concentration was normalised to Calnexin (75kDa), 
and expressed relative to control; SPF was taken as control for each blot. Box and whiskers 
represent quantification of samples from 4 animals per condition; n = 4; whiskers represent 
min to max. Unpaired two-tailed t-test, 95% confidence intervals. Abbreviations: PFC, 
prefrontal cortex; PLP, (myelin) proteolipid protein. 
 
5.4.5. Brain weight differences in GF animals 
Two-way ANOVA showed no significant interaction between genotype and 
microbiota presence (F (1, 64) = 0.14, p > 0.05), but a significant main effect 
of microbiota presence (F (1, 64) = 42.91, p < 0.0001), however no main 
effect of genotype (F (1, 64) = 0.14, p > 0.05). Sidak’s correction for multiple 
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(212.7±3.08 mg) GF mice showed significantly smaller brain weight when 
compared to SPF controls (WT SPF, 243.6±4.14 mg; BACHD SPF, 
236.5±4.47 mg; p < 0.0001; Figure 5.13A). When grouped by sex, two-way 
ANOVA showed no significant interaction between genotype and microbiota 
presence (F (1, 16) = 0.68, p > 0.05), no significant main effect of microbiota 
presence (F (1, 16) = 4.39, > 0.05), and no main effect of genotype (F (1, 16) 
= 0.38, p > 0.05). Female BACHD GF mice showed a trend towards smaller 
brain weights (222.4±5.57 mg) compared to SPF controls (246.1±9.39 mg; p 
< 0.05), whereas WT groups looked fairly similar in terms of brain weight 
(Figure 5.13B). When comparing males, two-way ANOVA showed no 
significant interaction between genotype and microbiota presence (F (1, 44) 
= 1.02, p > 0.05), but a significant main effect of microbiota presence (F (1, 
44) = 48.69, p < 0.0001), and a main effect of genotype (F (1, 44) = 6.32, p < 
0.05). Sidak’s correction for multiple comparisons post-hoc tests revealed the 
same trends of significance were seen as when comparing mixed sex groups 
(Figure 5.13C), in which WT GF (214±4.18 mg) animals had significantly 
smaller brains than WT SPF animals (246.4±4.27 mg; p < 0.0001), and 
BACHD GF (207.9±2.91 mg) brain weights were significantly smaller than 
those of BACHD SPF (232.1±4.63 mg; p < 0.001). In addition, BACHD SPF 
showed smaller brain weight compared to WT SPF animals (p < 0.05).  
For forebrain weight, two-way ANOVA showed no significant interaction 
between genotype and microbiota presence (F (1, 64) = 0.04, p > 0.05), but 
a significant main effect of microbiota presence (F (1, 64) = 21.62, p < 
0.0001), however no main effect of genotype (F (1, 64) = 3.87, p > 0.05). 
Sidak’s correction for multiple comparisons post-hoc tests revealed 
significantly decreased forebrain weight in the mixed sex GF group 
compared to SPF controls (p < 0.01; Figure 5.13D). When comparing male 
forebrains, two-way ANOVA showed no significant interaction between 
genotype and microbiota presence (F (1, 44) = 0.05, p > 0.05), but a 
significant main effect of microbiota presence (F (1, 44) = 17.91, p < 0.0001), 
however no main effect of genotype (F (1, 44) = 4.4, p > 0.05). Sidak’s 
correction for multiple comparisons post-hoc tests revealed significantly 
smaller forebrains in male WT GF animals (165.7±3.98 mg) and BACHD GF 
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animals (159.9±2.36 mg) compared to SPF controls (WT SPF, 179.5±2.72 
mg; BACHD SPF, 172.3g±3.08 mg; p < 0.05; Figure 5.13F). However, when 
comparing female forebrains, two-way ANOVA showed no significant 
interaction between genotype and microbiota presence (F (1, 16) = 0.08, p > 
0.05), no significant main effect of microbiota presence (F (1, 16) = 3.06, p > 
0.05), and no main effect of genotype (F (1, 16) = 0, p > 0.05; Figure 5.13E). 
5.4.6. Lack of microbiota affects body weight of GF BACHD 
animals  
Two-way ANOVA showed significant interaction between genotype and 
microbiota presence (F (1, 88) = 36.05, p < 0.0001), significant main effect of 
microbiota presence (F (1, 88) = 76.98, p < 0.0001), and significant main 
effect of genotype (F (1, 88) = 71.99, p < 0.0001). Sidak’s correction for 
multiple comparisons post-hoc tests revealed BACHD SPF (36.68±0.91g) 
bodyweights significantly exceeded those of WT SPF (27.16±0.75g) 
littermates (p < 0.0001). A significant difference in bodyweight was also seen 
between BACHD SPF and BACHD GF (26.97±0.45g, p < 0.0001). The 
BACHD GF body weight was comparable to that of WT groups (Figure 
5.14A). Female body weight characteristics across groups were similar to 
that observed for mixed sex (Figure 5.14B). When comparing the body 
weight of males, a similar effect of a GF environment on BACHD animals 
was also observed, with an additional significant effect (p < 0.05) of WT GF 
animals possessing a decreased body weight (25.84±0.46g) compared to 
WT SPF (29.27±0.80g) (Figure 5.14C).  
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Figure 5.13 Comparison of brain weight (left hemisphere and forebrain) 
in BACHD and WT mice housed under SPF and GF conditions 
(A) Both WT and BACHD GF mice were associated with significantly smaller brain 
weights compared to their SPF controls. 
(B) Female WT and BACHD GF mice were associated with smaller brain weights 
compared to their SPF controls, although this was only significant in the case of 
BACHD animals.  
(C) When comparing males only, the same trends of significance were seen as 
when comparing mixed sex groups (Fig. 2A). WT GF showed significantly 
smaller brain weights than WT SPF, and BACHD GF showed significantly 
smaller brain weights than BACHD SPF. 
(D) Forebrain weight was also significantly reduced in GF groups compared to SPF 
controls. 
(E) No significant differences in forebrain weight was observed when comparing 
females, although GF animals were associated with smaller forebrain weights 
compared to SPF animals, regardless of genotype.  
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(F) Significantly smaller forebrain weights were seen in male WT GF and BACHD 
GF animals compared to their SPF controls. 
 
Animals’ brains were weighed at 3 months of age. Weight shown in milligrams (mg). n = 11-
13 males per condition, and 4-6 females per condition; Bars represent mean±SEM. Two-way 
ANOVA, with Sidak’s correction for multiple comparisons. *p < 0.05; **p < 0.01; ***p < 0.001. 
For figures E, F and G, ‘Forebrain*’ refers to the left hemisphere, not including the olfactory 
bulb and cerebellum. 
 
   
Figure 5.14 Body weight of BACHD and WT mice housed under SPF 
and GF conditions 
(A) Expected significant difference in body weight between WT SPF and BACHD 
SPF animals. BACHD GF animals’ body weight was significantly reduced 
relative to BACHD SPF animals and similar to both WT groups.  
(B) Differences in body weight in females showed the same trend as when 
comparing mixed sex groups in figure 1(A). 
(C) When comparing males only, an additional difference was seen within the WT 
group, with WT GF animals showing significantly decreased body weight 
compared to WT SPF. 
 
Animals were weighed at 3 months of age. Body weight shown in grams (g). n = 10-13 
animals of each sex; Bar graphs represent mean±SEM. Two-way ANOVA, with Sidak’s 
correction for multiple comparisons.  *p < 0.05; ****p < 0.0001. Abbreviations: SPF, specific 
pathogen free; GF, germ free; WT, wild type; BACHD, bacterial artificial chromosome (BAC) 
mouse model of Huntington Disease (HD). 
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5.5. Discussion  
Myelination and axonal diameter differences as a result of microbiota 
manipulation 
Contrary to that in wild-type (WT) mice, we found that a germ-free (GF) 
environment markedly altered axonal and myelination-related characteristics 
in BACHD mice. This included an increase in population of regular-shaped 
myelinated axons, and a decrease in number of irregular shaped myelinated 
axons compared to BACHD animals housed under specific pathogen free 
(SPF) conditions. Furthermore, we found that germ-free BACHD mice were 
associated with a larger number of small-to-medium diameter axons, and 
that these possessed thicker myelin sheaths (i.e. with reduced g-ratio 
values), than BACHD SPF mice. Our results are at variance with a previous 
report that reported thicker myelin sheaths, or hypermyelination, in axons of 
the prefrontal cortex (PFC) of WT GF animals (Hoban et al., 2016b). This 
disparity may be due to differences in brain region investigated (anterior CC 
here vs PFC), age of the animals (12 weeks here vs 10 weeks), or the 
mouse genetic background (FVB/N here vs Swiss Webster).  
Myelin-related protein differences 
Myelin basic protein (MBP) expression levels were found to be significantly 
reduced in the PFC of WT GF mice compared to their SPF counterparts, with 
an analogous, albeit non-significant, decrease in proteolipid protein (PLP) 
expression also observed in the same animals as a result of germ-free 
conditions. In turn, BACHD GF animals were associated with a non-
significant decrease in MBP and PLP levels in PFC. Our finding in WT 
animals is in keeping with our observation (described in the next section) of a 
reduction in mature oligodendrocyte number in the PFC of WT GF animals, 
but in contrast to a recent study demonstrating increases in MBP levels in 
the same brain region and animals (Hoban et al., 2016b). This disparity may 
once again be due to differences in age and genetic background of wild-type 
mice used in both our and their studies.  
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Regulation of oligodendroglial population by microbiota 
Germ-free conditions were associated with a significant reduction in mature 
myelinating oligodendrocyte (GST-pi+) cells in the prefrontal cortex (PFC) of 
animals regardless of genotype. However, in the corpus callosum (CC) 
region, a small non-significant reduction was observed only for WT GF 
animals compared to SPF control, but not for BACHD GF compared to SPF 
control. A minor reduction was also observed in the number of 
oligodendrocyte lineage (Olig2+) of WT GF mice compared to SPF mice in 
both brain regions investigated. Olig2+ cell numbers of BACHD mice were 
comparable across housing conditions and brain regions. In contrast, there 
were no significant differences in number of oligodendrocyte precursor cells 
(OPCs / PDGFRα+) cells in either the CC or PFC of WT GF mice relative to 
WT SPF mice. In summary, these findings suggest that a proportion of OPC 
cells might lose their capacity to differentiate into mature oligodendrocytes 
when placed in a germ-free environment, which we found to be consistent in 
the PFC region of both WT and BACHD animals.   
Differences in brain weight 
We only found brain weights to differ significantly between WT and BACHD 
animals when comparing males. Brain and forebrain weights were fairly 
similar between WT and BACHD animals when males and females were 
grouped together and compared, or when females only were compared. This 
may be due to the early age at which measurements were taken (3 months) 
since a previous study demonstrated decreased forebrain weights at 12, but 
not at 6 months of age, in BACHD mice relative to WT animals (Gray et al., 
2008). Interestingly, we did find that both germ-free WT and BACHD mice 
exhibited a significant decrease in overall brain weight compared to their 
SPF housed counterparts. This effect was significant when examining male 
germ-free mice only, and also discernible in females, although only 
significant between female BACHD and BACHD SPF mice. 
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Differences in body weight 
BACHD animals housed under SPF conditions were associated with a 
significant increase in body weight relative to WT counterparts, as previously 
observed by us, and others (Hult et al., 2011; Pouladi, Morton, & Hayden, 
2013a; Slow et al., 2003). Interestingly, this weight gain was absent, and 
comparable to WT controls, in BACHD animals housed under germ-free 
conditions. We also found that male WT GF mice displayed a decrease in 
body weight relative to male WT SPF mice, while female weights remained 
unchanged. This appears to roughly consistent with early studies which 
reported germ-free WT animals to weigh either less, or the same, as SPF 
counterparts despite the former being associated with an increase in food 
intake (Bäckhed et al., 2004; Wostmann, 1981).  
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6.1. Overview of findings 
The research presented in this thesis employed environmental and 
microbiota manipulations as assays to interrogate white matter and 
behavioural abnormalities in two mouse models of Huntington disease 
(YAC128 and BACHD), as well as wild-type control animals. The 
environmental manipulation studies investigated the posterior (splenium) 
region of the corpus callosum (CC), whereas the microbiota manipulation 
study investigated the anterior mid-body region of the CC and the prefrontal 
cortex (PFC). Overall, the key findings presented here are as following; 
firstly, environmental enrichment (EE) of YAC128 and wild-type (WT) mice 
was associated with an increase in the number of small and mid-range 
diameter axons, which possessed thinner myelin in the posterior (splenium) 
region of the corpus callosum. Secondly, social deprivation was associated 
with reduced myelin sheath thickness across all axonal diameters in WT 
mice, but no clear myelination-related effects in YAC128 animals. Thirdly, in 
a germ-free environment (GF), BACHD mice were seen to have a larger 
number of small to mid-range diameter axons, and they possessed thicker 
myelin sheaths. Increases in the number of myelinated axons, and 
decreases in the number of unmyelinated axons, were observed in BACHD 
GF mice, compared to diseased controls housed under specific pathogen 
free (SPF) conditions. Myelin basic protein (MBP) and proteolipid protein 
(PLP) levels in WT and BACHD mice were generally reduced under germ-
free conditions. We further observed a reduction in mature myelinating 
oligodendrocytes (GST-pi+) in the PFC and CC of WT germ-free mice, but 
only a reduction of myelinating oligodendrocytes in the prefrontal cortex of 
BACHD germ-free animals. Additionally, oligodendrocyte precursor 
(PDGFRα+) cell numbers were fairly similar across groups in both regions 
investigated. Therefore, our findings suggested that myelination in the CC 
region of YAC128 mice was relatively insensitive to social deprivation, but 
responded to enrichment in a similar manner to wild-type mice. In contrast, 
manipulation of microbiota had complex effects on myelin-related 
characteristics, oligodendroglial populations, body and brain weight, 
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revealing a wide ranging influence of a germ-free environment in both the 
BACHD mouse model of Huntington disease, as well as wild-type animals. 
 
6.2. Environmental enrichment manipulation effects on 
the YAC128 mouse and WT control  
Enriched housing effects on behavioural performance 
Several behavioural tests have been established to assess HD specific 
phenotypes in the YAC128 mouse model and WT littermates (Brooks & 
Dunnett, 2009; Slow et al., 2003). These tests assess the habituation and 
acclimatization to a new environment, anxiety- and depressive-like 
behaviour, locomotor ability and motor learning. 
In the spontaneous activity and open field tests, habituation is measured 
during exposure to the testing chambers, whereas general locomotor activity 
is recorded throughout the duration of testing (Zhu et al., 2007). Here, we 
demonstrate that several measures of activity levels resulting from these 
behavioural tests indicated decreased overall locomotor activity in animals 
housed in an enriched environment, regardless of genotype. Specifically, 
YAC128 and WT animals allocated to an EH condition travelled less, and 
rested for longer compared to their respective SH controls during the 
spontaneous activity test. Other measures, such as vertical and jump counts, 
and average velocity, were also decreased in enriched YAC128 mice 
compared to healthy controls. On the other hand, in the open field test, WT 
EH mice travelled less in comparison to WT SH. Our findings are thus 
consistent with past studies where rats and mice reared in enriched 
conditions also explored less in spontaneous or open field activity tests 
compared to control animals reared in standard housing conditions (Brenes, 
Rodríguez, & Fornaguera, 2008a; Brenes, Padilla, & Fornaguera, 2009; 
Hellemans et al., 2004; Leger et al., 2015; Makinodan et al., 2012; Mosaferi 
et al., 2015; Segovia et al., 2008). This could be ascribed to decreased 
motivation of animals to explore, as enrichment could lead to faster 
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habituation since animals are exposed to complex stimuli in their home 
cages, while the open field and spontaneous activity tests lack object 
novelty. Although grooming time was not recorded in our study, it was also 
previously demonstrated that enriched rats exhibited prolonged grooming 
behaviour compared to rats housed in standard conditions (Brenes, 
Rodríguez, & Fornaguera, 2008a; Mosaferi et al., 2015). Additionally, 
another study showed that the proportion of area travelled was greater in 
early-enriched pups, although total distance travelled was comparable to 
standard housing mice (Simonetti et al., 2009). These two studies, then, 
could be a contributing factor for the low level of activity observed in our 
behavioural tests. Finally, we did not observe any difference in overall activity 
and exploratory behaviour between YAC128 mice and their WT control 
groups across housing conditions. This finding is consistent with previous 
studies, which found early manifest YAC128 mice to exhibit the same levels 
of general locomotion as their WT counterparts (Van Raamsdonk et al., 
2005). 
The OFT and EPM were used to test for anxiety-like behaviour and reduced 
time spent in the centre of the open field or the open arm of the EPM 
suggests increased anxiety-like behaviour in mice (Southwell, Ko, & 
Patterson, 2009). We found no differences between the four experimental 
groups in either of the two tests of anxiety. Moreover, animals, regardless of 
genotype or experimental condition, spent a similar proportion of time in the 
centre of the OFT arena, and in the open arms of the EPM. Although not 
commonly reported in studies, anxiety-like behaviour, as inferred by reduced 
time spent in the centre of the open field arena, was previously detected in 
the YAC128 mouse at 7 months of age (Southwell et al., 2009). However, we 
did not observe a similar phenotype manifest in the YAC128 SH group, 
possibly as a result of age differences between our mice (4.5 months of age) 
and those of the aforementioned study. In addition, previous reports related 
to the effect of enrichment on anxiety-like behaviour have been inconsistent. 
Some studies, like ours, found no effects of enrichment on anxiety-like 
behaviour (Brenes, Rodríguez, & Fornaguera, 2008a; Peña et al., 2006; 
2009). Others, however, reported reduced anxiety as an effect of enrichment 
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(Galani et al., 2007; Hellemans et al., 2004). Interestingly, in a study 
investigating the effects of different durations of enrichment (24hrs, 1, 3, 5 
and 6 weeks), anxiety-like behaviour in mice was only reduced by a 3-week 
exposure to enrichment, but not by any of the other enrichment durations 
(Leger et al., 2015).  
The climbing test is often used as a measure of motor ability in HD mouse 
models (Menalled et al., 2009; Southwell et al., 2009). No differences in any 
of the climbing measures (latency to fall, time spent climbing or number of 
climbing attempts) were found between YAC128 and WT at 18 weeks of age, 
regardless of housing condition. Elsewhere, decreased latency to climb was 
only observed at 16 weeks of age in the YAC128 FVB (as used here) 
compared to WT, but not at other preceding or succeeding age groups 
(Menalled et al., 2009). Decreased climbing time in YAC128 FVB animals 
compared to WT littermates was also previously reported at 7 months of age 
(Southwell et al., 2009). In addition, we observed no differences in latency to 
climb, or time spent climbing, in the climbing test between any of the 
experimental groups regardless of genotype. Interestingly, both YAC128 and 
WT mice from the EH groups had fewer number of climbing attempts 
compared to animals from the SH groups. Enriched cages contained stairs, 
tunnels and objects offering the possibility for climbing. Therefore, it is 
possible that enriched animals were less motivated, and habituated faster to 
the climbing mesh cylinders compared to standard housing animals, leading 
to reduced climbing activity, similarly to the reduction in exploratory activity 
observed in the spontaneous activity test. Thus, this test, and that of 
spontaneous activity, could be susceptible to confounds relating to the 
animal’s motivation to climb and explore.  
The rotarod is a commonly used test of motor performance in animal models 
of HD (Garcia-Miralles et al., 2016; Pouladi et al., 2008; Slow et al., 2003). In 
our study, the YAC128 SH group remained the least time on the fixed 
rotarod, and had the highest number of falls and the highest percentage of 
animals that fell off the rotarod, for the first 6 out of 8 training trials. However, 
statistically significant differences were only observed between YAC128 SH 
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and WT SH mice on the first trial of the first training day only. This suggests 
that YAC128 SH mice exhibit minor motor learning deficits in this behavioural 
test. Consistent with our findings, motor learning deficits were seen at 2 
months of age in the YAC128 HD model housed under standard conditions, 
as well as minor locomotor deficits from the age of 4 months, which 
worsened progressively and reached statistical significance after 6 months of 
age (Franciosi et al., 2012; Lawhorn et al., 2008; Slow et al., 2003; Van 
Raamsdonk et al., 2005). 
In addition, our study revealed that WT animals housed in enriched housing 
(EH) marginally outperformed other groups on fixed speed rotarod training 
sessions, as well as the accelerated rotarod test. Although not statistically 
significant, this group had an overall smaller number of falls compared to the 
other groups. In addition, WT EH animals also performed better on the 
accelerated rotarod testing session, showing a higher latency to fall 
compared to all the other groups. Furthermore, despite the YAC128 EH 
group starting the first training trial at a similar level to YAC128 SH controls, 
the YAC128 EH group consistently outperformed the YAC128 SH group over 
the next four training trials, remaining a greater time on the rotarod until the 
first fall, and a succumbing to a smaller number of falls. However, these 
differences in performance did not reach statistical significance. YAC128 EH 
animals attained the same performance as WT SH and WT EH animals after 
2 training trials, while YAC128 SH animals required 6 trials to learn the test 
and reach similar performance levels. Thus, the YAC128 EH animals learnt 
the rotarod task more quickly than the YAC128 SH control group. In contrast, 
no advantages were conferred to YAC128 EH animals compared to YAC128 
SH controls in the accelerated rotarod test. Taken together, these findings 
suggest a marginal effect of an enriched environment on motor learning and 
motor performance in the healthy WT group, and minor beneficial effects on 
learning, but not motor performance, on this task in the YAC128 HD mouse 
model at the tested age of 18 weeks (~4.5 months). In contrast, a previous 
study reported improvements in rotarod test performance in another HD 
model as a result of enrichment. Specifically, at 8 weeks of age, the R6/2 
mouse, an HD model with accelerated phenotype and impairments beginning 
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at 5-6 weeks and a life-span of about 12-14 weeks (Mangiarini et al., 1996), 
showed improvements in the latency to fall during the rotarod test after 4 
weeks of enriched housing (Hockly et al., 2002). On the other hand, no effect 
of post-weaning enrichment was found on the rotarod test at 10 or 25 weeks 
of age in the R6/1 mouse, an HD model with an aggressive onset and a 
shortened life-span of about 9 months (Lazic et al., 2006). An important 
caveat to this report, however, is that the R6/1 mouse performed relatively 
poorly relative to WT controls, regardless of housing condition (Lazic et al., 
2006). However, other studies showed that enrichment did have beneficial 
effects on the R6/1 mice in the performance on the horizontal rod test (very 
similar to rotarod test; van Dellen et al., 2000, Nature) and on the rotarod test 
(Spires, 2004). 
Overall, our results are roughly in keeping with the notion that environmental 
enrichment confers some beneficial effects on laboratory mice. While we did 
not observe clear and consistent positive effects of enrichment on behaviour 
and motor function in YAC128 HD mice above and beyond that seen in WT 
mice – which might be expected due to the background pathology - this may 
be due to this particular HD model being a late-onset phenotype, and/or the 
early manifest stage at which tests were conducted. Mouse models of HD 
with accelerated onset phenotypes, such as those described above, may 
therefore be more predisposed to displaying more overt behavioural and 
motor improvements due to environmental enrichment. Notwithstanding, and 
as described, the available literature examining behaviour and motor function 
in mouse models of HD has several inconsistencies, and underscores the 
need for standardization of relevant protocols across laboratories (Ross & 
Tabrizi, 2011).  
Impact of environmental manipulation on myelination and mature 
oligodendrocytes in the corpus callosum 
Myelination in the brain begins during development and continues into adult 
life (Miller et al., 2012), and it has been recently shown that myelin is 
adaptive and plastic to environmental and behaviorally driven experiences 
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(Forbes and Gallo, 2017; McKenzie et al., 2014; Mount and Monje, 2017; 
Tomlinson et al., 2015). Our study aimed to understand enrichment driven 
effects on adaptive myelination in the white matter tracts of the posterior 
region (splenium) of the corpus callosum in WT and YAC128 mice. By 
examining the variability of myelin thickness at different ranges of axonal 
diameters, we identified similar trends between the WT and YAC128 animals 
exposed to enrichment. Firstly, in the WT enriched animals, small and mid-
range axons exhibited thinner myelin thickness compared to SH controls, but 
no differences were seen for large axons. Furthermore, in enriched YAC128 
mice, mid-range and large axons had thinner myelin compared to YAC128 
SH mice, while no differences were observed in small axons. However, when 
g-ratios were averaged together across all axonal diameters, both enriched 
groups, regardless of genotype, showed increased g-ratio values, thus 
thinner myelin, compared to their corresponding standard housing controls. 
In addition, by analysing the distribution of myelinated axonal diameters, we 
revealed that both enriched groups, regardless of genotype, exhibited an 
overall larger number of small diameter axons, compared to their 
corresponding standard housing controls. Thus, EH animals in both 
genotypes were associated with a significantly reduced axonal diameter 
compared to their SH counterparts, and which was more pronounced in 
YAC128 animals.  
Interestingly, it has been established that the first axons to be myelinated 
both in the brain and spinal cord are those with the largest diameter within 
the population (Almeida et al., 2011; Hahn et al., 1987; Matthews & Duncan, 
1971). If this occurred in our animals during the time spent in the allocated 
environment, or prior to environmental manipulation, possibly at the peak of 
myelination (Matthieu et al., 1973; Wiggins, 1986), small and mid-range 
axons might still be in the process of being myelinated at the time of our 
analysis. This would support our observation of comparable g-ratios between 
WT SH and WT EH in large diameter axons, as well as a greater number of 
small diameter axons in EH animals relative to SH, regardless of genotype. A 
previous study has reported an increase in the number of myelinated axons 
of small and mid-range diameter (ID ≤ 1000) in aged rats after four months of 
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enriched housing, and showed that these newly myelinated axons had 
thinner myelin sheath (Yang et al., 2013). The authors suggested that the 
observed increased axon and myelin sheath volume in these animals was 
not due to increase in axonal size or increase myelin sheath thickness but, 
rather, could be explained by an increase in number of newly myelinated 
axons (Yang et al., 2013). Thus, it is possible that small axons get 
myelinated later as a result of an enriched environment, and these newly 
myelinated axons have thinner myelin compared to axons myelinated prior to 
allocation to experimental condition, resulting in overall thinner myelin 
sheaths in WT EH animals compared to WT SH, as we observed. Therefore, 
we speculate that myelination was on going, and had not reached the end 
point of this process, at the time of our analysis (Karttunen, 2017; Powers et 
al., 2013).  
Myelination in standard housed mice was reported to be achieved in almost 
all brain regions by p60 (Baumann & Pham-Dinh, 2001). However, others 
have shown that myelin continues to be synthetized later into adult life 
(Dimou et al., 2008; Rivers et al., 2008; Waly et al., 2014). In addition, 20% 
of oligodendrocytes are generated in the mouse CC after 7 weeks of age, 
whereas mature myelin producing oligodendrocytes continued to be 
generated until at least 8 months of age (Psachoulia et al., 2009; Rivers et 
al., 2008). In an interesting study using Cre-Lox fate mapping in mice, it was 
observed that myelin synthesized in adulthood (after p120) was associated 
with larger g-ratios (i.e. thinner myelin sheaths) compared to myelin that was 
synthetized earlier in life (Young et al., 2013). Our mice were placed in their 
allocated condition from p28 to p126; therefore, it is possible that EE used 
here could prolong the ‘window of myelination’, and thinner myelin sheaths 
could be a property of myelination in the adult CNS, as previously suggested 
(Franklin & Ffrench-Constant, 2008; Franklin & Hinks, 1999; Waly et al., 
2014; Young et al., 2013). Unfortunately, due to sparse literature 
investigating on the effects of enrichment on myelination, and the absence of 
further myelin-related measurements, such as total number of myelinated 
and unmyelinated axons, or total myelin sheath or axonal volume, it is 
difficult for this study to draw a clear conclusion on these findings. 
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Additionally, YAC128 SH mice had significantly thinner myelin at small 
axonal diameters, whereas a trend towards a minor decrease in g-ratio, thus 
thicker myelin, was observed in large diameter axons, compared to WT SH 
controls. However, since small diameter axons outnumber large ones, when 
averaged across all axonal diameters, a minor, non-significant, higher g-
ratio, suggestive of thinner myelin, was observed in YAC128 SH animals 
compared to WT SH. Previous work in our laboratory has demonstrated WM 
microstructural abnormalities in the anterior mid-body region of the CC of the 
YAC128 mouse from 1.5 months of age, and that these differences were 
accompanied by thinner myelin sheaths in the same region (Teo et al., 
2016). However, differences in the posterior region (splenium) of the CC 
were only detected from 6 months of age (Teo et al., 2016). Our current 
study has investigated the posterior region of the CC, thus it is possible that 
myelin pathology in the posterior region of the YAC128 HD mouse model is 
less severe compared to the anterior region, and/or or becomes manifest at 
a later age. Consistent with this possibility, curprizone-induced demyelination 
in mice induced regional differences in demyelination along the CC (Binder 
et al., 2008; Steelman, Thompson, & Li, 2012). Taken together, these results 
provide further evidence into the complex effects of enrichment on axonal 
and myelin-related characteristics, which may underpin the observed 
beneficial effects of enrichment on specific behaviours and motor function.  
Finally, no significant differences were observed in GST-pi positive cells in 
the corpus callosum between any of our experimental groups. This finding 
suggests that 14 weeks of post-weaning enrichment does not have an effect 
on the number of mature myelinating oligodendrocytes in the corpus 
callosum. Similarly, others have also found no differences in CNPase+ cells 
in the amygdala of mice after 40 days of enrichment, although an increase in 
number of OPCs was observed (Ehninger et al., 2011); while 28 days of 
enriched housing was linked to higher number of oligodendrocytes in the 
substantia nigra (Klaissle et al., 2012). However, no changes were found in 
PFC oligodendrocyte density or morphology, or in myelin transcript levels of 
young mice that spent 1.5 months in an enriched setting (Makinodan et al., 
2012). On the other hand, decreased number of OPCs and increased 
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number of mature oligodendrocytes were observed after 10 days, but not 42 
days (~1.4 months), in sensorimotor cortex, but not the CC, of enriched 
young rats compared to standard housing (Keiner et al., 2017). Therefore, it 
is possible that the differentiation of OPCs into mature oligodendrocytes, 
driven by enrichment and behavioural experience, could take place within the 
first week of manipulation, and would not be detected at later points (such as 
those used in our study). A caveat to this observation is that our use of 
oligodendrocyte counts might be considered a crude measure, and as such it 
is insensitive to myelin-related changes at the sub-cellular level (internode 
distance, number of branches, etc.). 
Brain and body weight changes as an effect of enriched housing 
No differences in brain weight between any of the groups were found at 4.5 
months of age, regardless of genotype or housing manipulation. Previous 
work in YAC128 mice (line 53), demonstrated a 5% and 10% decrease in 
mean brain weight at 9 and 12 months of age, respectively, compared to WT 
controls (Slow et al., 2003). In addition, a 10-15% decrease in striatal volume 
was also previously observed at 9 months of age and persisted at 12 
months, whereas a 7-8% decrease in cortical volume was only observed at 
12 months of age (Slow et al., 2003; van Oostrom et al., 2007; Van 
Raamsdonk et al., 2005). No differences in brain weight between YAC128 
mice and WT littermates were previously reported before 9 months of age. 
Interestingly, in terms of the effect of enrichment, global brain volume of adult 
rats was decreased after 6 weeks of enrichment compared to 1.5 weeks of 
enrichment (Keiner et al., 2017). 
Increased body weight is a known phenotype of the YAC128 mouse due to 
the influence of full-length mutant huntingtin levels in this HD model (Pouladi 
et al., 2010; Slow et al., 2003; Van Raamsdonk et al., 2006). Animals in the 
current study were weighed fortnightly from 7 weeks (50 days) to 18 weeks 
of age (126 days), and comparisons were made separately for females and 
males. A significant main effect of time indicated all groups gained weight 
over the duration of the study. In the standard housing conditions, YAC128 
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females and males weighed more than WT SH controls at two of the 
recorded time-points. In addition, comparison between the two enriched 
groups revealed that YAC128 EH females weighed more than WT EH at all 
time-points recorded with the exception of the first.  
Reports into the effects of enrichment on body weight are inconsistent, and 
vary with sex, strain or animal model, as well as duration or complexity of 
enrichment (Tsai et al., 2016; Tsai et al., 2003). With minimal enrichment 
containing a nest box, a wood bar and nesting material, no differences were 
found in body weights of three strains of mice: BALB/c, C57BL and A/J, at 
any recorded time-points between enrichment onset to 10 weeks later (Tsai 
et al., 2003). In 10 weeks old C3H/eB mice, 6 weeks of enrichment also did 
not have a significant effect on body weight (Benaroya-Milshtein et al., 2004). 
In the R6/1 HD mouse model, 4 months of enrichment was shown to partially 
rescue characteristic weight loss, eliminating the differences between WT 
and the disease model at 5 months of age (Spires, 2004). However, another 
study showed no effect of enrichment on body weight in the R6/1 model after 
4.5 months in their allocated condition (van Dellen et al., 2002). Interestingly, 
in our study, both enriched female groups, regardless of genotype, weighed 
more compared to their standard housing control. Enriched YAC128 female 
mice weighed significantly more than standard housing YAC128, between 
11-18 weeks of age. A non-significant trend was observed for increased 
body weight in WT EH females compared to WT SH females. In contrast, the 
effect of enrichment on male body weight was not as clear, although a trend 
of increased body weight in the WT EH group compared to WT SH was 
observed at several time points (11-15 weeks). These findings suggest a 
larger effect of enrichment on female body weight in the HD mouse model, 
and only a minor effect on the body weight of WT females and males. 
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6.3. Social deprivation effects on the YAC128 mouse and 
WT control  
Isolation effects on behavioural performance 
No significant patterns in measures of activity level were observed during 
spontaneous activity test in standard housed (SH) and socially isolated WT 
and YAC128 mice. Animals from all groups showed comparable resting time, 
mean vertical counts, mean jump counts, as well as average velocity. A trend 
was, however, observed in the mean distance travelled during this test, with 
both YAC128 groups travelling less than their WT counterparts, regardless of 
housing condition. This non-significant trend was replicated in the open field 
test, but only in the SH group, where YAC128 SH mice travelled less than 
WT SH mice. These findings indicate that general locomotor activity in WT 
controls and YAC128 mice was not affected by social isolation. This is 
consistent with previous studies in wild-type rodents, where four and eight 
weeks of social isolation in juvenile (Makinodan et al., 2012) and adult (Liu et 
al., 2012) mice, respectively, did not affect mean distance travelled in the OF 
test. Likewise, three weeks of social deprivation in adolescent or adult mice 
did not affect total distance travelled in the OF test (Lander et al., 2017). 
Being reared in social isolation also does not appear to affect the 
performance of healthy male rats in the OFT (Brenes, Rodríguez, & 
Fornaguera, 2008b), although others studies have reported hyperactivity 
(decreased resting time; Fone & Porkess, 2008). 
Furthermore, no clear trends in standard housed and socially isolated WT 
and YAC128 mice were distinguished in the two tests of anxiety. In contrast, 
a recent study found that three weeks of social deprivation caused male mice 
to spend less time in the centre of the open field arena regardless of whether 
they were allocated to isolation at adolescence or adulthood (Lander et al., 
2017). Additionally, male mice of the CD1 strain, after being socially isolated 
post-weaning for 8 weeks, besides showing decreased heterochromatin 
formation and MBP expression, also spent less time in the open arm, and 
entered the open arm less times, than standard controls (Cao et al., 2017), 
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suggesting that social isolation induced anxiety-like behaviour. However, 
anxiety-like behaviour in rats was also found to be highly variable, and 
somewhat dependent on the time spent in isolation (e.g. Butler, Carter, & 
Weiner, 2014; Mosaferi et al., 2015; Hermes et al., 2011). Therefore, our 
observation of a lack of an effect of social isolation anxiety-like behaviour 
may be due to differences in experimental protocol that were unable to 
unearth significant effects.  
Several measures, such as latency to climb, time spent climbing and number 
of climbing attempts, were recorded during the climbing test to assess motor 
ability. Although we found no statistically significant differences between 
groups related to any of these measures, socially deprived groups, 
regardless of genotype, took longer to attempt their first climb, spent less 
time climbing, and attempted climbing, on average, less than their respective 
standard-housing controls. Therefore, our results indicate a modest negative 
effect of isolation on climbing performance, and possibly motivation to climb, 
regardless of genotype. Furthermore, deprived housing appeared to have a 
slight negative effect on YAC128 mice motor learning, as this group 
performed worse than all the other groups on the first two trials of the fixed 
speed rotarod training, with a shorter latency to fall, more number of falls and 
a higher proportion of mice that fell off the rotarod. Subsequent sessions, 
however, showed comparable rotarod performance between all the groups. 
The YAC128 deprived animals also showed the lowest latency to first fall on 
all three trials of the accelerated rotarod testing, however, this was not found 
to differ statistically from the other groups. In addition, WT deprived animals 
were more likely to fall off the rotarod during the first two days of training, and 
these animals showed slightly decreased performance both in terms of 
latency to fall and number of falls during the first two training trials, compared 
to standard housing controls. Therefore, the rotarod test revealed that 
environmental deprivation had a mild impact on motor learning and motor 
performance on the early manifest YAC128 mouse at 18 weeks of age, and 
a minimal impact on WT deprived animals with regards to motor learning, but 
not performance, during testing.  
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Taken together, our observation of only minor negative behavioural and 
motor effects as a result of social isolation, across WT and YAC128 animals, 
is intriguing, since we expected this to be more pronounced, particularly in 
the YAC128 mouse model of HD. However, it is important to note that the 
available literature with which to contextualise our results is limited, and that 
there is lack of standardization between deprivation protocols across studies. 
A likely explanation is that HD pathology is such a dominant factor that social 
deprivation does not worsen it sufficiently to detect an effect with the 
measures used. Additionally, it is possible that the short time window, 
immediately after weaning (3 weeks of age), when deprivation seems to 
affect the mice more severely, could have been missed in our study, since 
mice were weaned and placed in their allocated condition at 4 weeks of age 
rather than 3 weeks. Nevertheless, we cannot exclude that our 
environmental deprivation protocol may not have been sufficiently severe to 
induce significant effects. One way to make deprivation conditions more 
severe for the current study would involve removing the bedding material 
altogether.   
Isolation effects on myelination and mature oligodendrocytes in the 
corpus callosum  
The current study aimed to understand social deprivation driven effects on 
adaptive myelination in the white matter tracts of the posterior (splenium) 
corpus callosum in the early manifest YAC128 mouse model of HD, as well 
as WT controls. Socially deprived WT animals exhibited significantly higher 
g-ratios, suggestive of thinner myelin sheaths, compared to all the other 
groups in our study. Higher g-ratios in socially deprived WT animals, 
compared to WT SH mice, persisted across all axonal diameter ranges. 
Consistent with our findings, an early study examining the relationship 
between white matter abnormalities and behavioural experience 
demonstrated that male rhesus monkeys raised in isolation from 2 to 12 
months of age had significant decreased corpus callosum (CC) size, which 
was particularly evident in the posterior region, when compared to monkeys 
raised in social groups (Sánchez et al., 1998)). Thinner myelin sheaths have 
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also been reported in the medial prefrontal cortex (mPFC) of healthy juvenile 
mice following 2, 4 or 8 weeks of post-weaning isolation (Cao et al., 2017;  
Liu et al., 2012; Makinodan et al., 2012). Moreover, juvenile male CD1 mice 
reared in isolation for 8 weeks post-weaning exhibited thinner myelin sheaths 
in the hippocampus, as well as decreased heterochromatin formation and 
MBP expression (Cao et al., 2017). Additionally, adult mice were also seen 
to exhibit hypomyelination in the PFC following 8 weeks of social deprivation, 
whereas myelin sheath thinning was milder after only 2 weeks of isolation 
(Liu et al., 2012). In contrast, other reported no differences in layer V of the 
mPFC myelin thickness of adult mice placed in social isolation for 4 weeks 
(Makinodan et al., 2016). Furthermore, no differences in myelin sheath 
thickness or myelin gene transcripts were found in the white matter tracts of 
the anterior commissure, the nucleus accumbens or the cerebellum, between 
isolated and standard house adult mice, placed in their allocated condition at 
16 weeks of age, regardless of the period of isolation (2 or 8 weeks) (Liu et 
al., 2012). These studies confirm that the predominant effect of social 
isolation is a thinning of myelin sheaths, but that that the variability in 
observations may be underpinned by brain-region, age dependencies, or 
duration of isolation paradigm employed.  
In terms of axonal diameter, our study revealed that WT deprived mice had 
fewer smaller diameter, and more mid-range to large diameter, myelinated 
axons compared to their WT standard housed control. Thus, on average, 
myelinated axons in deprived WT mice were of a significantly larger diameter 
compared to WT SH controls. This finding is at variance with a previous 
report of no differences in axonal diameter in juvenile mice after 4 weeks of 
deprivation, however, this was observed in a different region of the brain, the 
mPFC (Makinodan et al., 2012), suggesting that the duration of deprivation, 
age of the animal, and region of the brain investigated, could be important 
factors in determining the effect of social isolation on axonal characteristics.  
On the other hand, socially deprived YAC128 mice had comparable myelin 
sheath thickness to YAC128 and WT mice housed under standard 
conditions. However, at large axonal diameters, YAC128 DH animals 
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showed increased g-ratios, thus thinner myelin, compared to their standard 
house YAC128 controls. This difference, although considerable, did not 
influence the overall g-ratio average, because the population of large 
diameter axons was much smaller relative to mid-range and small axons, 
which make up the majority of axons in this region of the CC, as shown by 
our findings. In addition, socially deprived YAC128 mice were associated 
with, on average, a smaller axonal diameter compared to their standard 
housed YAC128 controls. These results indicate that social isolation does 
not appear to negatively influence myelination in YAC128 mice in the same 
manner as was observed in WT animals, possibly due to the dominant effect 
of the disease phenotype. However, mean axonal diameter changes due to 
social isolation in WT and YAC128 mice were diametrically opposed, which 
might suggest that the (currently unknown) environmental deprivation 
mechanism(s) leading to increases in axonal diameter in WT animals is 
reversed by the YAC128 disease phenotype. Regardless of mechanism, our 
results indicate that signal conduction velocities in deprived YAC128 mice 
may be decreased as a result of decreased axonal diameter (Waxman, 
1980), which could tentatively suggest that social isolation may exacerbate 
the development of symptoms in HD models.  
Finally, our study revealed no significant differences in mature 
oligodendrocyte population, labeled by GST-pi positive cells, to 14 weeks of 
social deprivation in 18-week-old mice. This observation appears in keeping 
with a previous report of no change in oligodendrocyte density in mPFC after 
a 2 or 4-week period of social deprivation in juvenile mice, although shorter 
processes, fewer branches and fewer internodes per cell in oligodendrocytes 
were also described (Makinodan et al., 2012). Also of note, 8 weeks of social 
isolation in adult mice (16 weeks old) did not affect nodal length in the PFC, 
however, the expression of some oligodendrocyte specific paranodal genes 
were lower compared to standard house control (Liu et al., 2012). Taken 
together, and in combination with our environmental enrichment study, these 
findings suggest that environmental manipulation in both directions has little 
effect on mature oligodendrocyte numbers, at least at the time points 
studied, and on this mouse background.  
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Brain and body weight changes as an effect of social deprivation 
No significant differences in brain weight between any of the groups were 
found at the age of 4.5 months regardless of genotype or housing 
manipulation. All groups gained in body weight over the duration of the study. 
No significant differences were observed between any of the female groups 
as a result of social deprivation, although the WT deprived female mice 
exhibited slightly increased body weights compared to WT females in 
standard housing conditions. This observation is consistent with a previous 
study that reported isolated female rats (7 weeks post-weaning) to weigh 
approximately 10% more than their standard housing counterparts (Hermes 
et al., 2011). In addition, our study showed no significant effect of deprivation 
on male groups either, although WT DH males were consistently of a lower 
body weight compared to WT SH males. A recent study has similarly shown 
that socially isolated juvenile C57BL/6 male mice (3 weeks of isolation) 
exhibited a decreased body weight, whereas isolated adult mice exhibited no 
alterations in body weight (Lander et al., 2017). Conflicting results related to 
the effect of social deprivation on body weight in animals have been ascribed 
to a number of factors, including paradigm duration, sex, strain or species of 
animal (Sakakibara et al., 2012; Sun et al., 2014). As for the reason for 
gender specific differences in body weight in deprived WT mice, it is possible 
that this is due to known difference in food intake in different sexes as a 
result of the potential chronic stress induced by the experimental condition 
(Sun et al., 2014). On the other hand, the body weights of YAC128 mice 
closely overlapped, regardless of sex or housing condition, suggesting that 
while social deprivation has minor effects on the body weights of WT 
animals, it does not affect YAC128 mice, at least at the time-points studied. 
This again would be consistent with a dominant effect of the disease as seen 
for myelin-related characteristics, as described earlier. 
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6.4. Microbiota manipulation effects on the BACHD mouse 
and WT control  
Myelination and axonal diameter differences as a result of microbiota 
manipulation 
Overall, ultrastructural analyses indicated that a germ free (GF) environment 
had a greater effect on the number, diameter size, and extent of myelination 
of axons in the anterior mid-body region of the corpus callosum (CC) in 
BACHD animals compared to WT controls. More specifically, overall 
myelination thickness in WT animals showed relatively little response to GF 
manipulation, and the number of regular and irregular myelinated axons was 
also not affected in these animals. In contrast, BACHD mice raised and 
maintained under GF conditions showed a larger number of small to mid-
range diameter axons associated with thicker myelin sheaths (lower g-ratios) 
compared to both BACHD SPF, as well as WT GF controls, and exhibited a 
higher number of regular shaped myelinated axons, and a lower number of 
irregular shaped myelinated axons compared to BACHD controls housed in 
SPF conditions. Thus, based on the literature presented in the introduction 
chapter, we speculate that a germ-free environment could promote 
myelination of small diameter axons through one or a combination of 
mechanisms. This may happen through facilitation of an increase in axonal 
myelination diameter of previously under-threshold diameter axons to above 
the required threshold for myelination, such that supra-threshold axons 
would then become new candidates for possible myelination, as previously 
observed in cerebellar granule cells (Goebbels et al., 2017). Alternatively, 
already myelinated axons could receive further ensheathment, and thus, 
become hypermyelinated, possibly through alterations in intrinsic 
oligodendrocytes programs (Bechler et al., 2017), or modifications of axonal 
cues (Brinkmann et al., 2008; Hines et al., 2015). Indeed, axonal signaling 
has been recently demonstrated to modulate myelin sheath characteristics 
(Gautier et al., 2015; Gibson et al., 2014; Hines et al., 2015; Wake et al., 
2015). Furthermore, increased neuronal activity, induced through 
optogenetic stimulation, was associated with thicker myelin sheaths in the 
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projection fibres arising from the premotor cortex and entering the CC 
(Gibson et al., 2014). Thus, although this remains to be demonstrated by 
future studies, it is possible that neuronal activity may be increased in 
BACHD animals raised in a germ-free environment, and lead to 
hypermyelination in small and medium-sized axons. On the other hand, an 
interesting follow-up would be to determine whether the hypermyelination 
observed, using g-ratio calculation, translates into thicker myelin, or whether 
the observation is rather due to decreased compactness of the myelin 
sheaths which could make the myelin sheaths appear thicker. Compactness 
can be easily determined in electron micrographs by calculating the ratio 
between myelin thickness and number of myelin lamellae. 
Hypermyelination was previously reported in wild-type GF animals, where 
male GF mice presented with thicker myelin sheaths in PFC axons, but no 
difference in axonal diameter, compared to SPF controls (Hoban et al., 
2016b). In contrast, our study indicates overall similar myelin sheath 
thickness between wild-type GF and SPF animal, although with small 
variations, such as hypomyelination at small diameter axons, and a trend 
towards hypermyelination at large diameter axons, while similar myelination 
was observed at mid-range diameter axons. The overall g-ratio in our 
findings is reflective of the fact that mid-range axons represent the majority of 
the axonal population in this anterior region of the CC investigated. Possible 
reasons for discrepancy in findings between our study and (Hoban et al., 
2016b) are the brain region investigated (anterior CC here vs PFC), the age 
of the animals (12 vs 10 weeks), or the mouse genetic background (FVB/N 
vs Swiss Webster). It is also possible that the PFC might be particularly 
susceptible to microbiota-driven changes in a way that the CC is not, since 
myelination in the PFC was previously speculated to be particularly plastic 
and susceptible to adaptation due to environmental, as well as social factors 
(Forbes & Gallo, 2017; Mount & Monje, 2017; Tomlinson, Leiton, & 
Colognato, 2016b). This possibility is further supported, by observations of 
no differences in relative myelin-related protein expression in other brain 
regions, such as the frontal cortex (rather than specifically the prefrontal 
region of the cortex), amygdala, cerebellum, hippocampus or striatum, as 
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result of a GF environment, although ultrastructural myelin characteristics in 
these regions were notably not investigated (Hoban et al., 2016b).  
Another method frequently used to deplete animals of gut microbiota, with 
similar effects of a germ-free environment, is through the use antibiotic 
treatment (Reikvam et al., 2011). The use of a cocktail of antibiotics, aimed 
at different bacterial strains, was shown to have transient alteration effects 
on the diversity and composition of the gut microbiota (Bercik et al., 2011; 
Minter et al., 2017; Puhl et al., 2012). Alternatively, alteration of microbiota 
composition can be obtained by transplant of faecal or cecal content from 
one subject to that of another. A combination of both methods, by first 
depleting existing host microbiota with antibiotics, followed by faecal / cecal 
transplant of microbiota from another host, can be used to examine the 
effects of certain strains of microbiota on the recipient host, and the impact of 
microbiota from a diseased donor to a healthy donor, or vice-versa. Using 
this combination of microbiota manipulation methods Gacias et al. (2016) 
initially depleted wild-type C57BL/6 mice of their own microbiota, followed by 
transplant of microbiota from diabetic mice, which were either treated with 
antibiotics or treated with a vehicle. They reported increased myelin 
thickness, in the medial region of the PFC (mPFC), but not nucleus 
accumbens, of 13 weeks old wild-type mice recipients of microbiota from 
antibiotic-treated diabetics, compared to recipients of microbiota from 
vehicle-treated diabetics (Gacias et al., 2016). This effect was ascribed to 
exposure of oligodendrocytes to raised levels of the metabolite cresol, the 
synthesis of which modified by gut microbiota, prevented myelin gene 
expression and differentiation (Gacias et al., 2016). It is therefore tempting to 
speculate that the effects of GF conditions on myelination in BACHD mice 
may also reflect intrinsic changes in HD oligodendroglia and their response 
to similar microbiota-derived metabolites.  
Therefore, our results, and the sparse available literature, suggest that gut 
microbiota can regulate myelination of cortical and callosal axons, and can 
exert this influence to different extents in different brain regions, and which 
could also be modulated, in part, by the health status of the animal. 
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Additionally, it is possible that the intrinsic pathological characteristics of HD 
animal models confers these animals with a higher susceptibility to 
myelination alterations in response to certain environmental manipulations, 
such as microbiota manipulation, but not others, such as social isolation (see 
previous chapter). 
Myelin-related protein differences 
Both MBP and PLP are compact myelin proteins, and among the most 
abundant specific myelin-related proteins in the CNS (Boggs, 2006). Our 
findings showed a general decrease in both MBP and PLP expression levels, 
in WT GF animals compared SPF controls. Notably, MBP expression levels 
were significantly lower in the PFC of WT GF animals compared to SPF 
controls, and a similar non-significant trend of lower levels of PLP expression 
was also identified in WT GF mice compared to SPF controls. This finding is 
consistent with a reduction of mature oligodendrocytes identified in the PFC 
of WT GF animals compared to WT SPF, but at variance to a previous study 
that found increased MBP levels in the PFC of wild-type GF animals (Hoban 
et al., 2016b). Again, differences in mouse genetic background (FVB/N here 
vs Swiss Webster), or possibly the age of the animals (12 vs 10 weeks) may 
underpin differences in findings.  
Interestingly, BACHD GF animals also showed a non-significant trend 
towards lower levels of MBP and PLP in the prefrontal cortex, compared to 
BACHD SPF animals. However, it is important to note that our findings 
related to hypermyelination in the BACHD GF mouse described earlier were 
identified in the anterior corpus callosum, which limits an overarching 
interpretation of our myelin-related measures. As a result, we cannot exclude 
that a germ-free environment produced differential myelin-related effects on 
the CC and PFC of the BACHD mouse.  
Regulation of oligodendroglial (OLs) population by microbiota 
We further used several markers to identify oligodendrocytes at different 
stages of development in the CC and PFC of our experimental groups. We 
used the following markers to identify oligodendrocyte precursor cells 
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(PDGFRα+), oligodendrocyte lineage population (Olig2+), and mature 
myelinating oligodendrocytes (GST-pi+).  
The comparison between wild-type groups revealed comparable numbers of 
oligodendrocyte precursor cells (OPCs) in both brain regions investigated, 
however, a minor reduction in number of oligodendroglial lineage, and a 
significant reduction of mature oligodendrocytes cells in the PFC of WT mice 
reared in GF conditions compared to SPF controls was also observed. The 
comparison between BACHD groups revealed OPC numbers in the PFC 
region to be comparable, while Olig2+ cell numbers were similar in both the 
PFC and CC regions. In addition, similarly to WT groups, a reduction in 
mature oligodendrocytes was identified in the PFC of BACHD GF animals 
compared to SPF controls. Analysis of microbiota influence on 
oligodendrocytes populations in the CC region of the WT mouse showed 
similar, statistically non-significant, trends to that in the PFC, although some 
variance was observed in BACHD animals. These findings suggest that while 
OPC numbers may not be affected by a germ-free environment, a proportion 
of these in the PFC region of both WT and BACHD animals might lose their 
capacity to differentiate into mature oligodendrocytes when placed in a germ-
free environment. Past studies observed that the rate of OPC differentiation 
into oligodendrocytes was faster in the cortex than other white matter regions 
(Young et al., 2013), while myelination in this region was previously 
demonstrated to be highly plastic and malleable, particularly in response to 
environmental manipulation (Forbes & Gallo, 2017; Mount & Monje, 2017). 
These findings highlight the possibility that cortical oligodendroglia may be 
more vulnerable to germ-free environments than populations in other regions 
of the brain. Thus, gut microbiota may be indirectly involved in the regulation 
of oligodendroglial development (Nishiyama et al., 2009), particularly the 
maturation of oligodendrocytes, in a regionally dependent manner in the 
mouse brain. The mechanisms by which microbiota regulate oligodendroglial 
differentiation of adult mouse brain remains to be fully elucidated. 
Finally, the possible hypermyelination observed in the corpus callosum of 
BACHD mice under GF conditions was not underpinned by an increase in 
 220 
the number of mature oligodendrocytes, as we did not observed this increase 
in the CC region. Possibly other mechanisms, such as axonal-related factors 
or signaling, as discussed earlier, or an altered capacity for oligodendrocytes 
to myelinate, were the cause of this possible hypermyelination. This is 
supported by recent evidence suggesting that the extent of axonal 
myelination is independent of the number of newly formed and matured 
oligodendrocytes (Young et al., 2013).  
Differences in brain weight 
We only found brain weights to differ between WT and BACHD animals 
when comparing males only. Brain and forebrain weights were fairly similar 
between WT and BACHD animals when males and females were grouped 
together and compared, or when females only were compared. Others have 
previously shown decreased forebrain weights at 12, but not 6 months of 
age, in BACHD animals compared to WT controls (Gray et al., 2008). 
Interestingly, in our study, both WT and BACHD showed a reduction in 
overall brain weight when placed in a germ-free environment. We also found 
a decrease in total brain weight in both WT and BACHD GF male mice 
compared to their respective SPF controls, whereas female mice brain 
weight reductions were only statistically significant in the BACHD GF 
condition compared to female BACHD SPF, although a similar trend was 
observed in WT GF animals compared to WT SPF.  
GF animals are born through caesarian, and reared by adoptive mothers. As 
a result, early developmental influence of maternal rearing, which was seen 
to play a significant effect in brain weight (Henderson, 1973), could 
potentially lead to the differences we observed between our GF and SPF 
animals, across both genotypes. However, both environmental and genetic 
aspects have also been demonstrated to influence brain weight (Kruska, 
2005). Thus, while it is difficult to link our finding to a particular factor, our 
observation does suggest that a lack of microbiota can have significant 
effects on the rodent brain weight. 
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Differences in body weight 
The findings of our study revealed that BACHD animals had reduced body 
weights, comparable to that of WT animals, when placed in a germ-free 
environment. Under normal environmental conditions, BACHD mice have 
been reported to display significant increases in body weight compared to 
WT littermates (Hult et al., 2011; Pouladi, Morton, & Hayden, 2013b). 
Healthy mice also expressed exaggerated metabolic phenotypes of the 
BACHD model when mutant HTT was selectively expressed in the 
hypothalamus (Hult et al., 2011). In addition, inactivation of mutant HTT in 
1/4th of hypothalamic neurons in the BACHD mouse was sufficient to prevent 
the metabolic phenotype (Hult et al., 2011). Furthermore, gut microbiota was 
shown to be involved in the development of the HPA axis (Clarke et al., 
2013; Sudo et al., 2004). Gut microbiota was associated with the regulation 
of HPA via the endocrine pathway, which involves microbiota acting on 
peptides released by enteroendocrine cells (EEC), present in the gut 
epithelium, such as orexin, galanin and ghrelin (Merlino et al., 2014; Yi & 
Tschöp, 2012). Altered orexin receptor levels were shown in BACHD mice 
(Hult et al., 2013). Therefore, gut microbiota may alter hypothalamus-related 
mechanisms and pathways, and contribute to the overweight and obesity 
related phenotype seen in BACHD animals. However, it is important to note 
that the transcriptional profile of the healthy GF mouse showed almost no 
differential alteration in hypothalamus gene expression (Heijtz et al., 2011). 
Hence, it is possible that the presence of mutant HTT is a requirement for 
metabolism-related effects of gut microbiota.  
In addition, our study indicated a decrease in body weight of WT GF male 
mice, while female mice showed very similar weights to animals reared in 
SPF conditions. Initial studies looking at body weight in GF animals, reported 
GF to weigh less, or about the same as SPF despite consuming more food 
(Bäckhed et al., 2004). However, it was later found that differences in body 
weight were dependent on the type of dietary interventions (Fleissner, 2010).  
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6.5. Potential future work  
Taking into consideration recent findings on the oligodendroglial population 
capacity to myelinate during certain windows of time, assigning the animals 
to several periods of enrichment or deprivation, such as short-term, mid-term 
and long-term manipulations, could reveal transient changes that might have 
been missed by our long-term manipulation. Furthermore, and as described 
earlier, a potential reason for our lack of observation of wide-ranging 
behavioural changes to environmental manipulation may be due to our 
choice of a relatively slow onset mouse model of HD (i.e. YAC128), at an 
early-manifest stage of the disease. Therefore, a potential avenue for further 
investigation may be to extend the work presented here to more aggressive 
models of HD, such as the R6/1 and R6/2 mouse lines, or to use the 
YAC128 model at a later stage in the disease progression. In addition, from a 
less technical perspective, future work to help standardise environmental 
manipulation and behavioural test protocols would be invaluable to 
minimising inconsistencies in findings across studies further down the line. 
An immediate follow-up to our own microbiota manipulation study would be 
to determine the microbiome profiling of BACHD and wild-type animals, and 
identify any shifts in relative abundance of gut microbial taxa at phylum or 
genera levels. Identifying certain bacteria strains previously correlated to 
neurodegeneration, inflammation, or myelin related abnormalities could aid 
to the understanding of the gut-microbiota-brain communication, and the 
potential effects of commensal bacteria on the brain.  
Furthermore, to examine the interaction between gut microbiota and 
oligodendroglial population on an HD background, future studies could 
repeat our experiments in a germ-free setting using recently developed 
transgenic models that selectively express mutant huntingtin in 
oligodendrocytes (e.g. PLP-150Q). Another interesting avenue for potential 
research would be to first deplete existing host microbiota with antibiotics, 
followed by faecal transplant of microbiota from another host (HD affected 
mouse or human). These combined methods can be used to examine the 
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effects of certain strains of microbiota on the recipient host, and the impact of 
microbiota from a diseased donor to a healthy donor, or vice-versa.  
Considering Huntington disease is an autosomal-dominant disorder, it would 
be of interest to determine whether human carries of the mutant HTT gene 
show any major or minor shifts in gut commensal bacteria at a pre-, early- 
and late-manifest stage. Correlating bacterial genera to symptoms severity, 
could aid to the understanding of whether certain populations of bacteria in 
combination with a diseased carrier could exacerbate symptoms. Moreover, 
it is now well known that for HD, a greater disease onset variance was 
associated with lower CAG repeats, potentially due to a greater influence of 
genetic and environmental modifiers (Langbehn et al., 2004).  In addition, 
treatments using combinations of antibiotics can partially decrease the 
microbial population in the gut (Reikvam et al., 2011), and alter microbiota 
make-up and diversity (Bercik et al., 2011; Puhl et al., 2012). Thus, a 
longitudinal study following mutant HTT gene carriers could determine 
whether the use of antibiotics at different stages of life could also contribute 
to the variance in disease onset which cannot be explained by the number of 
CAG repeats. Finally, other techniques to examine the effect of 
environmental and microbiota manipulations on white matter changes in HD, 
such as diffusion tensor imaging, might also be valuable, and would have the 
added benefit of ‘bench-to bedside’ appeal, given that this technique can be 
conducted in pre-clinical models and validated in HD patients.  
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Appendix 
Appendix A. Solutions 
Paraformaldehyde (PFA) 
1L of 1xPBS was placed in a 65oC water bath for 20-30min. For tissue 
staining purposes, 4% PFA, 40g of PFA and 3 pieces of NaOH (to aid 
clarification) was added to 1L of PBS. Otherwise, for TEM purposes, 2.5% 
paraformaldehyde (PFA, see Appendix xxxx) and 2.5% glutaraldehyde 
(GlutAH), and 3 pieces of NaOH were added to 1L of PBS.  The solution was 
stirred for ~30min under a fume hood until solution temperature reached 
60oC. The solution was then placed on ice for 15 minutes, after which the pH 
is measured and adjusted to 7.4 using HCl. Finally, the PFA solution was 
filtered using a filter pump.  
Hydrochloric acid (HCl) 
Using a normality and molarity calculator, the stock solution of HCl was 
calculated to be 12.178 N based on a density of 1.2 g/mL, a formula weight 
of 36.46 g/mol, and a concentration of 37% w/w. Depending on the desired 
concentration (1N or 2N) the stock solution (8.212 mL for 1N, and 16.423 mL 
for 2N) was slowly added to 25 mL deionized water. The final volume of 
solution was adjusted to 100 mL with deionized water.  
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Appendix B. Western blots 
 
 
 
 
With reference to figure 5.11. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B A 
MBP 
18-20kDa 
Calnexin 
75kDa 
WT BACHD 
 272 
 
 
 
 
With reference to figure 5.12 
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“When it all goes quiet behind my eyes, I see everything that made me lying 
around in invisible pieces. When I look too hard, it goes away. And when it all 
goes quiet, I see they are right here. I see that I'm a little piece in a big, big 
universe. And that makes things right. When I die, the scientists of the future, 
they're gonna find it all.” - Hushpuppy, Beasts of the Southern Wild (Benh 
Zeitlin, 2012) 
       
 
 
